Teleflex (TFX) 10-K 20 Feb 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 13, 2015	Jun. 27, 2014
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Trading Symbol	TFX
Entity Registrant Name	TELEFLEX INC
Entity Central Index Key	96943
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	No
Entity Voluntary Filers	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		41,442,707
Entity Public Float			$3,447,755,823

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Net revenues	$1,839,832	$1,696,271	$1,551,009
Cost of goods sold	897,404	857,326	802,784
Gross profit	942,428	838,945	748,225
Selling, general and administrative expenses	578,657	502,187	454,489
Research and development expenses	61,040	65,045	56,278
Goodwill impairment	0	0	332,128
Restructuring and other impairment charges	17,869	38,452	3,037
Net gain on sales of businesses and assets	0	0	-332
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	284,862	233,261	-97,375
Interest expense	65,458	56,905	69,565
Interest income	-706	-624	-1,571
Loss on extinguishments of debt	0	1,250	0
Income (loss) from continuing operations before taxes	220,110	175,730	-165,369
Taxes on income (loss) from continuing operations	28,650	23,547	16,413
Income (loss) from continuing operations	191,460	152,183	-181,782
Operating loss from discontinued operations (including gain on disposal of $2,205 for 2012)	-3,407	-2,205	-9,207
Tax benefit on loss from discontinued operations	-698	-1,770	-1,887
Loss from discontinued operations	-2,709	-435	-7,320
Net income (loss)	188,751	151,748	-189,102
Less: Income from continuing operations attributable to noncontrolling interest	1,072	867	955
Net income (loss)	187,679	150,881	-190,057
Basic:
Income (loss) from continuing operations, basic (in dollars per share)	$4.60	$3.68	($4.47)
Loss from discontinued operations, basic (in dollars per share)	($0.06)	($0.01)	($0.18)
Net income (loss) (in dollars per share)	$4.54	$3.67	($4.65)
Diluted:
Income (loss) from continuing operations, diluted (in dollars per share)	$4.10	$3.46	($4.47)
Loss from discontinued operations, diluted (in dollars per share)	($0.06)	($0.01)	($0.18)
Net income (loss) (in dollars per share)	$4.04	$3.45	($4.65)
Dividends per share	$1.36	$1.36	$1.36
Weighted average common shares outstanding:
Basic (in shares)	41,366	41,105	40,859
Diluted (in shares)	46,470	43,693	40,859
Amounts attributable to common shareholders:
Income (loss) from continuing operations, net of tax	190,388	151,316	-182,737
Loss from discontinued operations, net of tax	-2,709	-435	-7,320
Net income (loss)	$187,679	$150,881	($190,057)

CONSOLIDATED_STATEMENTS_OF_INC1

CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Income Statement [Abstract]
Gain (loss) on disposal of discontinued operations	$0	[1]	$0	[1]	$2,205	[1]
[1]	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the Company's former cargo systems and cargo container businesses.

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net income (loss)	$188,751	$151,748	($189,102)
Foreign currency:
Foreign currency translation continuing operations adjustments, net of tax of $24,818, $(8,086) and $(1,210), respectively	-105,410	-9,637	13,071
Foreign currency translation, net of tax	-105,410	-9,637	13,071
Pension and other postretirement benefits plans:
Prior service cost recognized in net periodic cost, net of tax of $9, $9 and $8, respectively	-12	-12	-12
Transition obligation recognized in net periodic cost, net of tax of $(2) and $(35) in 2013 and 2012, respectively	0	3	62
Unamortized (loss) gain arising during the period, net of tax of $26,624, $(14,638) and $(2,399), respectively	-48,245	25,641	2,796
Net loss recognized in net periodic cost, net of tax of $(1,544), $(2,446) and $(2,537), respectively	2,841	4,765	4,621
Settlement, net of tax of $(40) in 2012	0	0	66
Curtailment, net of tax of $44 in 2012	0	0	-74
Foreign currency translation, net of tax of $(265), $(66) and $58, respectively	709	-177	-168
Pension and other postretirement benefits plans adjustment, net of tax	-44,707	30,220	7,291
Derivatives qualifying as hedges:
Unrealized gain (loss) on derivatives arising during the period, net of tax $(111), $(265) and $(102), respectively	594	-549	515
Reclassification adjustment on derivatives included in net income, net of tax of $111, $46 and $(3,832), respectively	-594	930	6,361
Derivatives qualifying as hedges, net of tax	0	381	6,876
Other comprehensive (loss) income, net of tax	-150,117	20,964	27,238
Comprehensive income (loss)	38,634	172,712	-161,864
Less: comprehensive income attributable to noncontrolling interest	995	638	888
Comprehensive income (loss) attributable to common shareholders	$37,639	$172,074	($162,752)

CONSOLIDATED_STATEMENTS_OF_COM1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax	$24,818	($8,086)	($1,210)
Prior service cost recognized in net periodic cost, tax	9	9	8
Transition obligation recognized in net periodic cost, tax		-2	-35
Unamortized (loss) gain arising during the period, tax	26,624	-14,638	-2,399
Net loss recognized in net periodic cost, tax	-1,544	-2,446	-2,537
Settlement, tax	0	0	-40
Curtailment, tax	0	0	44
Foreign currency translation, tax	265	66	-58
Unrealized gain (loss) on derivatives arising during the period, tax	-111	-265	-102
Reclassification adjustment on derivatives included in net income, tax	$111	$46	($3,832)

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$303,236	$431,984	$303,236	$431,984
Accounts receivable, net	273,704	295,290	273,704	295,290
Inventories, net	335,593	333,621	335,593	333,621
Prepaid expenses and other current assets	35,697	39,810	35,697	39,810
Prepaid taxes	40,256	36,504	40,256	36,504
Deferred tax assets	57,301	52,917	57,301	52,917
Assets held for sale	7,422	10,428	7,422	10,428
Total current assets	1,053,209	1,200,554	1,053,209	1,200,554
Property, plant and equipment, net	317,435	325,900	317,435	325,900
Goodwill	1,323,553	1,354,203	1,323,553	1,354,203
Intangibles assets, net	1,216,720	1,255,597	1,216,720	1,255,597
Investments in affiliates	1,150	1,715	1,150	1,715
Deferred tax assets	1,178	943	1,178	943
Other assets	64,010	70,095	64,010	70,095
Total assets	3,977,255	4,209,007	3,977,255	4,209,007
Debt, Current	368,401	356,287	368,401	356,287
Current liabilities
Accounts payable	64,100	71,967	64,100	71,967
Accrued expenses	72,383	74,868	72,383	74,868
Current portion of contingent consideration	11,276	4,131	11,276	4,131
Payroll and benefit-related liabilities	85,442	73,090	85,442	73,090
Accrued interest	9,169	8,725	9,169	8,725
Income taxes payable	13,768	23,821	13,768	23,821
Other current liabilities	10,360	22,231	10,360	22,231
Total current liabilities	634,899	635,120	634,899	635,120
Long-term borrowings	700,000	930,000	700,000	930,000
Deferred tax liabilities	451,541	514,715	451,541	514,715
Pension and postretirement benefit liabilities	167,241	109,498	167,241	109,498
Noncurrent liability for uncertain tax positions	50,884	55,152	50,884	55,152
Other liabilities	58,991	48,506	58,991	48,506
Total liabilities	2,063,556	2,292,991	2,063,556	2,292,991
Commitments and contingencies (See Note 15)
Common shareholders’ equity
Common shares, $1 par value Issued: 2014 — 43,420 shares; 2013 — 43,243 shares	43,420	43,243	43,420	43,243
Additional paid-in capital	422,394	409,338	422,394	409,338
Retained earnings	1,827,845	1,696,424	1,827,845	1,696,424
Accumulated other comprehensive loss	-260,895	-110,855	-260,895	-110,855
Shareholders equity before treasury stock, total	2,032,764	2,038,150	2,032,764	2,038,150
Less: Treasury stock, at cost	121,455	124,623	121,455	124,623
Total common shareholders’ equity	1,911,309	1,913,527	1,911,309	1,913,527
Noncontrolling interest	2,390	2,489	2,390	2,489
Total equity	1,913,699	1,916,016	1,913,699	1,916,016
Total liabilities and equity	3,977,255	4,209,007	3,977,255	4,209,007
Net revenues	$476,008	$450,539	$1,839,832	$1,696,271

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Common shares, par value	$1	$1
Common shares, shares Issued	43,420,000	43,243,000

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities of Continuing Operations:
Net income (loss)	$188,751	$151,748	($189,102)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss from discontinued operations	2,709	435	7,320
Depreciation expense	50,207	42,368	36,204
Amortization expense of intangible assets	60,926	50,608	44,264
Amortization expense of deferred financing costs and debt discount	15,897	14,959	14,416
Loss on extinguishments of debt	0	1,250	0
Changes in contingent consideration	-7,418	-12,642	263
Impairment of long-lived assets	0	3,460	0
Stock-based compensation	12,227	11,871	8,623
Net gain on sales of businesses and assets	0	0	-332
Goodwill impairment	0	0	332,128
Deferred income taxes, net	-14,153	-10,182	-39,980
Other	-8,968	-1,319	-3,776
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable	9,394	-1,294	-2,932
Inventories	-15,531	-8,931	-1,970
Prepaid expenses and other current assets	1,422	-5,926	9,595
Accounts payable and accrued expenses	9,818	2,001	155
Income taxes receivable and payable, net	-15,040	-7,107	-20,258
Net cash provided by operating activities from continuing operations	290,241	231,299	194,618
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment	-67,571	-63,580	-65,394
Payments for businesses and intangibles acquired, net of cash acquired	-45,777	-309,008	-369,444
Proceeds from sales of businesses and assets	5,251	0	66,660
Investments in affiliates	-40	-50	-80
Net cash used in investing activities from continuing operations	-108,137	-372,638	-368,258
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings	250,000	680,000	0
Repayment of long-term borrowings	-480,102	-375,000	0
Debt extinguishment, issuance and amendment fees	-4,494	-6,400	0
Decrease in notes payable and current borrowings	0	0	-706
Proceeds from share based compensation plans and the related tax impacts	4,245	6,181	8,238
Payments to noncontrolling shareholders	-1,094	-736	0
Payments for contingent consideration	0	-16,958	-17,596
Dividends	-56,258	-55,917	-55,589
Net cash (used in) provided by financing activities from continuing operations	-287,703	231,170	-65,653
Cash Flows from Discontinued Operations:
Net cash used in operating activities	-3,676	-3,327	-7,799
Net cash used in investing activities	0	0	-2,351
Net cash used in discontinued operations	-3,676	-3,327	-10,150
Effect of exchange rate changes on cash and cash equivalents	-19,473	8,441	2,394
Net (decrease) increase in cash and cash equivalents	-128,748	94,945	-247,049
Cash and cash equivalents at the beginning of the year	431,984	337,039	584,088
Cash and cash equivalents at the end of the year	303,236	431,984	337,039
Supplemental Cash Flow Information:
Cash interest paid	49,797	43,581	46,683
Income taxes paid, net of refunds	$52,869	$43,975	$74,908

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $)	Total	Common Stock	Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income (loss)	Treasury Stock	Noncontrolling Interest
In Thousands, unless otherwise specified
Beginning Balance at Dec. 31, 2011	$1,982,783	$42,923	$380,965	$1,847,106	($159,353)	($131,053)	$2,195
Beginning Balance (in shares) at Dec. 31, 2011		42,923				2,183
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	-189,102			-190,057			955
Cash dividends ($1.36 per share)	-55,589			-55,589
Other comprehensive income	27,238				27,305		-67
Distributions to noncontrolling interest shareholders	-496						-496
Shares issued under compensation plans (in shares)		179				49
Shares issued under compensation plans	16,597	179	13,429			2,989
Deferred compensation (in shares)						-4
Deferred compensation	106		-10			116
Ending Balance at Dec. 31, 2012	1,781,537	43,102	394,384	1,601,460	-132,048	-127,948	2,587
Ending Balance (in shares) at Dec. 31, 2012		43,102				2,130
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	151,748			150,881			867
Cash dividends ($1.36 per share)	-55,917			-55,917
Other comprehensive income	20,964				21,193		-229
Distributions to noncontrolling interest shareholders	-736						-736
Shares issued under compensation plans (in shares)		141				65
Shares issued under compensation plans	18,374	141	14,963			3,270
Deferred compensation (in shares)						-1
Deferred compensation	46		-9			55
Ending Balance at Dec. 31, 2013	1,916,016	43,243	409,338	1,696,424	-110,855	-124,623	2,489
Ending Balance (in shares) at Dec. 31, 2013		43,243				2,064
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	188,751			187,679			1,072
Cash dividends ($1.36 per share)	-56,258			-56,258
Other comprehensive income	-150,117				-150,040		-77
Distributions to noncontrolling interest shareholders	-1,094						-1,094
Settlement of convertible notes (in shares)						-1
Settlement of convertible notes	1		-42			43
Settlement of note hedges associated with convertible notes (in shares)						1
Settlement of note hedges associated with convertible notes	2		79			-77
Shares issued under compensation plans (in shares)		177				81
Shares issued under compensation plans	16,277	177	13,019			3,081
Deferred compensation (in shares)						-2
Deferred compensation	121					121
Ending Balance at Dec. 31, 2014	$1,913,699	$43,420	$422,394	$1,827,845	($260,895)	($121,455)	$2,390
Ending Balance (in shares) at Dec. 31, 2014		43,420				1,981

CONSOLIDATED_STATEMENTS_OF_CHA1

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Stockholders' Equity [Abstract]
Dividends per common share	$1.36	$1.36	$1.36

Summary_of_significant_account

Summary of significant accounting policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of significant accounting policies	Summary of significant accounting policies
	Consolidation: The consolidated financial statements include the accounts of Teleflex Incorporated and its subsidiaries (the “Company”). Intercompany transactions are eliminated in consolidation. Investments in affiliates over which the Company has significant influence but not a controlling equity interest, including variable interest entities where the Company is not the primary beneficiary, are accounted for using the equity method. Investments in affiliates over which the Company does not have significant influence are accounted for using the cost method of accounting. These consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and include management’s estimates and assumptions that affect the recorded amounts.
	Effective January 1, 2014, the Company realigned its operating segments to reflect changes in the Company's internal financial reporting structure. All prior comparative periods have been restated to reflect these changes. Refer to Note 16 to the consolidated financial statements for additional information on the Company's changed reporting structure.
	The Company’s share-based compensation plan permits employees to elect to have shares withheld by the Company to satisfy their minimum statutory tax withholding obligations arising from the exercise or vesting of share-based awards.  The Company then remits, in cash, the withholding taxes to the appropriate tax authorities on behalf of the employee.  For the year ended December 31, 2014, the Company classified such payments as a cash outflow from financing activities under the line item “Proceeds from share-based compensation plans and the related tax impacts” within the consolidated statement of cash flows (i.e., the payment by the Company of the withholding taxes offsets, in part, increases in cash flow from financing activities resulting from the proceeds of the exercise and vesting of share-based awards and tax benefits related to such exercise and vesting).  The Company views the activity as, in effect, a repurchase of the employee’s shares.  The Company's payments were previously reported as a cash outflow from operating activities; therefore, the Company reclassified the cash outflows of $2.7 million and $1.6 million from operating to financing activities for the years ended December 31, 2013 and 2012, respectively, to conform to the presentation for the year ended December 31, 2014 within the consolidated statement of cash flows and within the condensed consolidating statement of cash flows included in Note 17.
	Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and cash equivalents: All highly liquid debt instruments with an original maturity of three months or less are classified as cash equivalents. The carrying value of cash equivalents approximates their current market value.
	Accounts receivable: Accounts receivable represents amounts due from customers related to the sale of products and provision of services. An allowance for doubtful accounts is maintained and represents the Company’s estimate of the amount of uncollectible receivables. The allowance is provided at such time as management believes reasonable doubt exists that such balances will be collected within a reasonable period of time. The allowance is based on the Company’s historical experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. In addition, the Company maintains a reserve for returns and allowances based on its historical experience. See Note 9 to the consolidated financial statements for information on the Company’s concentration of credit risk.
	Inventories:  Inventories are valued at the lower of cost or market. The cost of the Company’s inventories is determined using the average cost method. Elements of cost in inventory include raw materials, direct labor, and manufacturing overhead. In estimating market value, the Company evaluates inventory for excess and obsolete quantities based on estimated usage and sales.
	Property, plant and equipment: Property, plant and equipment are stated at cost, net of accumulated depreciation. Costs incurred to develop internal-use computer software during the application development stage generally are capitalized. Costs of enhancements to internal-use computer software are capitalized, provided that these enhancements result in additional functionality. Other additions and those improvements which increase the capacity or lengthen the useful lives of the assets are also capitalized. With minor exceptions, composite useful lives for property, plant and equipment, which are depreciated on a straight-line basis are as follows: land improvements — 5 years; buildings — 30 years; machinery and equipment — 3 to 10 years; computer equipment and software — 3 to 10 years. Leasehold improvements are depreciated over the lesser of the useful lives of the leasehold improvements or the remaining lease periods. Repairs and maintenance costs are expensed as incurred.
	Goodwill and other intangible assets: Goodwill and other intangible assets with indefinite lives are not amortized but are tested for impairment annually during the fourth quarter or more frequently if events or changes in circumstances indicate that an impairment may exist. Impairment losses, if any, are included in income from operations. The goodwill impairment test is applied to each of the Company’s reporting units whose assets include goodwill. For purposes of this assessment, a reporting unit is an operating segment, or a business one level below that operating segment (also known as a component) if discrete financial information is prepared and regularly reviewed by segment management. However, separate components are aggregated as a single reporting unit if they have similar economic characteristics.
	In applying the goodwill impairment test, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors may include, but are not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, and entity specific factors such as strategies and financial performance. If, after completing such assessment, it is determined more likely than not that the fair value of a reporting unit is less than its carrying value, the Company proceeds to a two-step quantitative impairment test. Alternatively, the Company may proceed directly to testing goodwill for impairment through the two-step quantitative impairment test, described below, without conducting the qualitative analysis. In the fourth quarter of 2014, the Company performed a qualitative assessment on five of its reporting units whose assets include goodwill and determined, based on the assessment, that the fair value of each of the reporting units was more likely than not higher than its carrying value. For the three remaining reporting units whose assets include goodwill, the Company elected to forego the qualitative assessment and apply the two-step quantitative impairment test.
	The first step of the two-step impairment test is to quantitatively compare the fair value of a reporting unit, including goodwill, to its carrying value. In performing the first step, the Company calculates the fair value of the reporting unit using equal weighting of two methods; one which estimates the discounted cash flows of the reporting unit based on projected earnings in the future (the Income Approach) and one which is based on sales of similar businesses or assets to those of the reporting unit in actual transactions (the Market Approach). If the reporting unit fair value exceeds the carrying value, there is no impairment. If the reporting unit carrying value exceeds the fair value, the Company would perform the second step of the goodwill impairment test, in which the Company would recognize an impairment loss if the carrying value of goodwill exceeds its implied fair value. The implied fair value of goodwill is determined by deducting the fair value of a reporting unit's identifiable assets and liabilities from the fair value of the reporting unit as a whole, as if that reporting unit had just been acquired and the fair value of the individual assets acquired and liabilities assumed were being determined initially. The Company performed the quantitative goodwill impairment test during the fourth quarter of 2014, on three of its reporting units whose assets include goodwill, and determined that the fair value of each of the reporting units exceeded the carrying value.  As a result, no impairment in the carrying value of any of the Company’s reporting units was evident.
	The Company’s intangible assets consist of customer lists, intellectual property, distribution rights and trade names. The Company tests its indefinite-lived intangible assets for impairment annually, and more frequently if events or changes in circumstances indicate that an impairment may have occurred. Similar to the goodwill impairment test process, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If, after completing the qualitative assessment, the Company determines it is more likely than not that the fair value of the indefinite-lived intangible asset is greater than its carrying amount, the asset is not impaired. If the Company concludes it is more likely than not that the fair value of the indefinite-lived intangible assets is less than the carrying value, the Company then proceeds to a quantitative impairment test, which consists of a comparison of the fair value of the intangible assets to their carrying amounts. Alternatively, the Company may elect to forgo the qualitative analysis and proceed directly to testing the indefinite-lived intangible asset for impairment through the quantitative impairment test. In the fourth quarter of 2014, the Company performed a qualitative assessment on all of its indefinite lived assets, except for two trade names, and determined, based on its assessment, that their fair values were more likely than not higher than their carrying values. For the remaining two trade names, the Company elected to test impairment through the quantitative test and determined that the fair value of the trade names exceeded the respective carrying values. As a result, no impairment in the carrying value of any of the Company's intangible assets was evident. The Company recorded in process research and development (IPR&D) impairment charges of $7.4 million in 2013, following its decision to abandon certain IPR&D projects. See Note 4 to the consolidated financial statements for further information related to these charges.
	Intangible assets consisting of intellectual property, customer lists, distribution rights and trade names that do not have indefinite lives are being amortized over their estimated useful lives, which are as follows: intellectual property, 3 to 20 years; customer lists, 5 to 30 years; distribution rights, 3 to 22 years; trade names, 1 to 30 years. The weighted average amortization period is approximately 13 years. The Company periodically evaluates the reasonableness of the useful lives of these assets.
	Long-lived assets: The Company assesses the remaining useful life and recoverability of long-lived assets whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. The evaluation is based on various analyses, including undiscounted cash flow and profitability projections that incorporate, as applicable, the impact on the existing business.  Therefore, the evaluation involves significant management judgment. Any impairment loss, if indicated, is measured as the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset.
	Foreign currency translation: Assets and liabilities of subsidiaries with non-United States dollar denominated functional currencies are translated into United States dollars at the rates of exchange at the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the year. The translation adjustments are reported as a component of accumulated other comprehensive income.
	Derivative financial instruments: The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in foreign currency exchange rates. All instruments are entered into for other than trading purposes. All derivatives are recognized on the balance sheet at fair value. Changes in the fair value of derivatives are recorded in the consolidated statement of comprehensive income (loss) as other comprehensive income, based on whether the instrument is designated as part of a hedge transaction and, if so, the type of hedge transaction. Gains or losses on derivative instruments reported in other comprehensive income are reclassified to the consolidated statement of income (loss) in the period in which earnings are affected by the underlying hedged item. The ineffective portion of all hedges is recognized in the current period consolidated statement of income (loss). If the hedging relationship ceases to be highly effective or it becomes probable that an expected transaction will no longer occur, gains or losses on the derivative are recorded in the current period consolidated statement of income (loss).
	Share-based compensation: The Company estimates the fair value of share-based awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods. Share-based compensation expense related to stock options is measured using a Black-Scholes option pricing model that takes into account highly subjective and complex assumptions. The expected life of options granted is derived from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that options granted are expected to be outstanding. Expected volatility is based on a blend of historical volatility and implied volatility derived from publicly traded options to purchase the Company’s common stock, which the Company believes is more reflective of the market conditions and a better indicator of expected volatility than would be the case if the Company only used historical volatility. The risk-free interest rate is the implied yield currently available on United States Treasury zero-coupon issues with a remaining term equal to the expected life of the option.
	Share-based compensation expense recognized is based on the value of the portion of stock-based awards that is ultimately expected to vest during the period less estimated forfeitures. Forfeitures are required to be estimated at the time of grant. To minimize fluctuations in share-based compensation expense, management reviews and revises the estimate of forfeitures for all share-based awards on a quarterly basis based on management’s expectation of the awards that will ultimately vest.
	As previously noted, the Company modified the presentation of payments made by the Company to tax authorities for employee tax withholding obligations related to share-based compensation.
	Income taxes: The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized to reflect the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases, and to reflect operating loss and tax credit carryforwards. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Provision has been made for income taxes on unremitted earnings of subsidiaries and affiliates, except for subsidiaries in which earnings are deemed to be permanently reinvested.
	Significant judgment is required in determining income tax provisions and in evaluating tax positions. The Company establishes additional provisions for income taxes when, despite the belief that tax positions are supportable, there remain certain positions that do not meet the minimum probability threshold, which is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of its provision for income taxes. Interest accrued with respect to unrecognized tax benefits and income tax related penalties are both included in taxes on income from continuing operations. The Company periodically assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, the current tax liability and deferred taxes in the period in which the facts that give rise to an adjustment become known.
	Pensions and other postretirement benefits: The Company provides a range of benefits to eligible employees and retired employees, including pensions and postretirement healthcare. The Company records annual amounts relating to these plans based on calculations which include various actuarial assumptions such as discount rates, expected rates of return on plan assets, compensation increases, turnover rates and healthcare cost trend rates. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends when appropriate. The effect of the modifications is generally amortized over future periods.
	Restructuring costs: Restructuring costs, which include termination benefits, facility closure costs, contract termination costs and other restructuring costs are recorded at estimated fair value. Key assumptions in calculating the restructuring costs include the terms and payments that may be negotiated to terminate certain contractual obligations and the timing of reductions in force.
	Contingent consideration related to business acquisitions: In connection with business acquisitions, the Company may be required to pay future consideration that is contingent upon the achievement of specified objectives such as receipt of regulatory approval, commercialization of a product, achievement of sales targets, or the passage of time (collectively, "milestone payments"). As of the acquisition date, the Company records a contingent liability representing the estimated fair value of the contingent consideration that it expects to pay. The Company is required to reevaluate the fair value of contingent consideration each reporting period based on new developments and record changes in fair value until the contingent consideration obligation either is satisfied through payment upon the achievement of the specified objectives or is no longer payable due to the failure to achieve the specified objectives. The change in the fair value is recorded in the consolidated statement of income (loss). A contingent payment is classified as a financing activity in the consolidated statement of cash flows to the extent it was recorded as a liability as of the acquisition date. Any additional amount paid in excess of the amount initially accrued is classified as an operating activity in the consolidated statement of cash flows.
	Revenue recognition: The Company recognizes revenues from product sales, including sales to distributors, or services provided when the following revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectability is reasonably assured. This generally occurs when products are shipped, when services are rendered or upon customers’ acceptance. Revenues are net of estimated returns and other allowances including rebates.
	The Company’s normal policy is to accept returns only in cases in which the product is defective and covered under the Company’s standard warranty provisions. However, in the limited cases where an arrangement provides a right of return to the customer, including a distributor, the Company believes it has the ability to reasonably estimate the amount of returns based on its substantial historical experience with respect to these arrangements. The Company accrues any costs or losses that may be expected in connection with any returns in accordance with FASB Accounting Standards Codification (“ASC”) Topic 450, “Contingencies.” Revenues and cost of goods sold are reduced to reflect estimated returns. The reserve for returns and allowances was $4.1 million and $3.3 million as of December 31, 2014 and 2013, respectively.
	Allowances related to customer incentive programs, which include discounts or rebates, are estimated and provided for in the period that the related sales are recorded. These allowances are recorded as a reduction of revenue. The Company also offers rebates to certain distributors and records the estimated rebate as a reduction of revenue at the time of sale. In estimating rebates, the Company considers the lag time between the point of sale and the payment of the distributor’s rebate claim, distributor-specific trend analyses, contractual commitments, including stated rebate rates, historical experience with respect to specific customers and other relevant information. The Company adjusts estimated rebates based on actual experience and records the adjustment as a reduction of sales in the period of adjustment.  The estimated reserve for the customer incentive programs, including distributor rebates, was $10.4 million and $7.8 million at December 31, 2014 and 2013, respectively. The Company expects the estimated rebates as of December 31, 2014 to be paid within 90 days subsequent to year-end.

New_accounting_standards

New accounting standards	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
New accounting standards	New accounting standards
	Recently issued not yet effective
	In April 2014, the Financial Accounting Standards Board (FASB) issued guidance for the reporting of discontinued operations. Under the new guidance, only those disposals of components of an entity that represent a strategic shift that has or will have a major effect on an entity's operations and financial results will be reported as discontinued operations in an entity's financial statements. In addition, the new guidance requires additional disclosures for discontinued operations designed to provide users of financial statements with more information about the assets, liabilities, revenues and expenses of discontinued operations. The new guidance also requires disclosures regarding disposals of a significant component of an entity that does not qualify for discontinued operations reporting.This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014 with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s results of operations, cash flows or financial position.
	In May 2014, the FASB, in a joint effort with the International Accounting Standards Board, issued new accounting guidance to clarify the principles for recognizing revenue.  The new guidance is designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, and will affect any entity that enters into contracts with customers or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards.  The new guidance establishes principles for reporting information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity's contracts with customers.  The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new guidance is effective prospectively for annual periods beginning after December 15, 2016, and interim periods within those years.  Early application is not permitted. The Company is currently evaluating this guidance to determine the impact on the Company’s results of operations, cash flows, and financial position.
	From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has assessed these recently issued standards that are not yet effective and believes the new standards will not have a material impact on the Company’s results of operations, cash flows or financial position.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Acquisitions	Acquisitions
	The Company made the following acquisitions during 2014, which were accounted for as business combinations:
	•	On February 3, 2014, the Company acquired Mayo Healthcare Pty Limited, ("Mayo Healthcare"), a distributor of medical devices and supplies primarily in the Australian market.
	•	On December 2, 2014, the Company acquired the assets of Mini-Lap Technologies, Inc. ("Mini-Lap"), a developer of micro-laparoscopic instrumentation, which complements the Company's surgical product portfolio.
	The aggregate total fair value of consideration for the 2014 acquisitions is estimated at $66.3 million, which included initial payments of $46.3 million in cash and $20.5 million in estimated fair value of contingent consideration (see Note 10 for additional information), partially offset by $0.5 million in favorable working capital adjustments. Transaction expenses associated with the acquisitions, which are included in selling, general and administrative expenses in the consolidated statements of income (loss) were $0.5 million for the twelve months ended December 31, 2014. For the twelve month period ended December 31, 2014, the Company recorded revenue and operating profit of $27.2 million and $3.6 million, respectively, related to the businesses acquired in 2014. The results of operations and assets of the acquired businesses are included in the consolidated statements of income (loss) from their respective acquisition dates. Pro forma information is not presented as the operations of the acquired businesses are not significant to the overall operations of the Company.
	The following table presents the preliminary fair value determination of the assets acquired and liabilities assumed in the acquisitions that occurred during 2014:
		(Dollars in thousands)
	Assets
	Current assets	$	10,512
	Property, plant and equipment	344
	Intangible assets:
	Intellectual property	37,000
	Trade name	300
	Customer list	9,335
	Goodwill	16,392
	Total assets acquired	73,883
	Less:
	Current liabilities	4,769
	Deferred tax liabilities	2,800
	Liabilities assumed	7,569
	Net assets acquired	$	66,314
	The Company is continuing to evaluate the 2014 acquisitions. Further adjustments may be necessary as a result of the Company’s assessment of additional information related to the fair values of assets acquired and liabilities assumed, primarily related to deferred tax assets and liabilities and goodwill.
	Among the acquired assets, intellectual property and the trade name have useful lives of 15 years and the customer list has a useful life of 10 years. The goodwill resulting from the acquisitions primarily reflects the synergies expected to be realized from the integration of the acquired business. Goodwill and the step-up in basis of the intangible assets in connection with stock acquisitions are not deductible for tax purposes.
	The Company made the following acquisitions during 2013, which were accounted for as business combinations:
	•	On December 2, 2013, the Company acquired Vidacare Corporation, a provider of intraosseous, or inside the bone, access devices. This acquisition complements the Company's vascular access and specialty product portfolios.
	•	On June 11, 2013, the Company acquired the assets of Ultimate Medical Pty. Ltd. and its affiliates (“Ultimate”), a supplier of airway management devices with a related portfolio of patented products. This acquisition complements the Company's anesthesia product portfolio.
	•	On June 6, 2013, the Company acquired Eon Surgical, Ltd. (“Eon”), a developer of a minimally invasive microlaparoscopy surgical platform technology designed to enhance a surgeon’s ability to perform scarless surgery while producing better patient outcomes. This technology complements the Company's surgical product portfolio.
	The total fair value of consideration for the 2013 acquisitions was estimated at $307.0 million. The results of operations of the acquired businesses and assets are included in the consolidated statements of income (loss) from their respective acquisition dates. Pro forma information is not presented as the operations of the acquired businesses are not significant to the overall operations of the Company.

Restructuring_and_other_impair

Restructuring and other impairment charges	12 Months Ended
	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
Restructuring and other impairment charges	Restructuring and other impairment charges
	2014 Manufacturing Footprint Realignment Plan
	On April 28, 2014, the Board of Directors approved a restructuring plan (the “2014 Manufacturing Footprint Realignment Plan”) involving the consolidation of operations and a related reduction in workforce at certain of the Company’s facilities, and the relocation of manufacturing operations from certain higher-cost locations to existing lower-cost locations. These actions commenced in the quarter ended June 29, 2014 and are expected to be substantially completed by the end of 2017.
	The Company estimates that it will incur aggregate pre-tax charges in connection with the 2014 Manufacturing Footprint Realignment Plan of approximately $37 million to $44 million, of which an estimated $26 million to $31 million are expected to result in future cash outlays. Most of these charges are expected to be incurred prior to the end of 2016.
	The following table provides a summary of the Company’s current cost estimates by major type of expense associated with the 2014 Manufacturing Footprint Realignment Plan:
	Type of expense	Total estimated amount expected to be incurred
	Termination benefits	$11 million to $13 million
	Facility closure and other exit costs (1)	$2 million to $3 million
	Accelerated depreciation charges	$10 million to $11 million
	Other (2)	$14 million to $17 million
		$37 million to $44 million
	-1	Includes costs to transfer product lines among facilities and outplacement and employee relocation costs.
	-2	Consists of other costs directly related to the Plan, including project management, legal and regulatory costs.
	For the twelve months ended December 31, 2014, the Company recorded expenses of $14.2 million related to the 2014 Manufacturing Footprint Realignment Plan. Of this amount, $9.3 million related to termination benefits and was included in restructuring expense and $4.9 million related to accelerated depreciation and certain other costs resulting from the plan and was included in cost of goods sold. As of December 31, 2014, the Company had a restructuring reserve of $9.1 million in connection with this plan, all of which relates to termination benefits.
	As the 2014 Manufacturing Footprint Realignment Plan progresses, management will reevaluate the estimated expenses and charges set forth above, and may revise its estimates, as appropriate, consistent with generally accepted accounting principles.
	2014 European Restructuring Plan
	On February 27, 2014, the Company committed to a restructuring plan (the “2014 European Restructuring Plan”), which impacts certain administrative functions in Europe and involves the consolidation of operations and a related reduction in workforce at certain of the Company’s European facilities.
	The Company recorded charges of $7.8 million for the twelve months ended December 31, 2014 related to this program, primarily pertaining to termination benefits. The Company expects future restructuring expenses associated with the 2014 European Restructuring Plan, if any, to be nominal. As of December 31, 2014, the Company had a reserve of $0.4 million in connection with the 2014 European Restructuring Plan.  The Company expects to complete this plan in 2015.
	Other 2014 Restructuring Programs
	In June 2014, the Company initiated programs to consolidate locations in Australia and terminate certain European distributor agreements in an effort to reduce costs. As a result of these actions, the Company expects to incur an aggregate of approximately $4 million in restructuring and other impairment charges over the term of these programs, of which $3.6 million has been incurred through December 31, 2014. These programs include costs related to termination benefits, contract termination costs and other exit costs. As of December 31, 2014, the Company has a reserve of $0.9 million in connection with these programs. The Company expects to complete the programs in 2015.
	2013 Restructuring Charges
	In 2013, the Company initiated restructuring programs to consolidate administrative and manufacturing facilities in North America and warehouse facilities in Europe and terminate certain European distributor agreements in an effort to reduce costs. As a result of these actions, the Company estimates that it will incur an aggregate of approximately $11 to $12 million in restructuring and other impairment charges over the term of these programs, of which $11.0 million was incurred through December 31, 2014. These programs entail costs related to termination benefits, contract termination costs and post-closing obligations associated with acquired businesses. As of December 31, 2014, the Company had a reserve of $0.9 million in connection with these projects. The Company expects to complete the programs in 2015.
	LMA Restructuring Program
	In connection with the acquisition of substantially all of the assets of LMA International N.V. (the “LMA business”) in 2012, the Company commenced a program (the "LMA Restructuring Program") related to the integration of the LMA business and the Company’s other businesses. The program focuses on the closure of the LMA business's corporate functions and the consolidation of manufacturing, sales, marketing, and distribution functions in North America, Europe and Asia.
	A reconciliation of the changes in accrued liabilities associated with the LMA Restructuring Program from December 31, 2012 through December 31, 2014 is set forth in the following table:
		Termination			Facility Closure Costs			Contract			Other			Total
		benefits						Termination			Restructuring
								Costs			Costs
		(Dollars in thousands)
	Balance at December 31, 2012	$	1,744		$	—		$	277		$	12		$	2,033
	Subsequent accruals	3,282			788			7,906			176			12,152
	Cash payments	(4,461		)	(362		)	(4,560		)	(164		)	(9,547		)
	Foreign currency translation	(13		)	1			63			(8		)	43
	Balance at December 31, 2013	552			427			3,686			16			4,681
	Subsequent accruals (reversals)	(29		)	(112		)	(3,188		)	—			(3,329		)
	Cash payments	(503		)	(317		)	(260		)	(4		)	(1,084		)
	Foreign currency translation	(20		)	2			(26		)	—			(44		)
	Balance at December 31, 2014	$	—		$	—		$	212		$	12		$	224
	During the twelve months ended December 31, 2014, the Company reversed $3.2 million in contract termination costs due to the favorable settlement of a terminated distributor agreement.
	As of December 31, 2014, the Company incurred net aggregate restructuring and other impairment charges over the term of this program of $11.4 million. The Company expects future restructuring expenses associated with this program, if any, to be nominal. The Company expects to complete the program in 2015.
	2012 Restructuring Charges
	In 2012, the Company initiated a program to improve the effectiveness of its supply chain by consolidating its three North American warehouses into one centralized warehouse and to lower costs and improve operating efficiencies through the termination of certain distributor agreements in Europe, the closure of certain North American facilities, and workforce reductions. The Company has incurred an aggregate of approximately $6.3 million over the term of this program. The Company expects future restructuring expenses associated with this program, if any, to be nominal. As of December 31, 2014, the Company had a reserve of $0.6 million in connection with the program. The Company expects to complete this program in 2015.
	2011 Restructuring Program
	In 2011, the Company initiated a restructuring program at three facilities to consolidate operations and reduce costs. In connection with this program, the Company recorded contract termination costs of approximately $2.6 million associated with a lease termination, as the Company had vacated 50% of the premises during 2011. In addition, the Company recorded approximately $0.4 million for employee termination benefits in connection with workforce consolidations. In 2013, the Company recorded an additional $0.8 million in contract termination costs and has completely exited the leased facility. This program was completed in 2013.
	2007 Arrow Integration Program
	In connection with the Company’s acquisition of Arrow International, Inc. (“Arrow”) in 2007, the Company implemented a program in 2007 to integrate Arrow’s businesses into the Company’s other businesses. The aspects of this program that affected legacy Teleflex employees and facilities were charged to earnings and classified as restructuring and other impairment charges. A net credit of $1.9 million with respect to the program was recorded during the year ended December 31, 2012, primarily due to a settlement of a dispute involving the termination of a European distributor agreement that was established in connection with the Company's acquisition of Arrow. This program was completed in 2013.
	Impairment Charges
	The Company incurred the following asset impairment charges during the twelve months ended December 31, 2013. These asset impairments were measured at fair value using significant unobservable inputs that are categorized as Level 3 under the fair value hierarchy, which is described in Note 10 to the consolidated financial statements.
	•	During the fourth quarter 2013, the Company recorded a $2.9 million IPR&D charge following its decision to abandon a research and development project associated with the Company’s vascular business.
	•	During the third quarter 2013, the Company recorded $3.5 million in impairment charges related to assets held for sale that had a carrying value in excess of their appraised fair value.
	•	During the first quarter 2013, the Company recorded a $4.5 million IPR&D charge pertaining to a research and development project associated with the Company's acquisition of substantially all of the assets of Axiom Technology Partners LLC because technological feasibility had not yet been achieved and the Company determined that the subject technology had no future alternative use.
	There were no impairment charges recorded for the twelve months ended December 31, 2014 or 2012.
	The restructuring and other impairment charges recognized for the twelve months ended December 31, 2014, 2013 and 2012 consisted of the following:
		2014
	(in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs			Total
	2014 Manufacturing footprint realignment plan	$	9,200		$	—		$	—		$	60		$	9,260
	2014 European restructuring plan	7,237			1			345			225			7,808
	Other 2014 restructuring programs	552			—			2,754			244			3,550
	2013 Restructuring programs	562			—			249			22			833
	LMA restructuring program	(29		)	(112		)	(3,188		)	—			(3,329		)
	2012 Restructuring program	(619		)	354			—			—			(265		)
	2011 Restructuring program	—			12			—			—			12
	Total restructuring and other impairment charges	$	16,903		$	255		$	160		$	551		$	17,869
		2013
(in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs			Total
2013 Restructuring programs	4,787			—			3,326			2,117			10,230
LMA restructuring program	3,282			788			7,906			176			12,152
2012 Restructuring program	2,993			935			296			5			4,229
2011 Restructuring	—			42			728			—			770
2007 Arrow integration program	—			230			—			—			230
	11,062			1,995			12,256			2,298			27,611
Impairment charges	—			—			—			10,841			10,841
Total restructuring and other impairment charges	$	11,062		$	1,995		$	12,256		$	13,139		$	38,452
	2012
(in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs			Total
LMA restructuring program	$	2,229		$	—		$	274		$	12		2,515
2012 Restructuring program	1,681			—			758			20			2,459
2007 Arrow integration program	20			230			(2,166		)	(21		)	(1,937		)
Total restructuring and other impairment charges	$	3,930		$	230		$	(1,134	)	$	11		$	3,037
Termination benefits include employee retention payments and severance payments and benefits for terminated employees. Facility closure costs include general operating costs incurred subsequent to production shut-down as well as equipment relocation and other associated costs. Contract termination costs include costs associated with terminating existing leases and distributor agreements. Other costs include legal, outplacement and employee relocation costs and other employee-related costs.
Restructuring and other impairment charges by reportable segment for the twelve months ended December 31, 2014, 2013, and 2012 are set forth in the following table:
	2014			2013			2012
	(Dollars in thousands)
Restructuring and other impairment charges
Vascular North America	$	7,069		$	5,348		$	(1,120	)
Anesthesia/Respiratory North America	1,379			3,207			983
Surgical North America	—			6,525			278
EMEA	6,375			16,122			1,995
Asia	1,305			603			442
OEM	—			588			83
All other	1,741			6,059			376
Total restructuring and other impairment charges	$	17,869		$	38,452		$	3,037

Inventories

Inventories	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventories	Inventories
	Inventories at December 31, 2014 and 2013 consisted of the following:
		2014			2013
		(Dollars in thousands)
	Raw materials	$	68,191		$	70,209
	Work-in-process	58,526			53,672
	Finished goods	242,750			242,113
		369,467			365,994
	Less: Inventory reserves	(33,874		)	(32,373		)
	Inventories, net	$	335,593		$	333,621

Property_plant_and_equipment

Property, plant and equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, plant and equipment	Property, plant and equipment
	The major classes of property, plant and equipment, at cost, at December 31, 2014 and 2013 are as follows:
		2014			2013
		(Dollars in thousands)
	Land, buildings and leasehold improvements	$	194,923		$	199,741
	Machinery and equipment	320,999			322,060
	Computer equipment and software	107,743			102,527
	Construction in progress	51,834			55,092
		675,499			679,420
	Less: Accumulated depreciation	(358,064		)	(353,520		)
	Property, plant and equipment, net	$	317,435		$	325,900

Goodwill_and_other_intangible_

Goodwill and other intangible assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and other intangible assets	Goodwill and other intangible assets
	Changes in the carrying amount of goodwill, by reporting segment, for the twelve months ended December 31, 2014 and 2013 are as follows:
		Vascular North America			Anesthesia/Respiratory North America			Surgical North America			EMEA			Asia			All Other			Total
		(Dollars in thousands)
	Balance as of December 31, 2013
	Goodwill	$	459,696		$	167,195		$	250,506		$	373,417		$	136,946		$	298,571		$	1,686,331
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		240,169			60,122			250,506			373,417			136,946			293,043			1,354,203
	Goodwill related to acquisitions	—			—			406						15,986			—			$	16,392
	Translation adjustment	—			(681		)	—			(34,388		)	(8,220		)	(3,753		)	(47,042		)
	Balance as of December 31, 2014
	Goodwill	459,696			166,514			250,912			339,029			144,712			294,818			1,655,681
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		$	240,169		$	59,441		$	250,912		$	339,029		$	144,712		$	289,290		$	1,323,553
		Vascular North America			Anesthesia/Respiratory North America			Surgical North America			EMEA			Asia			All Other			Total
		(Dollars in thousands)
	Balance as of December 31, 2012
	Goodwill	$	407,090		$	167,942		$	245,794		$	353,282		$	139,469		$	257,003		1,570,580
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		187,563			60,869			245,794			353,282			139,469			251,475			1,238,452
	Goodwill related to acquisitions	52,606			—			4,712			17,922			6,394			41,650			123,284
	Translation adjustment	—			(747		)	—			2,213			(8,917		)	(82		)	(7,533		)
	Balance as of December 31, 2013
	Goodwill	459,696			167,195			250,506			373,417			136,946			298,571			1,686,331
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		$	240,169		$	60,122		$	250,506		$	373,417		$	136,946		$	293,043		$	1,354,203
	Intangible assets at December 31, 2014 and 2013 consisted of the following:
		Gross Carrying Amount						Accumulated Amortization
		2014			2013			2014			2013
		(Dollars in thousands)
	Customer lists	$	624,574		$	628,020		$	(192,876	)	$	(168,223	)
	In-process research and development	68,694			68,786			—			—
	Intellectual property	467,068			435,869			(146,131		)	(118,086		)
	Distribution rights	16,101			16,797			(14,243		)	(14,592		)
	Trade names	396,269			407,879			(2,764		)	(1,148		)
	Noncompete agreements	337			337			(309		)	(42		)
		$	1,573,043		$	1,557,688		$	(356,323	)	$	(302,091	)
	As of December 31, 2014, trade names of $359.3 million and all of the IPR&D are considered indefinite lived. Acquired in-process research and development is indefinite-lived until the completion of the associated efforts, at which point amortization of the carrying value of the technology will commence.
	In May 2012, the Company acquired Semprus BioSciences, a biomedical research and development company that developed a polymer surface treatment technology intended to reduce thrombus related complications. As previously disclosed, the Company experienced difficulties with respect to the development of the Semprus technology and was devoting further research and testing towards attempting to resolve the issue. As a result of these efforts, the Company believes it has resolved the issue and is focused on seeking regulatory approval and engaging in additional research and development efforts to achieve commercialization of this technology. Despite this progress, significant challenges to commercialization of the Semprus technology remain, and the Company ultimately may find it necessary to recognize future impairment charges with respect to the related assets, which could be material. As of December 31, 2014, the Company has recorded IPR&D intangible assets of approximately $41.0 million related to this investment which are recorded in intangible assets, net.
	Amortization expense related to intangible assets was $60.9 million, $50.6 million, and $44.3 million for the twelve months ended December 31, 2014, 2013 and 2012, respectively. Estimated annual amortization expense for each of the five succeeding years is as follows:
		(Dollars in thousands)
	2015	$	55,750
	2016	55,400
	2017	54,950
	2018	54,700
	2019	54,500

Borrowings

Borrowings	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Borrowings	Borrowings
	The Company's debt obligations at December 31, 2014 and 2013 are set forth in the following table:
		2014			2013
		(Dollars in thousands)
	Senior Credit Facility:
	Revolving credit facility, at a rate of 1.92% at December 31, 2014 and 2013, due July 16, 2018	$	200,000		$	680,000
	3.875% Convertible Senior Subordinated Notes due 2017	399,898			400,000
	6.875% Senior Subordinated Notes due 2019	250,000			250,000
	5.25% Senior Notes due 2024	250,000			—
	Securitization program, at a rate of 0.92% at December 31, 2014 and 2013	4,700			4,700
		1,104,598			1,334,700
	Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017	(36,197		)	(48,413		)
		1,068,401			1,286,287
	Current borrowings	(368,401		)	(356,287		)
	Long-term borrowings	$	700,000		$	930,000
	Senior Credit Facility
	On July 16, 2013, the Company replaced its $775 million senior credit facility comprised of a $375 million term loan and a $400 million revolving credit facility with a new $850 million senior credit facility consisting solely of a revolving credit facility. In connection with this transaction, the Company incurred transaction fees of $6.4 million, which were recorded as a deferred asset and are being amortized over the term of the facility. Additionally, during the third quarter 2013, in connection with the early repayment of its $375 million term loan, the Company recognized expense of approximately $1.3 million resulting from the write-off of unamortized debt issuance costs. The Company borrowed $382.0 million at the inception of the new $850 million senior credit facility and an additional $298.0 million under the senior credit facility to fund the purchase of the Vidacare business. In 2014, the Company used $245 million of the proceeds from the issuance of the 5.25% Senior Notes due 2024 (the “2024 Notes”) to repay borrowings under its revolving credit facility. See Note 3 to the consolidated financial statements.
	The new $850 million senior credit facility bears interest at an applicable rate elected by the Company generally equal to either the “base rate” (the greater of either the federal funds effective rate plus 0.5%, the prime rate or one month LIBOR plus 1.0%) plus an applicable margin of 0.25% to 1.00%, or a “LIBOR rate” for the period corresponding to the applicable interest period of the borrowings plus an applicable margin of 1.25% to 2.00%. As of December 31, 2014, the interest rate on the $850 million senior credit facility was 1.92% (comprised of the LIBOR rate of 0.17% plus a margin of 1.75%). The obligations under the senior credit facility are guaranteed (subject to certain exceptions) by substantially all of the material domestic subsidiaries of the Company and (subject to certain exceptions and limitations) secured by a pledge on substantially all of the equity interests owned by the Company and each guarantor.
	As of December 31, 2014, the Company had outstanding irrevocable standby letters of credit of approximately $6.0 million with various third parties. The letters of credit, which expire in 2015, reduce the amount of available funds under our revolving credit facility by an equal amount.
	Convertible Notes
	On August 9, 2010, the Company issued $400.0 million of its 3.875% Convertible Senior Subordinated Notes due 2017 (the “Convertible Notes”). The Company pays interest on the Convertible Notes semi-annually on February 1 and August 1 of each year at a rate of 3.875% per year. The Convertible Notes mature on August 1, 2017. The Convertible Notes are the Company’s unsecured senior subordinated obligations and are (i) not guaranteed by any of the Company’s subsidiaries; (ii) subordinated in right of payment to all of the Company’s existing and future senior indebtedness; and (iii) junior to the Company’s existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.
	The Convertible Notes are convertible at the option of the holder upon the occurrence of any of the following circumstances (i) during any fiscal quarter, if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter exceeds 130% of the conversion price on each applicable trading day; or (ii) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Notes is less than 98% of the product of the last reported sale price of the common stock and the applicable conversion rate on each trading day during the measurement period; or (iii) upon the occurrence of specified corporate events; or (iv) at any time on or after May 1, 2017 up to and including July 28, 2017. The Convertible Notes are convertible at a conversion rate of 16.3084 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to a conversion price of approximately $61.32. The conversion rate is subject to adjustment upon certain events. Upon conversion, the Company’s conversion obligation may be satisfied, at the Company’s option, in shares of common stock, cash or a combination of cash and shares of common stock. The Company has elected a net-settlement method to satisfy its conversion obligation. Under the net-settlement method, the Company will settle the $1,000 principal amount of the Convertible Notes in cash and settle the excess conversion value in shares, plus cash in lieu of fractional shares.
	Since the fourth quarter 2013, the Company's last reported sale price has exceeded the 130% threshold described above and accordingly the Convertible Notes have been classified as a current liability as of December 31, 2014 and 2013. The determination of whether or not the Convertible Notes are convertible as described above is made each quarter until maturity, conversion or repurchase.  Consequently, it is possible that the Convertible Notes may not be convertible in one or more future quarters, in which case the Convertible Notes would again be classified as long-term debt, unless one of the other conversion contingencies described above were to be satisfied. While the Company believes it has sufficient liquidity to repay the principal amount due through a combination of utilizing its existing cash on hand and accessing its credit facility, the Company's use of these funds could adversely affect its results of operations and liquidity.
	In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions with two counterparties pursuant to which it purchased call options for $88.0 million ($56.0 million net of tax) in private transactions. The call options enable the Company to receive, in effect for no additional consideration, shares of the Company’s common stock and/or cash from counterparties equal to the amounts of common stock and/or cash related to the excess value over the conversion price that it would pay to the holders of the Convertible Notes upon conversion. These call options will terminate upon the earlier of July 28, 2017 or the first day all of the related Convertible Notes are no longer outstanding due to conversion or otherwise.
	The Company also entered into privately negotiated warrant transactions with the same counterparties generally relating to the same number of shares of common stock with each of the option counterparties. Under certain circumstances, the Company may be required under the terms of the warrant transactions to issue up to 7,981,422 shares of common stock (subject to adjustments). The warrants have been divided into components that expire ratably over a 180 day period commencing November 1, 2017. The strike price of the warrants is approximately $74.65 per share of common stock, subject to customary anti-dilution adjustments. Proceeds received from the issuance of the warrants totaled approximately $59.4 million.
	The convertible note hedge and warrant transactions described above are intended to reduce the potential dilution with respect to the Company’s common stock and/or reduce the Company’s exposure to potential cash payments that the Company may be required to make upon conversion of the Convertible Notes by, in effect, increasing the conversion price, from the Company’s economic standpoint, to $74.65 per share. However, the warrant transactions could have a dilutive effect with respect to the common stock or, if the Company so elects, obligate the Company to make cash payments to the extent that the market price per share of common stock exceeds $74.65 per share on any expiration date of the warrants.
	The Company allocated the proceeds of the Convertible Notes between the liability and equity components of the debt. The initial $316.3 million liability component was determined based on the fair value of a similar debt instrument excluding the conversion feature. The initial $83.7 million ($53.3 million net of tax) equity component represented the difference between the fair value or carrying value of $316.3 million of the debt and the $400.0 million of proceeds. The related debt discount of $83.7 million is being amortized under the interest method over the remaining life of the Convertible Notes, which, at December 31, 2014, is approximately 2.6 years. An effective interest rate of 7.814% was used to calculate the debt discount on the Convertible Notes. The following table provides interest expense amounts related to the Convertible Notes for the periods presented:
	(in millions)	Year Ended December 31, 2014			Year Ended December 31, 2013			Year Ended December 31, 2012
	Interest cost related to contractual interest coupon	$	15.5		$	15.5		$	15.5
	Interest cost related to amortization of the discount	$	12.2		$	11.3		$	10.5
	The following table provides the carrying value of the Convertible Notes as of December 31, 2014 and 2013:
	(in millions)	31-Dec-14			31-Dec-13
	Principal amount of the Convertible Notes	$	399.9		$	400
	Unamortized discount	(36.2		)	(48.4		)
	Net carrying amount	$	363.7		$	351.6
	6.875% Senior Subordinated Notes
	On June 13, 2011, the Company issued $250.0 million of 6.875% Senior Subordinated Notes due 2019 (the “2019 Notes”). The Company pays interest on the 2019 Notes semi-annually on June 1 and December 1. The 2019 Notes will mature on June 1, 2019, unless earlier redeemed by the Company at its option, as described below, or purchased by the Company at the holder’s option under specified circumstances following a Change of Control or Asset Sale (each as defined in the indenture relating to the 2019 Notes).
	The 2019 Notes constitute the Company’s general unsecured senior subordinated obligations and are subordinated in right of payment to all of the Company’s existing and future senior indebtedness, including the Company’s indebtedness under its senior credit facilities, and are equal in right of payment with all of the Company’s existing and future senior subordinated indebtedness, including the Company’s Convertible Notes. The obligations under the 2019 Notes are guaranteed, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is a guarantor or other obligor under the Company’s senior credit facilities and by certain of the Company’s other domestic subsidiaries. The guarantees are full and unconditional, subject to certain customary automatic release provisions. The guarantees of the 2019 Notes are subordinated in right of payment to all of the existing and future senior indebtedness of such Guarantors and are equal in right of payment with all of the future senior subordinated indebtedness of such Guarantors. The 2019 Notes and the guarantees are junior to the existing and future secured indebtedness of the Company and the Guarantors to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all of the existing and future indebtedness and other liabilities of the Company’s non-guarantor subsidiaries.
	At any time on or after June 1, 2015, the Company may redeem some or all of the 2019 Notes at a redemption price of 103.438% of the principal amount of the 2019 Notes subject to redemption, declining, in annual increments of 1.719%%, to 100% of the principal amount on June 1, 2017, plus accrued and unpaid interest. In addition, at any time prior to June 1, 2015, the Company may, on one or more occasions, redeem some or all of the 2019 Notes at a redemption price equal to 100% of the principal amount of the 2019 Notes redeemed plus a “make-whole” premium and any accrued and unpaid interest. The “make-whole” premium is the greater of (i) 1.0% of the principal amount of the 2019 Notes subject to redemption or (ii) the excess, if any, over the principal amount of the 2019 Notes of the present value, on the redemption date, of the sum of (a) the June 1, 2015 optional redemption price, plus (b) all required interest payments on the 2019 Notes through June 1, 2015 (other than accrued and unpaid interest to the redemption date), calculated based on a specified Treasury rate for the period most closely corresponding to the period from the redemption date to June 1, 2015, plus 50 basis points.
	The 2019 Notes contain covenants that, among other things, limit or restrict the Company’s ability, and the ability of its subsidiaries, to incur debt, create liens, consolidate, merge or dispose of certain assets, make certain investments, engage in acquisitions, and pay dividends on, repurchase or make distributions in respect of capital stock.
	5.25% Senior Notes
	On May 21, 2014, the Company issued $250 million of its 2024 Notes. The Company pays interest on the 2024 Notes semi-annually on June 15 and December 15, at a rate of 5.25% per year. The 2024 Notes will mature on June 15, 2024, unless earlier redeemed by the Company at its option, as described below, or purchased by the Company at the holder’s option under specified circumstances following a Change of Control or Asset Sale (each as defined in the indenture related to the 2024 Notes). The Company incurred transaction fees of approximately $4.5 million, including underwriters’ discounts and commissions, in connection with the offering of the 2024 Notes, which were recorded as a deferred asset and are being amortized over the term of the 2024 Notes. As previously mentioned, the Company used $245.0 million of the proceeds to repay borrowings under its revolving credit facility.
	The Company's obligations under the 2024 Notes are fully and unconditionally guaranteed, jointly and severally, by each of the Company’s existing and future 100% owned domestic subsidiaries that is a guarantor or other obligor under the Company’s revolving credit facility and by certain of the Company’s other 100% owned domestic subsidiaries. The guarantees are subject to certain customary automatic release provisions.
	At any time on or after June 15, 2019, the Company may, on one or more occasions, redeem some or all of the 2024 Notes at a redemption price of 102.625% of the principal amount of the 2024 Notes subject to redemption, declining, in annual increments of 0.875%, to 100% of the principal amount on June 15, 2022, plus accrued and unpaid interest.  In addition, at any time prior to June 15, 2019, the Company may, on one or more occasions, redeem some or all of the 2024 Notes at a redemption price equal to 100% of the principal amount of the 2024 Notes redeemed, plus a “make-whole” premium and any accrued and unpaid interest.  The “make-whole” premium is the greater of (a) 1.0% of the principal amount of the 2024 Notes subject to redemption or (b) the excess, if any, over the principal amount of the 2024 Notes of the present value, on the redemption date, of the sum of (i) the June 15, 2019 optional redemption price  plus (ii) all required interest payments on the 2024 Notes through June 15, 2019 (other than accrued and unpaid interest to the redemption date), calculated based on a specified Treasury rate, generally for the period most nearly equal to the period from the redemption date to June 15, 2019, plus 50 basis points.
	In addition, at any time prior to June 15, 2017, the Company may, on one or more occasions, redeem up to 35% of the aggregate principal amount of the 2024 Notes, using the proceeds of specified types of Company equity offerings and subject to specified conditions, at a redemption price equal to 105.25% of the principal amount of the Notes redeemed, plus accrued and unpaid interest.
	The indenture relating to the 2024 Notes contains covenants that, among other things, limit or restrict the Company’s ability, and the ability of its subsidiaries, to incur debt, create liens, consolidate, merge or dispose of certain assets, make certain investments, engage in acquisitions, and pay dividends on, repurchase or make distributions in respect of capital stock.
	Securitization Program
	The Company has an accounts receivable securitization facility under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of Teleflex. Accordingly, the assets of the SPE are not available to satisfy the obligations of Teleflex or any of its subsidiaries. The SPE sells undivided interests in those receivables to an asset backed commercial paper conduit for consideration of up to $50.0 million. As of December 31, 2014, the maximum amount available for borrowing under this facility was $45.3 million. This facility is utilized from time to time for increased flexibility in funding short term working capital requirements. The agreement governing the accounts receivable securitization facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this facility may give rise to the right of its counterparty to terminate this facility. As of December 31, 2014 and 2013, the Company had $4.7 million of outstanding borrowings under its accounts receivable securitization facility.
	Fair Value of Long-Term Debt
	The carrying amount of long-term debt reported in the consolidated balance sheet as of December 31, 2014 is $1,068.4 million. The Company uses a discounted cash flow technique that incorporates a market interest yield curve with adjustments for duration, optionality, and risk profile to determine the fair value of its debt. The Company’s implied credit rating is a factor in determining the market interest yield curve. The following table provides the fair value of the Company’s debt by fair value hierarchy level (see Note 10 to the consolidated financial statements for further information) as of December 31, 2014 and 2013:
		Fair value of debt
		31-Dec-14			31-Dec-13
		(Dollars in thousands)
	Level 1	$	1,024,806		$	899,390
	Level 2	455,222			648,712
	Total	$	1,480,028		$	1,548,102
	Debt Maturities
	As of December 31, 2014, the aggregate amounts of long-term debt, demand loans and debt under the Company’s securitization program that will mature during each of the next four fiscal years and thereafter were as follows:
		(Dollars in thousands)
	2015(1)	$	404,598
	2016	—
	2017	—
	2018	200,000
	2019 and thereafter	500,000
-1	The Convertible Notes are included in amounts that will mature in 2015 because, at December 31, 2014, they were convertible in accordance with their terms, which are described in more detail above in this section under “Convertible Notes.”

Financial_instruments

Financial instruments	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments	Financial instruments
	The Company uses derivative instruments for risk management purposes. Foreign currency forward contracts are used to manage foreign currency transaction exposure. These derivative instruments are designated as cash flow hedges and are recorded on the balance sheet at fair market value. The effective portion of the gains or losses on derivatives is reported as a component of other comprehensive income and thereafter is recognized in the consolidated statement of income (loss) in the period or periods during which the hedged transaction affects earnings. Gains and losses on the derivatives representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in the consolidated statement of income (loss) in the period in which such gains and losses occur. As of December 31, 2014 and 2013, the Company had no open foreign currency forward contracts.
	The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (“OCI”) for the years ended December 31, 2014, 2013 and 2012:
		After Tax Gain/(Loss)
		Recognized in OCI
		2014			2013			2012
		(Dollars in thousands)
	Interest rate swap	$	—		$	—		$	7,032
	Foreign currency exchange contracts	—			381			(156		)
	Total	$	—		$	381		$	6,876
	See Note 11 to the consolidated financial statements for information on the location and amount of gains and losses attributable to derivatives that were reclassified from accumulated other comprehensive income (“AOCI”) to expense (income), net of tax.
	For the years ended December 31, 2014, 2013 and 2012, there was no ineffectiveness related to the Company’s derivatives.
	During 2012, the Company entered into forward exchange contracts for Singapore dollars and U.S. dollars in anticipation of its acquisition of the LMA business. In accordance with applicable accounting guidance, a forecasted transaction is not eligible for hedge accounting if the forecasted transaction involves a business combination. Therefore, gains and losses relating to this arrangement were recognized as incurred. The Company realized a pre-tax loss of $7.6 million upon settlement of the forward exchange contracts in 2012.
	In 2011, the Company terminated its interest rate swap covering a notional amount of $350 million designated as a hedge against the variability of the cash flows in the interest payments under the Company's previously outstanding term loan. During 2012, all remaining losses associated with this interest rate swap were reclassified from AOCI to the consolidated statement of income.
	Concentration of Credit Risk
	Concentration of credit risk with respect to trade accounts receivable is generally limited due to the Company’s large number of customers and their diversity across many geographic areas. A portion of the Company’s trade accounts receivable outside the United States, however, include sales to government-owned or supported healthcare systems in several countries which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries’ economies.
	In the ordinary course of business, the Company grants non-interest bearing trade credit to customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all of its customer relationships, (ii) performs ongoing credit evaluations of its customers’ financial condition, (iii) monitors the payment history and aging of its customers’ receivables, and (iv) monitors open orders against an individual customer’s outstanding receivable balance.
	An allowance for doubtful accounts is maintained for accounts receivable based on the Company’s historical collection experience and expected collectability of the accounts receivable, considering the period an account is outstanding, the financial position of the customer and information provided by credit rating services. The adequacy of this allowance is reviewed each reporting period and adjusted as necessary. The allowance for doubtful accounts was $8.8 million and $10.7 million at December 31, 2014 and 2013, respectively. The current portion of the allowance for doubtful accounts at December 31, 2014 and 2013 of $2.4 million and $5.2 million, respectively, is presented as part of accounts receivable, net. The allowance for doubtful accounts on receivables outstanding for greater than one year at December 31, 2014 and 2013 of $6.4 million and $5.5 million, respectively, is presented as part of other assets.
	In light of the disruptions in global economic markets, the Company instituted enhanced measures, within countries for which the Company has collectability concerns, to facilitate customer-by-customer risk assessment when estimating the allowance for doubtful accounts. Such measures included, among others, monthly credit control committee meetings, at which customer credit risks are identified after review of, among other things, accounts that exceed specified credit limits, payment delinquencies and other customer issues. In addition, with respect to certain of the Company’s non-government customers, the Company instituted measures designed to reduce its risk exposures, including issuing dunning letters, reducing credit limits, requiring that payments accompany orders and instituting legal action with respect to delinquent accounts. With respect to government customers, the Company evaluates receivables for potential collection risks associated with any limitations on the availability of government funding and reimbursement practices.
	Certain of the Company’s customers, particularly in Europe, have extended or delayed payments for products and services already provided, resulting in potential collectability concerns regarding the Company's accounts receivable from these customers, for the most part in Greece, Italy, Spain and Portugal. If the financial condition of these customers or the healthcare systems in these countries deteriorate to the extent that the ability of an increasing number of customers to make payments is uncertain, additional allowances may be required in future periods. The aggregate net current and long-term accounts receivable for customers in Spain, Italy, Greece and Portugal and the percentage of the Company’s total net current and long-term accounts receivable represented by the net current and long-term accounts receivables for customers in those countries at December 31, 2014 and 2013 are as follows:
		31-Dec-14			31-Dec-13
		(Dollars in thousands)
	Current and long-term accounts receivable (net of allowances of $8.1 million and $7.9 million in 2014 and 2013, respectively) in Spain, Italy, Greece and Portugal (1)	$	76,190		$	97,852
	Percentage of total net current and long-term accounts receivables	27.3		%	31		%
	(1)    The long-term portion of accounts receivable, net from customers in Spain, Italy, Greece and Portugal at December 31, 2014 and 2013 was $11.3 million and $17.6 million, respectively, and is reported in other assets.
	For the years ended December 31, 2014, 2013 and 2012, net revenues from customers in Spain, Italy, Greece and Portugal were $150.5 million, $142.6 million and $132.5 million, respectively.

Fair_value_measurement

Fair value measurement	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair value measurement	Fair value measurement
	Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The FASB's fair value guidance establishes a three-level hierarchy of the inputs (i.e., assumptions that market participants would use in pricing an asset or liability) used to measure fair value, which is designed to maximize the use of observable inputs and minimize the use of unobservable inputs in measuring fair value. The levels within the hierarchy are as follows:
	Level 1 inputs — quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
	Level 2 inputs — inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 2 inputs include:
	1	Quoted prices for similar assets or liabilities in active markets.
	2	Quoted prices for identical or similar assets or liabilities in markets that are not active.
	3	Inputs other than quoted prices that are observable for the asset or liability.
	4	Inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	Level 3 inputs — unobservable inputs for the asset or liability. Unobservable inputs may be used to measure fair value only when observable inputs are not available. Unobservable inputs reflect the Company’s views about the assumptions market participants would use in pricing the asset or liability in achieving the fair value measurement objective of an exit price perspective. An exit price is the price that would be received to sell an asset or paid to transfer a liability.
	The following tables provide information regarding the financial assets and liabilities reported at fair value and measured on a recurring basis as of December 31, 2014 and 2013:
		Total carrying			Quoted prices in			Significant		Significant
		value at			active markets			other		unobservable
		December 31,			(Level 1)			observable		inputs (Level 3)
		2014						inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	6,863		$	6,863		$	—	$	—
	Contingent consideration liabilities	33,433			—			—		33,433
		Total carrying			Quoted prices in			Significant		Significant
		value at			active markets			other		unobservable
		December 31,			(Level 1)			observable		inputs (Level 3)
		2013						inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	6,150		$	6,150		$	—	$	—
	Contingent consideration liabilities	20,313			—			—		20,313
	There were no transfers of financial assets or liabilities carried at fair value among Level 1, Level 2 or Level 3 inputs within the valuation hierarchy during the twelve months ended December 31, 2014 or 2013.
	The following table provides information regarding changes in financial liabilities, the fair value of which is based on Level 3 inputs, related to contingent consideration in connection with various Company acquisitions, including those described in Note 3 to the consolidated financial statements, during the twelve months ended December 31, 2014 and 2013:
		Contingent consideration
		2014			2013
		(Dollars in thousands)
	Beginning balance – January 1	$	20,313		$	51,196
	Initial estimate upon acquisition	20,538			—
	Payment	—			(18,880		)
	Revaluations	(7,418		)	(11,982		)
	Translation adjustment	—			(21		)
	Ending balance – December 31	$	33,433		$	20,313
	The Company reduced contingent consideration liabilities and selling, general and administrative expense by $8.2 million and $12.3 million for the years ended December 31, 2014 and 2013, respectively. These reductions were the result of changes in the estimated probability that specified objectives on which the contingent consideration is conditioned will be achieved.
	See Note 8 to the consolidated financial statements  for a discussion of the fair value of the Company’s long-term debt.
	Valuation Techniques Used to Determine Fair Value
	The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to satisfy benefit obligations under Company benefit plans and other arrangements. The investment assets of the trust are valued using quoted market prices.
	The Company’s financial assets and liabilities valued based upon Level 2 inputs are comprised of foreign currency forward contracts. The Company uses foreign currency forward contracts to manage currency transaction exposure. The fair value of the foreign currency forward contracts represents the amount required to enter into offsetting contracts with similar remaining maturities based on quoted market prices. The Company has taken into account the creditworthiness of the counterparties in measuring fair value. As of December 31, 2014 and 2013, there are no open forward contracts. See Note 9 to the consolidated financial statements for additional information.
	The Company’s financial liabilities valued based upon Level 3 inputs are contingent consideration arrangements pertaining to the Company’s acquisitions. The Company estimates that contingent consideration payments will occur in 2015 and extend until 2029. As of December 31, 2014, the range of undiscounted amounts the Company could be required to pay under contingent consideration arrangements is between $15.0 million and $83.0 million. The Company determines the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market, which therefore constitute Level 3 inputs within the valuation hierarchy. The fair value of the contingent consideration liability associated with possible future payments of contingent consideration is based on several factors including:
	•	estimated cash flows projected from the success of market launches;
	•	the estimated time and resources needed to complete the development of acquired technologies;
	•	the uncertainty of obtaining regulatory approvals within the required time periods; and
	•	the risk adjusted discount rate for fair value measurement.
	The following table provides information regarding the valuation techniques and inputs used in determining the fair value of the contingent consideration liabilities measured by Level 3 inputs:
		Valuation Technique		Unobservable Input	Range (Weighted Average)
	Contingent consideration	Discounted cash flow		Discount rate	2.3% - 10% (7.0%)
				Probability of payment	0% - 100% (52.6%)
	As of December 31, 2014, the Company recorded $33.4 million of total liabilities for contingent consideration, of which $11.3 million and $22.1 million were recorded as the current portion of contingent consideration and Other liabilities, respectively, in the consolidated balance sheet.

Shareholders_equity

Shareholders' equity	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Shareholders' equity	Shareholders' equity
	The authorized capital of the Company is comprised of 200 million common shares, $1 par value, and 500,000 preference shares. No preference shares have been outstanding during the last four years.
	In 2007, the Company’s Board of Directors authorized the repurchase of up to $300 million of outstanding Company common stock. Repurchases of Company stock under the Board authorization may be made from time to time in the open market and may include privately-negotiated transactions as market conditions warrant and subject to regulatory considerations. The stock repurchase program has no expiration date and the Company’s ability to execute on the program will depend on, among other factors, cash requirements for acquisitions, cash generation from operations, debt repayment obligations, market conditions and regulatory requirements. In addition, under the Company’s senior credit agreements, the Company is subject to certain restrictions relating to its ability to repurchase shares in the event the Company’s consolidated leverage ratio (generally, the ratio of Consolidated Total Indebtedness to Consolidated EBITDA, as defined in the senior credit agreement) exceeds certain levels, which may limit the Company’s ability to repurchase shares under this Board authorization. Through December 31, 2014, no shares have been purchased under this Board authorization.
	Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased for dilutive securities. The following table provides a reconciliation of basic to diluted weighted average shares outstanding:
		2014			2013			2012
		(Shares in thousands)
	Basic	41,366			41,105			40,859
	Dilutive effect of share based awards	450			410			—
	Dilutive effect of 3.875% Convertible Notes and warrants	4,654			2,178			—
	Diluted	46,470			43,693			40,859
	Weighted average shares that were antidilutive and therefore not included in the calculation of earnings per share were approximately 6.3 million, 7.7 million and 9.0 million for the twelve months ended December 31, 2014, 2013 and 2012, respectively.
	During periods in which the average market price of the Company's common stock is above the applicable conversion price of the Convertible Notes, or $61.32 per share, the impact of conversion would be dilutive and the dilutive effect of conversion of the Convertibles Notes is reflected in diluted earnings per share. As previously noted in Note 8, the Company has elected the net settlement method of accounting for these conversions and as a result, in these periods, under the treasury stock method, the Company calculates the number of shares issuable under the terms of these notes based on the average market price of the stock during the period, and includes that number in the total diluted shares outstanding for the period.
	In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge and warrant agreements. The convertible note hedge economically reduces the dilutive impact of the Convertible Notes. However, because the Company separately analyzes the impact of the convertible note hedge and the impact of the warrant agreements on diluted weighted average shares outstanding, the effect of the convertible note hedges are disregarded because their impact would be anti-dilutive. The reductions in diluted shares that would result from the convertible note hedges are 2.7 million, 1.6 million, and 0.3 million for the twelve month periods ended December 31, 2014, 2013 and 2012, respectively. The treasury stock method is applied when the warrants are in-the-money, assuming the proceeds from the exercise of the warrants are used to repurchase shares based on the average stock price during the period. The strike price of the warrants is approximately $74.65 per share of common stock. Shares issuable upon exercise of the warrants that were included in the total diluted shares outstanding were 1.9 million and 0.6 million for the twelve month periods ended December 31, 2014 and 2013, respectively. The warrants had no dilutive impact for the twelve month period ended December 31, 2012. For additional information regarding the convertible notes and convertible note hedge and warrant agreements, see Note 8 to the consolidated financial statements.
	The following tables provide information relating to the changes in accumulated other comprehensive income (loss), net of tax, for the twelve months ended December 31, 2014 and 2013:
		Cash Flow				Pension and			Foreign			Accumulated
		Hedges				Other			Currency			Other
						Postretirement			Translation			Comprehensive
						Benefit Plans			Adjustment			Income (Loss)
		(Dollars in thousands)
	Balance at December 31, 2012	$	(381	)		$	(127,257	)	$	(4,410	)	$	(132,048	)
	Other comprehensive income (loss) before reclassifications	(549		)		25,464			(9,408		)	15,507
	Amounts reclassified from accumulated other comprehensive income (loss)	930				4,756			—			5,686
	Net current-period other comprehensive income (loss)	381				30,220			(9,408		)	21,193
	Balance at December 31, 2013	—				(97,037		)	(13,818		)	(110,855		)
	Other comprehensive income (loss) before reclassifications	594				(47,536		)	(105,333		)	(152,275		)
	Amounts reclassified from accumulated other comprehensive income (loss)	(594		)		2,829			—			2,235
	Net current-period other comprehensive loss	—				(44,707		)	(105,333		)	(150,040		)
	Balance at December 31, 2014	$	—			$	(141,744	)	$	(119,151	)	$	(260,895	)
	The following table provides information relating to the reclassifications of losses/(gain) in accumulated other comprehensive income into expense/(income), net of tax, for the twelve months ended December 31, 2014 and 2013:
		31-Dec-14				31-Dec-13
		(Dollars in thousands)
	Gains and losses on foreign exchange contracts:
	Cost of goods sold	(705		)		884
	Total before tax	(705		)		884
	Taxes	111				46
	Net of tax	$	(594	)		$	930
	Amortization of pension and other postretirement benefits items (1):
	Actuarial losses	$	4,385			$	7,211
	Prior-service costs	(21		)		(21		)
	Transition obligation	—				5
	Total before tax	4,364				7,195
	Tax benefit	(1,535		)		(2,439		)
	Net of tax	$	2,829			$	4,756
	Total reclassifications, net of tax	$	2,235			$	5,686
	-1	These accumulated other comprehensive income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 14 to the consolidated financial statements  for additional information).

Stock_compensation_plans

Stock compensation plans	12 Months Ended
	Dec. 31, 2014
Share-based Compensation [Abstract]
Stock compensation plans	Stock compensation plans
	In May of 2014, the shareholders of the Company approved the Teleflex Incorporated 2014 Stock Incentive Plan (the "2014 Plan") which replaced the Company's 2008 Stock Incentive Plan and 2000 Stock Compensation Plan (the "Prior Plans"), under which stock options and restricted stock awards previously were granted. The 2014 Plan provides for several different kinds of awards, including stock options, stock appreciation rights, stock awards and other stock-based awards to directors, officers and key employees. Under the 2014 Plan, the Company is authorized to issue up to 5.3 million shares of common stock, subject to adjustment in accordance with special share counting rules in the 2014 Plan that, among other things, (i) count shares underlying a stock option or stock appreciation right (each, an "option award") as one share and each share underlying any other type of award (a "stock award") as 1.8 shares, (ii) increases the shares the Company is authorized to issue by one or 1.8 shares for each share underlying an option award or stock award, respectively, under the Prior Plans that have been cancelled, expired, settled in cash or forfeited after December 31, 2013 and (iii) decrease the number of shares the Company is authorized to issue by one share and 1.8 shares for each share underlying an option award or stock award, respectively, granted under the Prior Plans between January 1, 2014 and the May 2, 2014 adoption of the 2014 Plan by the Company's stockholders. Options granted under the 2014 Plan have an exercise price equal to the closing price of the Company's common stock on the date of the grant. In 2014, the Company granted incentive and non-qualified options to purchase 343,580 shares of common stock and granted restricted stock units representing 116,258 shares of common stock under the 2014 Plan. The unrecognized compensation expense for these awards as of the grant date was $17.6 million, which will be recognized over the vesting period of the awards. As of December 31, 2014, 4,903,018 shares were available for future grants under the 2014 Plan.
	Share-based compensation expense for 2014, 2013 and 2012 was $12.2 million, $11.9 million and $8.6 million, respectively, and is included in selling, general and administrative expenses. The total income tax benefit recognized for share-based compensation arrangements for 2014, 2013 and 2012 was $3.3 million, $3.8 million and $2.7 million, respectively. The higher share-based compensation expense in 2014 and 2013 is primarily due to the increase in the market price of the Company’s common stock.
	The fair value of options granted in 2014, 2013 and 2012 was estimated at the date of grant using a multiple point Black-Scholes option pricing model. The following weighted-average assumptions were used:
		2014		2013		2012
	Risk-free interest rate	1.45	%	0.75	%	0.81	%
	Expected life of option	4.89 years		4.87 years		4.85 years
	Expected dividend yield	1.34	%	1.73	%	2.28	%
	Expected volatility	21.44	%	24.65	%	28.46	%
	The fair value for non-vested equity awards granted in 2014, 2013 and 2012 was estimated at the date of grant based on the market price for the underlying stock on the grant date discounted for the risk free interest rate and the present value of expected dividends over the vesting period. The following weighted-average assumptions were used:
		2014		2013		2012
	Risk-free interest rate	0.65	%	0.36	%	0.37	%
	Expected dividend yield	1.34	%	1.71	%	2.24	%
	The Company applied a simplified method to establish the beginning balance of the additional paid-in capital pool (“APIC Pool”) related to the tax effects of employee stock-based compensation and to determine the subsequent impact on the APIC Pool and consolidated statements of cash flows of the tax effects of employee stock-based compensation awards that are outstanding.
	The following table summarizes the option activity during 2014:
		Shares Subject to Options		Weighted Average Exercise Price			Weighted Average Remaining Contractual Life In Years	Aggregate
								Intrinsic
								Value
								(Dollars in thousands)
	Outstanding, beginning of the year	1,279,480		$	65.05
	Granted	343,580		101.45
	Exercised	(362,719	)	60.86
	Forfeited or expired	(26,669	)	87.37
	Outstanding, end of the year	1,233,672		75.93			7.3	$	47,974
	Exercisable, end of the year	647,425		$	64.82		6.1	$	32,373
	The weighted average grant date fair value for options granted during 2014, 2013 and 2012 was $18.01, $14.30 and $11.78, respectively. The total intrinsic value of options exercised was $15.4 million, $4.1 million and $2.7 million during 2014, 2013 and 2012, respectively. As of December 31, 2014, the unamortized share-based compensation cost related to non-vested stock options, net of expected forfeitures, was $5.4 million, which is expected to be recognized over a weighted-average period of 1.8 years. New shares of the Company’s common stock are issued upon exercises of options.
	The Company recorded $4.6 million of expense related to the portion of the shares underlying options that vested during 2014, which is included in selling, general and administrative expenses.
	The following table summarizes the non-vested restricted stock unit activity during 2014:
		Number of		Weighted			Weighted	Aggregate
		Non-Vested		Average			Average	Intrinsic
		Shares		Grant-Date			Remaining	Value
				Fair Value			Contractual
							Life In Years
								(Dollars in thousands)
	Outstanding, beginning of the year	353,357		$	62.49
	Granted	116,258		97.87
	Vested	(128,101	)	57.57
	Forfeited	(27,811	)	71.63
	Outstanding, end of the year	313,703		76.8			1.2	$	36,019
	The Company issued 116,258, 148,191 and 178,690 of non-vested restricted stock units in 2014, 2013 and 2012, respectively, the majority of which vest on the third anniversary of the grant date (cliff vesting). The weighted average grant-date fair value for non-vested restricted stock units granted during 2014, 2013 and 2012 was $97.87, $75.60 and $56.95, respectively. The unamortized share-based compensation cost related to non-vested restricted stock units, net of expected forfeitures, was $10.4 million, which is expected to be recognized over a weighted-average period of 1.8 years. The Company delivers shares of treasury stock upon vesting of the restricted stock award.
	The Company recorded $7.6 million of expense related to the portion of the restricted stock units that vested during 2014, which is included in selling, general and administrative expenses.

Income_taxes

Income taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income taxes	Income taxes
	The following table summarizes the components of the provision for income taxes from continuing operations:
		2014				2013				2012
		(Dollars in thousands)
	Current:
	Federal	$	12,348			$	(2,996	)		$	21,046
	State	1,912				1,736				3,623
	Foreign	30,748				36,422				30,389
	Deferred:
	Federal	(6,593		)		(9,565		)		(34,629		)
	State	3,435				(1,825		)		(720		)
	Foreign	(13,200		)		(225		)		(3,296		)
		$	28,650			$	23,547			$	16,413
	At December 31, 2014, the cumulative unremitted earnings of subsidiaries outside the United States, which are considered non-permanently reinvested and for which U.S. taxes have been provided, approximated $545.5 million.  At December 31, 2014, the cumulative unremitted earnings of subsidiaries outside the United States that are considered permanently reinvested, and, accordingly, for which no income or withholding taxes have been provided, approximated $966.2 million. Earnings considered permanently reinvested are expected to be reinvested indefinitely and, as a result, no deferred tax liability has been recognized with regard to these earnings. It is not practical to determine the deferred income tax liability on these earnings if, in the future, they are remitted to the United States because the income tax liability to be incurred, if any, is dependent on circumstances existing when remittance occurs.
	The following table summarizes the United States and non-United States components of income from continuing operations before taxes:
		2014				2013				2012
		(Dollars in thousands)
	United States	$	(23,875	)		$	(3,323	)		$	(315,707	)
	Other	243,985				179,053				150,338
		$	220,110			$	175,730			$	(165,369	)
	Reconciliations between the statutory federal income tax rate and the effective income tax rate are as follows:
		2014			2013			2012
	Federal statutory rate	35	%		35	%		35	%
	Goodwill impairment	—			—			(60.84	)
	Tax effect of International items	(22.54	)		(14.83	)		11.28
	State taxes, net of federal benefit	2.1			(0.32	)		(0.90	)
	Uncertain tax contingencies	(0.83	)		(4.06	)		4.85
	Contingent consideration reversals	(1.18	)		(2.04	)		—
	Other, net	0.47			(0.35	)		0.68
		13.02	%		13.4	%		(9.93	)%
	The effective income tax rate for 2014 was 13.0% compared to 13.4% for 2013. The effective income tax rate for 2014 was impacted by a benefit from a shift in the mix of income to jurisdictions with lower statutory tax rates, tax benefits associated with U.S. federal tax return filings and, although to a lesser extent than 2013, the realization of net tax benefits resulting from the expiration of statutes of limitation for U.S. state and foreign matters.
	The effective income tax rate for 2013 was impacted by the realization of net tax benefits resulting from the expiration of statutes of limitation for U.S. federal and state and for foreign matters, tax benefits associated with U.S. and foreign tax return filings and the realization of tax benefits resulting from the resolution of a foreign tax matter.
	The Company and its subsidiaries are routinely subject to examinations by various taxing authorities. In conjunction with these examinations and as a regular practice, the Company establishes and adjusts reserves with respect to its uncertain tax positions to address developments related to those positions. The Company realized a net benefit of approximately $1.8 million, $7.1 million and $8.0 million in 2014, 2013 and 2012, respectively, as a result of reducing its reserves with respect to uncertain tax positions. These reductions principally resulted from the expiration of a number of applicable statutes of limitations.
	The following table summarizes significant components of the Company’s deferred tax assets and liabilities at December 31, 2014 and 2013:
		2014				2013
		(Dollars in thousands)
	Deferred tax assets:
	Tax loss and credit carryforwards	$	112,796			$	104,043
	Pension	63,669				39,310
	Reserves and accruals	42,296				38,684
	Other	28,416				27,886
	Less: valuation allowances	(99,141		)		(86,510		)
	Total deferred tax assets	148,036				123,413
	Deferred tax liabilities:
	Property, plant and equipment	31,143				26,550
	Intangibles — stock acquisitions	384,734				400,297
	Unremitted foreign earnings	116,595				147,326
	Other	10,756				12,030
	Total deferred tax liabilities	543,228				586,203
	Net deferred tax liability	$	(395,192	)		$	(462,790	)
	Under the tax laws of various jurisdictions in which the Company operates, deductions or credits that cannot be fully utilized for tax purposes during the current year may be carried forward, subject to statutory limitations, to reduce taxable income or taxes payable in a future tax year. At December 31, 2014, the tax effect of such carryforwards approximated $112.8 million. Of this amount, $12.6 million has no expiration date, $0.3 million expires after 2014 but before the end of 2019 and $99.9 million expires after 2019. A portion of these carryforwards consists of tax losses and credits obtained by the Company as a result of acquisitions; the utilization of these carryforwards are subject to an annual limitation imposed by Section 382 of the Internal Revenue Code, which limits a company’s ability to deduct prior net operating losses following a more than 50 percent change in ownership. It is not expected that the Section 382 limitation will prevent the Company from utilizing its loss carryforwards. The determination of state net operating loss carryforwards is dependent upon the United States subsidiaries’ taxable income or loss, the state’s proportion of taxable net income and the application of state laws, which can change from year to year and impact the amount of such carryforward.
	The valuation allowance for deferred tax assets of $99.1 million and $86.5 million at December 31, 2014 and 2013, respectively, relates principally to the uncertainty of the Company’s ability to utilize certain deferred tax assets, primarily tax loss and credit carryforwards in various jurisdictions. The valuation allowance was calculated in accordance with applicable accounting standards, which require that a valuation allowance be established and maintained when it is “more likely than not” that all or a portion of deferred tax assets will not be realized.
	Uncertain Tax Positions: The following table is a reconciliation of the beginning and ending balances for liabilities associated with unrecognized tax benefits for the twelve month periods ending December 31, 2014, 2013 and 2012:
		2014				2013				2012
		(Dollars in thousands)
	Balance at January 1	$	55,771			$	62,108			$	75,026
	Increase in unrecognized tax benefits related to prior years	—				—				1,110
	Decrease in unrecognized tax benefits related to prior years	—				—				(6,134		)
	Unrecognized tax benefits related to the current year	910				1,838				4,256
	Reductions in unrecognized tax benefits due to settlements	(132		)		—				(8,816		)
	Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations	(3,235		)		(8,433		)		(3,503		)
	Increase (decrease) in unrecognized tax benefits due to foreign currency translation	(2,230		)		258				169
	Balance at December 31	$	51,084			$	55,771			$	62,108
	The total liabilities associated with the unrecognized tax benefits that, if recognized would impact the effective tax rate for continuing operations, were $21.6 million at December 31, 2014.
The Company accrues interest and penalties associated with unrecognized tax benefits in income tax expense in the consolidated statements of operations, and the corresponding liability is included in the consolidated balance sheets. The interest (benefit) expense (net of related tax benefits where applicable) and penalties reflected in income from continuing operations for the year ended December 31, 2014 was $1.0 million and $(0.8) million, respectively; for the year ended December 31, 2013 was $1.3 million and $(0.8) million, respectively; and for the year ended December 31, 2012 was $0.8 million and $0.2 million, respectively. The corresponding liabilities in the consolidated balance sheets for interest and penalties at December 31, 2014 were $6.2 million and $5.0 million, respectively, and at December 31, 2013 were $5.7 million and $6.0 million, respectively.
The taxable years that remain subject to examination by major tax jurisdictions are as follows:
	Beginning		Ending
United States	2010		2014
Canada	2005		2014
China	2009		2014
Czech Republic	2011		2014
France	2012		2014
Germany	2007		2014
India	2008		2014
Ireland	2010		2014
Italy	2010		2014
Malaysia	2010		2014
Singapore	2010		2014
The Company and its subsidiaries are routinely subject to income tax examinations by various taxing authorities. As of December 31, 2014, the most significant tax examinations in process are in the jurisdictions of Austria, Canada, Germany and the United States. The date at which these examinations may be concluded and the ultimate outcome of such examinations is uncertain. As a result of the uncertain outcome of these ongoing examinations, future examinations or the expiration of statutes of limitation, it is reasonably possible that the related unrecognized tax benefits for tax positions taken could materially change from those recorded as liabilities at December 31, 2014. Due to the potential for resolution of certain examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Company’s unrecognized tax benefits may change within the next twelve months by a range of zero to $2.6 million.

Pension_and_other_postretireme

Pension and other postretirement benefits	12 Months Ended
	Dec. 31, 2014
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Pension and other postretirement benefits	Pension and other postretirement benefits
	The Company has a number of defined benefit pension and other postretirement plans covering eligible U.S. and non-U.S. employees. The defined benefit pension plans are noncontributory. The benefits under these plans are based primarily on years of service and employees’ pay near retirement. The Company’s funding policy for U.S. plans is to contribute annually, at a minimum, amounts required by applicable laws and regulations. Obligations under non-U.S. plans are systematically provided for by depositing funds with trustees or by book reserves.  As of December 31, 2014, the Company’s U.S. defined benefit pension plans and the Company’s other postretirement benefit plans, except certain postretirement benefit plans covering employees subject to a collective bargaining agreement, are frozen.
	The Company and certain of its subsidiaries provide medical, dental and life insurance benefits to pensioners and survivors. The associated plans are unfunded and approved claims are paid from Company funds.
	The following table provides information regarding the net benefit cost of pension and postretirement benefit plans for continuing operations:
		Pension											Other Benefits
		2014				2013				2012			2014				2013			2012
		(Dollars in thousands)
	Service cost	$	1,794			$	1,819			$	2,331		$	424			$	663		$	704
	Interest cost	18,000				16,842				16,561			2,169				2,707			2,122
	Expected return on plan assets	(25,006		)		(23,122		)		(20,245		)	—				—			—
	Net amortization and deferral	4,371				5,847				6,474			(7		)		1,348			761
	Curtailment gain	—				—				(197		)	—				—			—
	Settlement loss	—				—				106			—				—			—
	Net benefit cost	$	(841	)		$	1,386			$	5,030		$	2,586			$	4,718		$	3,587
	The following table provides the weighted average assumptions for United States and foreign plans used in determining net benefit cost:
		Pension									Other Benefits
		2014			2013			2012			2014		2013			2012
	Discount rate	5	%		4.3	%		4.3	%		4.7	%	3.8	%		4	%
	Rate of return	8.3	%		8.3	%		8.3	%		—	%	—	%		—	%
	Initial healthcare trend rate	—	%		—	%		—	%		7.5	%	8.2	%		8.5	%
	Ultimate healthcare trend rate	—	%		—	%		—	%		5	%	5	%		5	%
	The following table provides summarized information with respect to the Company’s pension and postretirement benefit plans, measured as of December 31, 2014 and 2013:
		Pension								Other Benefits
		2014				2013				2014			2013
		Under Funded								Under Funded
		(Dollars in thousands)
	Benefit obligation, beginning of year	$	367,731			$	397,184			$	52,448		$	55,609
	Service cost	1,794				1,819				424			663
	Interest cost	18,000				16,842				2,169			2,707
	Actuarial loss (gain)	82,922				(30,755		)		1,273			(3,833		)
	Currency translation	(2,973		)		861				—			—
	Benefits paid	(17,988		)		(17,004		)		(3,287		)	(2,860		)
	Medicare Part D reimbursement	—				—				127			162
	Administrative costs	(1,522		)		(1,216		)		—			—
	Projected benefit obligation, end of year	447,964				367,731				53,154			52,448
	Fair value of plan assets, beginning of year	305,481				276,863				—			—
	Actual return on plan assets	34,332				28,813				—			—
	Contributions	9,539				17,724				—			—
	Benefits paid	(17,988		)		(17,004		)		—			—
	Settlements paid	—				—				—			—
	Administrative costs	(1,522		)		(1,216		)		—			—
	Currency translation	(1,012		)		301				—			—
	Fair value of plan assets, end of year	328,830				305,481				—			—
	Funded status, end of year	$	(119,134	)		$	(62,250	)		$	(53,154	)	$	(52,448	)
	The following table sets forth the amounts recognized in the consolidated balance sheet with respect to the plans:
		Pension								Other Benefits
		2014				2013				2014			2013
		(Dollars in thousands)
	Payroll and benefit-related liabilities	$	(1,779	)		$	(1,819	)		$	(3,268	)	$	(3,381	)
	Pension and postretirement benefit liabilities	(117,355		)		(60,431		)		(49,886		)	(49,067		)
	Accumulated other comprehensive loss	213,117				144,866				8,353			7,073
		$	93,983			$	82,616			$	(44,801	)	$	(45,375	)
	The following tables set forth the amounts recognized in accumulated other comprehensive income (loss) with respect to the plans:
		Pension
		Prior Service				Net (Gain)				Deferred			Accumulated
		Cost (Credit)				or Loss				Taxes			Other
													Comprehensive
													(Income) Loss,
													Net of Tax
		(Dollars in thousands)
	Balance at December 31, 2012	$	216			$	186,700			$	(67,567	)	$	119,349
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net amortization and deferral	(34		)		(5,813		)		1,947			(3,900		)
	Amounts arising during the period:
Actuarial changes in benefit obligation	—				(36,446		)		13,206			(23,240		)
Impact of currency translation	—				243				(66		)	177
Balance at December 31, 2013	182				144,684				(52,480		)	92,386
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net amortization and deferral	(34		)		(4,337		)		1,539			(2,832		)
Amounts arising during the period:
Actuarial changes in benefit obligation	—				73,596				(26,131		)	47,465
Impact of currency translation	—				(974		)		265			(709		)
Balance at December 31, 2014	$	148			$	212,969			$	(76,807	)	$	136,310
	Other Benefits
	Prior Service				Initial				Net (Gain) or			Deferred				Accumulated
	Cost (Credit)				Obligation				Loss			Taxes				Other
																Comprehensive
																(Income) Loss,
																Net of Tax
	(Dollars in thousands)
Balance at December 31, 2012	$	(38	)		$	5			$	12,287		$	(4,346	)		$	7,908
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net Amortization and deferral	55				(5		)		(1,398		)	492				(856		)
Amounts Arising During the period:
Actuarial changes in benefit obligation	—				—				(3,833		)	1,432				(2,401		)
Balance at December 31, 2013	17				—				7,056			(2,422		)		4,651
Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
Net Amortization and deferral	55				—				(48		)	(4		)		3
Amounts Arising During the period:
Actuarial changes in benefit obligation	—				—				1,273			(493		)		780
Balance at December 31, 2014	$	72			$	—			$	8,281		$	(2,919	)		$	5,434
The following table provides the weighted average assumptions for United States and foreign plans used in determining benefit obligations:
	Pension						Other Benefits
	2014			2013			2014			2013
Discount rate	4.1	%		5	%		4	%		4.7	%
Rate of compensation increase	3	%		3	%		—			—
Initial healthcare trend rate	—			—			7.3	%		7	%
Ultimate healthcare trend rate	—			—			5	%		5	%
The discount rate represents the interest rate used to determine the present value of future cash flows currently expected to be required to settle the Company’s pension and other benefit obligations. The weighted average discount rates for United States pension plans and other benefit plans of 4.24% and 3.97%, respectively, were established by comparing the projection of expected benefit payments to the AA Above Median yield curve as of December 31, 2014. The expected benefit payments are discounted by each corresponding discount rate on the yield curve. For payments beyond 30 years, the Company extends the curve assuming that the discount rate derived in year 30 is extended to the end of the plan’s payment expectations. Once the present value of the string of benefit payments is established, the Company determines the single rate on the yield curve that, when applied to all obligations of the plan, will exactly match the previously determined present value.
As part of the evaluation of pension and other postretirement assumptions, the Company applied assumptions for mortality and healthcare cost trends that incorporate generational white and blue collar mortality trends. In determining its benefit obligations, the Company used generational tables that take into consideration increases in plan participant longevity. During 2014, the Society of Actuaries published new mortality tables (RP-2014), which generally reflect longer life expectancy than was projected by past tables (RP-2000). The Company used the new mortality tables when applying mortality assumptions to the calculation of its projected benefit obligations as of December 31, 2014, which resulted in a 9% increase to the Company’s projected benefit obligation.
The Company’s assumption for the Expected Return on Plan Assets is primarily based on the determination of an expected return for its current portfolio. This determination is made using assumptions for return and volatility of the portfolio. Asset class assumptions are set using a combination of empirical and forward-looking analysis. To the extent historical results have been affected by unsustainable trends or events, the effects of those trends are quantified and removed. The Company applies a variety of models for filtering historical data and isolating the fundamental characteristics of asset classes. These models provide empirical return estimates for each asset class, which are then reviewed and combined with a qualitative assessment of long term relationships between asset classes before a return estimate is finalized. The qualitative analysis is intended to provide an additional means for addressing the effect of unrealistic or unsustainable short-term valuations or trends, resulting in return levels and behavior the Company believes are more likely to prevail over long periods. Effective in 2015, the Company changed its Expected Return on Plan Assets of the United States pension plans from 8.50% to 8.25% to reflect modifications to assumptions resulting from the analysis described above. This change had no impact on the results for the year ended December 31, 2014.
Increasing the assumed healthcare trend rate by 1% would increase the benefit obligation at December 31, 2014 by $4.4 million and would increase the 2014 benefit expense by $0.2 million. Decreasing the trend rate by 1% would decrease the benefit obligation at December 31, 2014 by $3.8 million and would decrease the 2014 benefit expense by $0.2 million.
The accumulated benefit obligation for all United States and foreign defined benefit pension plans was $447.4 million and $367.3 million for 2014 and 2013, respectively. All of our pension plans had accumulated benefit obligations in excess of their respective plan assets as of December 31, 2014 and 2013.
The Company’s investment objective is to achieve an enhanced long-term rate of return on plan assets, subject to a prudent level of portfolio risk, for the purpose of enhancing the availability of benefits for participants. These investments are held primarily in equity and fixed income mutual funds. The Company’s other investments are largely comprised of a hedge fund of funds and a structured credit fund. The equity funds are diversified in terms of domestic and international equity securities, as well as small, middle and large capitalization stocks. The domestic mutual funds held in the plans are subject to the diversification standards and industry limitations on concentration of holdings set forth in the Investment Company Act of 1940, as amended, and SEC staff guidance. The Company’s target allocation percentage is as follows: equity securities (45%); fixed-income securities (35%) and other securities (20%). Equity funds are held for their expected return over inflation. Fixed-income funds are held for diversification relative to equities and as a partial hedge of interest rate risk to plan liabilities. The other investments are held to further diversify assets within the plans and are designed to provide a mix of equity and bond like return with a bond like risk profile. The plans may also hold cash to meet liquidity requirements. Actual performance may not be consistent with the respective investment strategies. Investment risks and returns are measured and monitored on an ongoing basis through annual liability measurements and investment portfolio reviews to determine whether the asset allocation targets continue to represent an appropriate balance of expected risk and reward.
The following table provides the fair values of the Company’s pension plan assets at December 31, 2014 by asset category:
		Fair Value Measurements
Asset Category (a)		Total				Quoted Prices in				Significant			Significant
						Active Markets for				Observable			Unobservable
						Identical Assets				Inputs			Inputs
						(Level 1)				(Level 2)			(Level 3)
		(Dollars in thousands)
Cash		$	659			$	659			$	—		$	—
Money market funds		31				31				—			—
Equity securities:
Managed volatility (b)		83,068				83,068				—			—
United States small/mid-cap equity (c)		20,312				20,312				—			—
World Equity (excluding United States) (d)		26,064				26,064				—			—
Common Equity Securities – Teleflex Incorporated		13,422				13,422				—			—
Diversified United Kingdom Equity		875				875				—			—
Diversified Global		2,884				2,884				—			—
Emerging Markets		1,266				1,266				—			—
Fixed income securities:
Long duration bond fund (e)		92,553				92,553				—			—
UK corporate bond fund		2,719				2,719				—			—
UK Government bond fund		5,078				5,078				—			—
High yield bond fund (f)		11,618				11,618				—			—
Emerging markets debt fund (g)		8,531								8,531			—
Corporate, government and foreign bonds		81								81			—
Asset backed – home loans		782								782			—
Other types of investments:
Structured credit (h)		31,176								—			31,176
Hedge fund of funds (i)		23,171								—			23,171
UK Property Fund (j)		1,549								1,549			—
Multi asset fund  (k)		2,986				2,986				—			—
Other		5				—				—			5
Total		$	328,830			$	263,535			$	10,943		$	54,352
The following table provides the fair values of the Company’s pension plan assets at December 31, 2013 by asset category:
		Fair Value Measurements
Asset Category (a)		Total				Quoted Prices in				Significant			Significant
						Active Markets for				Observable			Unobservable
						Identical Assets				Inputs			Inputs
						(Level 1)				(Level 2)			(Level 3)
		(Dollars in thousands)
Cash		$	472			$	472			$	—		$	—
Money market funds		310				310				—			—
Equity securities:
Managed volatility (b)		77,140				77,140				—			—
United States small/mid-cap equity (c)		19,760				19,760				—			—
World Equity (excluding United States) (d)		30,183				30,183				—			—
Common Equity Securities – Teleflex Incorporated		10,972				10,972				—			—
Diversified United Kingdom Equity		928				928				—			—
Diversified Global		2,319				2,319				—			—
Emerging Markets		1,270				1,270				—			—
Fixed income securities:
Long duration bond fund (e)		76,608				76,608				—			—
UK corporate bond fund		2,569				2,569				—			—
UK Government bond fund		4,455				4,455				—			—
High yield bond fund (f)		12,754				12,754				—			—
Emerging markets debt fund (g)		9,003				—				9,003			—
Corporate, government and foreign bonds		87				—				87			—
Asset backed – home loans		847				—				847			—
Other types of investments:
Structured credit (h)		29,109				—				—			29,109
Hedge fund of funds (i)		22,540				—				—			22,540
UK Property Fund (j)		1,402				—				1,402			—
Multi asset fund  (k)		2,748				2,748				—			—
Other		5				—				—			5
Total		$	305,481			$	242,488			$	11,339		$	51,654
(a)	Information on asset categories described in notes (b)-(k) is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.
(b)	This category comprises mutual funds that invest in securities of United States and non-United States companies of all capitalization ranges that exhibit relatively low volatility.
(c)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of small and mid-sized companies. The fund invests in common stocks or exchange traded funds holding common stock of United States companies with market capitalizations in the range of companies in the Russell 2500 Index.
(d)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of foreign companies. These securities may include common stocks, preferred stocks, warrants, exchange traded funds based on an international equity index and derivative instruments whose value is based on an international equity index and derivative instruments whose value is based on an underlying equity security or a basket of equity securities. The fund invests in securities of foreign issuers located in developed and emerging market countries. However, the fund will not invest more than 30% of its assets in the common stocks or other equity securities of issuers located in emerging market countries.
(e)	This category comprises a mutual fund that invests in instruments or derivatives having economic characteristics similar to fixed income securities. The fund invests in investment grade fixed income instruments, including securities issued or guaranteed by the United States Government and its agencies and instrumentalities, corporate bonds, asset-backed securities, exchange traded funds, mortgage-backed securities and collateralized mortgage-backed securities. The fund invests primarily in long duration government and corporate fixed income securities, and uses derivative instruments, including interest rate swap agreements and Treasury futures contracts, for the purpose of managing the overall duration and yield curve exposure of the Fund’s portfolio of fixed income securities.
(f)	This category comprises a mutual fund that invests at least 80% of its net assets in higher-yielding fixed income securities, including corporate bonds and debentures, convertible and preferred securities and zero coupon obligations.
(g)	This category comprises a mutual fund that invests at least 80% of its net assets in fixed income securities of emerging market issuers, primarily in United States dollar-denominated debt of foreign governments, government-related and corporate issuers in emerging market countries and entities organized to restructure the debt of those issuers.
(h)	This category comprises a fund that invests primarily in collateralized debt obligations (“CDOs”) and other structured credit vehicles. The fund investments may include fixed income securities, loan participants, credit-linked notes, medium-term notes, pooled investment vehicles and derivative instruments.
(i)	This category comprises a hedge fund that invests in various other hedge funds. As of December 31, 2014 and 2013:
•	approximately 33% and 28%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;
•	approximately 10% and 18%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;
•	approximately 24% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;
•	approximately 33% and 23%, respectively, of the assets were held in funds with an event driven strategy; and
•	approximately 6% of the assets were held in cash as of December 31, 2013.
(j)	This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
(k)	This category comprises a mutual fund that invests primarily in equities, bonds and alternatives.
The following table provides a reconciliation of changes in pension assets measured at fair value on a recurring basis, using Level 3 inputs, from December 31, 2012 through December 31, 2014:
	(Dollars in thousands)
Balance at December 31, 2012	$	48,198
Unrealized gain on assets	3,456
Balance at December 31, 2013	51,654
Unrealized gain on assets	2,698
Balance at December 31, 2014	$	54,352
The Company’s contributions to United States and foreign pension plans during 2015 are expected to be approximately $2.9 million. Contributions to postretirement healthcare plans during 2015 are expected to be approximately $3.3 million.
The following table provides information about the Company’s expected benefit payments for U.S. and foreign plans for each of the five succeeding years and the aggregate of the five years thereafter, net of the annual average Medicare Part D subsidy of approximately $0.2 million:
	Pension				Other Benefits
	(Dollars in thousands)
2015	$	17,841			$	3,268
2016	18,449				3,362
2017	19,023				3,334
2018	19,653				3,367
2019	20,472				3,416
Years 2020 — 2024	114,185				18,229
The Company maintains a number of defined contribution savings plans covering eligible United States and non-United States employees. The Company partially matches employee contributions. Costs related to these plans were $11.5 million, $12.1 million and $10.1 million for 2014, 2013 and 2012, respectively.

Commitments_and_contingent_lia

Commitments and contingent liabilities	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingent liabilities	Commitments and contingent liabilities
	Operating leases: The Company uses various leased facilities and equipment in its operations. The lease terms for these leased assets vary depending on the terms of the applicable lease agreement. At December 31, 2014, the Company had no residual value guarantees related to its operating leases.
	Future minimum lease payments as of December 31, 2014 under noncancelable operating leases are as follows:
		Future Lease Payments
		(Dollars in thousands)
	2015	$	27,706
	2016	23,292
	2017	18,846
	2018	15,474
	2019 and thereafter	32,182
	Rental expense under operating leases was $29.4 million, $26.4 million and $24.0 million in 2014, 2013 and 2012, respectively.
	The Company entered into a build-to-suit lease pertaining to a U.S. operating facility in August 2013, and construction on the facility commenced in September 2013. The estimated fair value of the Company’s percentage of the construction costs to complete the build-to-suit lease was approximately $28.3 million. For accounting purposes, the Company was deemed the owner of the asset during the construction period and was required to record the estimated fair value of the Company’s percentage of the construction costs as construction in progress during the construction period and a related liability in the same amount. This noncash activity is not reflective of the Company’s cash obligations, but represents the landlord’s costs to construct the Company’s portion of the building and tenant improvements. The construction pertaining to the build-to-suit leased facility was completed in the fourth quarter 2014, at which point the Company derecognized the assets and related liabilities pertaining to the leased operating facility.
	Environmental:  The Company is subject to contingencies as a result of environmental laws and regulations that in the future may require the Company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the Company or other parties. Much of this liability results from the United States Comprehensive Environmental Response, Compensation and Liability Act, often referred to as Superfund, the United States Resource Conservation and Recovery Act and similar state laws. These laws require the Company to undertake certain investigative and remedial activities at sites where the Company conducts or once conducted operations or at sites where Company-generated waste was disposed.
	Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, the regulatory agencies involved and their enforcement policies, as well as the presence or absence of other potentially responsible parties. At December 31, 2014 and 2013, the Company has recorded discounted liabilities of $1.3 million and $2.5 million, respectively, in accrued liabilities and $6.5 million and $5.8 million, respectively, in other liabilities relating to these matters. Considerable uncertainty exists with respect to these liabilities and, if adverse changes in circumstances occur, potential liability may exceed the amount accrued as of December 31, 2014. The time frame over which the accrued amounts may be paid out, based on past history, is estimated to be 15-20 years.
	Litigation:  The Company is a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, intellectual property, employment and environmental matters. As of December 31, 2014 and 2013, the Company has accrued liabilities of approximately $6.0 million and $6.8 million, respectively, in connection with these matters, representing its best estimate of the cost within the range of estimated possible loss that will be incurred to resolve these matters. Of the amounts accrued as of December 31, 2014 and 2013, $2.4 million and $1.4 million, respectively, pertain to discontinued operations.
	In 2006, the Company was named as a defendant in a wrongful death product liability lawsuit filed in the Louisiana State District Court for the Parish of Calcasieu, involving a product manufactured by the Company’s former marine business. In September 2014, the case was tried before a jury, which returned a verdict in favor of the Company. The plaintiff subsequently filed a motion for a new trial, which was granted, and the case was re-tried before a jury in December 2014. On December 5, 2014, the jury returned a verdict in favor of the plaintiff, awarding $125,000 in compensatory damages and $23 million in punitive damages, plus pre- and post-judgment interest on the compensatory damages and post-judgment interest on the punitive damages. The Company has filed post-trial motions seeking to overturn the verdict or reduce the amount of damages, which the Company believes are excessive. If the Court denies the motions, the Company intends to pursue an appeal. As of December 31, 2014, the Company has accrued a liability representing its best estimate of any probable loss associated with this matter which, is included in the Company’s accrued liabilities relating to discontinued operations discussed in the preceding paragraph. The Company believes that any liability arising from this matter in excess of $10 million will be covered by the Company’s product liability insurance.
	Based on information currently available, advice of counsel, established reserves and other resources, the Company does not believe that the outcome of any outstanding litigation and claims is likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. Legal costs such as outside counsel fees and expenses are charged to selling, general and administrative expenses in the period incurred.
	Tax audits and examinations: The Company and its subsidiaries are routinely subject to tax examinations by various taxing authorities. As of December 31, 2014, the most significant tax examinations in process were in Austria, Canada, Germany and the United States. In conjunction with these examinations and as a regular and routine practice, the Company may establish reserves or adjust existing reserves with respect to uncertain tax positions. Accordingly, developments occurring with respect to these examinations, including resolution of uncertain tax positions, could result in increases or decreases to the Company’s recorded tax liabilities, which could impact the Company’s financial results.
	Other: The Company has various purchase commitments for materials, supplies and items of permanent investment incident to the ordinary conduct of business. On average, such commitments are not at prices in excess of current market prices.

Business_segments_and_other_in

Business segments and other information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Business segments and other information	The following tables present the Company’s segment results for the twelve months ended December 31, 2014, 2013 and 2012:
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Revenue
	Vascular North America	$	259,227		$	231,112		$	222,749
	Anesthesia/Respiratory North America	222,650			228,485			180,363
	Surgical North America	150,121			146,058			143,875
	EMEA	593,065			557,427			510,248
	Asia	237,696			207,207			173,721
	OEM	143,966			131,173			140,230
	All other	233,107			194,809			179,823
	Consolidated net revenues	$	1,839,832		$	1,696,271		$	1,551,009
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Operating Profit
	Vascular North America	$	41,079		$	23,798		$	26,048
	Anesthesia/Respiratory North America	26,574			21,910			14,048
	Surgical North America	49,592			50,334			50,615
	EMEA	114,650			87,902			65,822
	Asia	62,152			63,822			52,541
	OEM	30,635			27,328			31,664
	All other	40,482			27,191			18,759
	Total segment operating profit (1)	365,164			302,285			259,497
	Unallocated expenses (2)	(80,302		)	(69,024		)	(356,872		)
	Income from continuing operations before interest, loss on extinguishments of debt and taxes	$	284,862		$	233,261		$	(97,375	)
	-1	Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for certain manufacturing variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
	-2	Unallocated expenses primarily include manufacturing variances and fixed manufacturing costs, with the exception of certain manufacturing variances allocated to the segments as noted above, as well as net gain on sales of assets, goodwill impairment and restructuring and other impairment charges.
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Depreciation and Amortization
	Vascular North America	$	31,782		$	28,719		$	23,063
	Anesthesia/Respiratory North America	17,109			13,162			7,955
	Surgical North America	6,316			10,549			3,646
	EMEA	38,062			29,947			22,975
	Asia	8,515			4,960			3,653
	OEM	6,175			4,876			4,083
	All other	19,071			15,722			29,509
	Consolidated depreciation and amortization	$	127,030		$	107,935		$	94,884
	Business segments and other information
	An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The Company does not evaluate its operating segments using discrete asset information.
	Effective January 1, 2014, the Company realigned its operating segments due to changes in the Company’s internal financial reporting structure. The Company’s North American Vascular, Anesthesia/Respiratory and Surgical businesses, which previously comprised much of the former Americas reportable segment, are now separate reportable segments.  As a result, the Company now has six reportable segments: Vascular North America, Anesthesia/Respiratory North America, Surgical North America, EMEA, Asia and OEM. Certain operating segments are not material and are therefore included in the “All other” line item in tabular presentations of segment information. Additionally, the Company changed the allocation methodology for certain corporate costs, including manufacturing variances and research and development costs, among its businesses to improve accountability, which resulted in changes to the previously reported segment operating profit. All prior comparative periods have been restated to reflect these changes.
	The Company’s reportable segments other than the OEM segment design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care and generally serve two end markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers.
	The following tables present the Company’s segment results for the twelve months ended December 31, 2014, 2013 and 2012:
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Revenue
	Vascular North America	$	259,227		$	231,112		$	222,749
	Anesthesia/Respiratory North America	222,650			228,485			180,363
	Surgical North America	150,121			146,058			143,875
	EMEA	593,065			557,427			510,248
	Asia	237,696			207,207			173,721
	OEM	143,966			131,173			140,230
	All other	233,107			194,809			179,823
	Consolidated net revenues	$	1,839,832		$	1,696,271		$	1,551,009
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Operating Profit
	Vascular North America	$	41,079		$	23,798		$	26,048
	Anesthesia/Respiratory North America	26,574			21,910			14,048
Surgical North America	49,592			50,334			50,615
EMEA	114,650			87,902			65,822
Asia	62,152			63,822			52,541
OEM	30,635			27,328			31,664
All other	40,482			27,191			18,759
Total segment operating profit (1)	365,164			302,285			259,497
Unallocated expenses (2)	(80,302		)	(69,024		)	(356,872		)
Income from continuing operations before interest, loss on extinguishments of debt and taxes	$	284,862		$	233,261		$	(97,375	)
-1	Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for certain manufacturing variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
-2	Unallocated expenses primarily include manufacturing variances and fixed manufacturing costs, with the exception of certain manufacturing variances allocated to the segments as noted above, as well as net gain on sales of assets, goodwill impairment and restructuring and other impairment charges.
	Year Ended December 31:
	2014			2013			2012
	(Dollars in thousands)
Depreciation and Amortization
Vascular North America	$	31,782		$	28,719		$	23,063
Anesthesia/Respiratory North America	17,109			13,162			7,955
Surgical North America	6,316			10,549			3,646
EMEA	38,062			29,947			22,975
Asia	8,515			4,960			3,653
OEM	6,175			4,876			4,083
All other	19,071			15,722			29,509
Consolidated depreciation and amortization	$	127,030		$	107,935		$	94,884
The following table provides total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2014, 2013 and 2012:
	Year Ended
	2014			2013			2012
	(Dollars in thousands)
Net revenues (based on the Company's selling location):
United States	$	916,619		$	844,884		$	789,771
Other Americas	60,736			57,098			53,665
Europe	664,982			568,559			516,982
All Other	197,495			225,730			190,591
	$	1,839,832		$	1,696,271		$	1,551,009
Net property, plant and equipment:
United States	$	174,893		$	203,985		$	180,833
Malaysia	36,427			29,313			27,764
Czech Republic	35,655			41,607			45,884
All Other	70,460			50,995			43,464
	$	317,435		$	325,900		$	297,945

Condensed_consolidating_guaran

Condensed consolidating guarantor financial information	12 Months Ended
	Dec. 31, 2014
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed consolidating guarantor financial information	Condensed consolidating guarantor financial information
	In June 2011, Teleflex Incorporated (referred to below as “Parent Company”) issued $250 million of 6.875% senior subordinated notes through a registered public offering. The notes are guaranteed, jointly and severally, by certain of the Parent Company’s subsidiaries (each, a “Guarantor Subsidiary” and collectively, the “Guarantor Subsidiaries”). The guarantees are full and unconditional, subject to certain customary release provisions. Each Guarantor Subsidiary is directly or indirectly 100% owned by the Parent Company. The Company’s condensed consolidating statements of income (loss) and comprehensive income (loss) and condensed consolidating statements of cash flows for the years ended December 31, 2014, 2013 and 2012 and condensed consolidating balance sheets as of December 31, 2014 and 2013, each of which are set forth below, provide condensed consolidating information for:
	a.Parent Company, the issuer of the guaranteed obligations;
	b.Guarantor Subsidiaries, on a combined basis;
	c.Non-guarantor subsidiaries, on a combined basis; and
	d.Parent Company and its subsidiaries on a consolidating basis.
	The same accounting policies as described in Note 1 to the consolidated financial statements are used by the Parent Company and each of its subsidiaries in connection with the condensed consolidating financial information set forth below, with the exception that the Parent Company and Guarantor Subsidiaries use the equity method of accounting to reflect ownership interests in subsidiaries which are eliminated upon consolidation.
	Consolidating entries and eliminations in the following condensed consolidating financial statements represent adjustments to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor Subsidiaries and the Non-guarantor subsidiaries, (b) eliminate the investments in subsidiaries and (c) record consolidating entries.
	TELEFLEX INCORPORATED AND SUBSIDIARIES
	CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2014
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net revenues	$	—		$	1,078,851		$	1,132,152		$	(371,171	)	$	1,839,832
	Cost of goods sold	—			652,742			608,256			(363,594		)	897,404
	Gross profit	—			426,109			523,896			(7,577		)	942,428
	Selling, general and administrative expenses	42,829			326,282			209,930			(384		)	578,657
	Research and development expenses	—			40,546			20,494			—			61,040
	Restructuring and other impairment charges	—			10,189			7,680			—			17,869
	Income (loss) from continuing operations before interest and taxes	(42,829		)	49,092			285,792			(7,193		)	284,862
	Interest expense	144,869			(85,885		)	6,474			—			65,458
	Interest income	—			(1		)	(705		)	—			(706		)
	Income (loss) from continuing operations before taxes	(187,698		)	134,978			280,023			(7,193		)	220,110
	Taxes (benefit) on income (loss) from continuing operations	(68,307		)	68,690			28,159			108			28,650
	Equity in net income of consolidated subsidiaries	308,396			233,827			252			(542,475		)	—
	Income from continuing operations	189,005			300,115			252,116			(549,776		)	191,460
	Operating loss from discontinued operations	(2,196		)	—			(1,211		)	—			(3,407		)
	Taxes (benefit) on loss from discontinued operations	(870		)	—			172			—			(698		)
	Loss from discontinued operations	(1,326		)	—			(1,383		)	—			(2,709		)
	Net income	187,679			300,115			250,733			(549,776		)	188,751
	Less: Income from continuing operations attributable to noncontrolling interests	—			—			1,072			—			1,072
	Net income attributable to common shareholders	187,679			300,115			249,661			(549,776		)	187,679
	Other comprehensive loss attributable to common shareholders	(150,040		)	(130,691		)	(126,317		)	257,008			(150,040		)
	Comprehensive income attributable to common shareholders	$	37,639		$	169,424		$	123,344		$	(292,768	)	$	37,639
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net revenues	$	—		$	1,001,404		$	963,184		$	(268,317	)	$	1,696,271
	Cost of goods sold	—			582,110			543,717			(268,501		)	857,326
	Gross profit	—			419,294			419,467			184			838,945
	Selling, general and administrative expenses	39,176			284,960			178,358			(307		)	502,187
	Research and development expenses	—			55,694			9,351			—			65,045
	Restructuring and other impairment charges	935			15,288			22,229			—			38,452
	Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	(40,111		)	63,352			209,529			491			233,261
	Interest expense	134,879			(85,058		)	7,084			—			56,905
	Interest income	(15		)	(5		)	(604		)	—			(624		)
	Loss on extinguishments of debt	1,250			—			—			—			1,250
	Income (loss) from continuing operations before taxes	(176,225		)	148,415			203,049			491			175,730
	Taxes (benefit) on income (loss) from continuing operations	(63,857		)	42,804			45,354			(754		)	23,547
	Equity in net income of consolidated subsidiaries	263,469			141,773			288			(405,530		)	—
	Income from continuing operations	151,101			247,384			157,983			(404,285		)	152,183
	Operating loss from discontinued operations	(1,947		)	—			(258		)	—			(2,205		)
	Taxes (benefit) on loss from discontinued operations	(1,727		)	(170		)	127			—			(1,770		)
	Income (loss) from discontinued operations	(220		)	170			(385		)	—			(435		)
	Net income	150,881			247,554			157,598			(404,285		)	151,748
	Less: Income from continuing operations attributable to noncontrolling interests	—			—			867			—			867
	Net income attributable to common shareholders	150,881			247,554			156,731			(404,285		)	150,881
	Other comprehensive income attributable to common shareholders	21,193			1,960			5,442			(7,402		)	21,193
	Comprehensive income attributable to common shareholders	$	172,074		$	249,514		$	162,173		$	(411,687	)	$	172,074
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
	(Dollars in thousands)
Net revenues	$	—		$	950,888		$	833,903		$	(233,782	)	$	1,551,009
Cost of goods sold	—			552,726			482,881			(232,823		)	802,784
Gross profit	—			398,162			351,022			(959		)	748,225
Selling, general and administrative expenses	34,657			259,476			160,089			267			454,489
Research and development expenses	—			48,649			7,629			—			56,278
Goodwill impairment	—			331,779			349			—			332,128
Restructuring and other impairment charges	—			598			2,439			—			3,037
Net gain on sales of businesses and assets	(116,193		)	(149,240		)	(332		)	265,433			(332		)
Income (loss) from continuing operations before interest and taxes	81,536			(93,100		)	180,848			(266,659		)	(97,375		)
Interest expense	143,653			(81,328		)	7,240			—			69,565
Interest income	(372		)	(23		)	(1,176		)	—			(1,571		)
Income (loss) from continuing operations before taxes	(61,745		)	(11,749		)	174,784			(266,659		)	(165,369		)
Taxes (benefit) on income (loss) from continuing operations	(63,806		)	45,068			35,670			(519		)	16,413
Equity in net income (loss) of consolidated subsidiaries	(190,742		)	124,918			—			65,824			—
Income (loss) from continuing operations	(188,681		)	68,101			139,114			(200,316		)	(181,782		)
Operating income (loss) from discontinued operations	(2,647		)	(9,179		)	2,619			—			(9,207		)
Tax benefit on income (loss) from discontinued operations	(1,271		)	(129		)	(487		)	—			(1,887		)
Income (loss) from discontinued operations	(1,376		)	(9,050		)	3,106			—			(7,320		)
Net income (loss)	(190,057		)	59,051			142,220			(200,316		)	(189,102		)
Less: Income from continuing operations attributable to noncontrolling interests	—			—			955			—			955
Net income (loss) attributable to common shareholders	(190,057		)	59,051			141,265			(200,316		)	(190,057		)
Other comprehensive income attributable to common shareholders	27,305			10,475			8,907			(19,382		)	27,305
Comprehensive income (loss) attributable to common shareholders	$	(162,752	)	$	69,526		$	150,172		$	(219,698	)	$	(162,752	)
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
	31-Dec-14
	Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
	Company			Subsidiaries			Subsidiaries						Consolidated
	(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents	$	27,996		$	—		$	275,240		$	—		$	303,236
Accounts receivable, net	2,346			2,422			265,081			3,855			273,704
Accounts receivable from consolidated subsidiaries	37,378			2,303,284			272,811			(2,613,473		)	—
Inventories, net	—			204,335			154,544			(23,286		)	335,593
Prepaid expenses and other current assets	14,301			4,786			16,610			—			35,697
Prepaid taxes	23,493			—			16,763			—			40,256
Deferred tax assets	30,248			17,387			9,666			—			57,301
Assets held for sale	2,901			—			4,521			—			7,422
Total current assets	138,663			2,532,214			1,015,236			(2,632,904		)	1,053,209
Property, plant and equipment, net	3,489			170,054			143,892			—			317,435
Goodwill	—			703,663			619,890			—			1,323,553
Intangibles assets, net	—			743,222			473,498			—			1,216,720
Investments in affiliates	5,662,773			1,359,661			21,253			(7,042,537		)	1,150
Deferred tax assets	52,244			—			5,535			(56,601		)	1,178
Notes receivable and other amounts due from consolidated subsidiaries	1,025,859			1,489,994			—			(2,515,853		)	—
Other assets	27,999			6,801			29,210			—			64,010
Total assets	$	6,911,027		$	7,005,609		$	2,308,514		$	(12,247,895	)	$	3,977,255
LIABILITIES AND EQUITY
Current liabilities
Current borrowings	$	363,701		$	—		$	4,700		$	—		$	368,401
Accounts payable	1,449			32,692			29,959			—			64,100
Accounts payable to consolidated subsidiaries	2,259,891			188,908			163,291			(2,612,090		)	—
Accrued expenses	17,149			21,479			33,755			—			72,383
Current portion of contingent consideration	—			11,276			—			—			11,276
Payroll and benefit-related liabilities	20,693			27,228			37,521			—			85,442
Accrued interest	9,152			—			17			—			9,169
Income taxes payable	—			—			13,768			—			13,768
Other current liabilities	5			3,065			7,290			—			10,360
Total current liabilities	2,672,040			284,648			290,301			(2,612,090		)	634,899
Long-term borrowings	700,000			—			—			—			700,000
Deferred tax liabilities	—			462,274			45,867			(56,600		)	451,541
Pension and other postretirement benefit liabilities	110,830			35,074			21,337			—			167,241
Noncurrent liability for uncertain tax positions	11,431			15,569			23,884			—			50,884
Notes payable and other amounts due to consolidated subsidiaries	1,483,984			932,718			103,908			(2,520,610		)	—
Other liabilities	21,433			24,900			12,658			—			58,991
Total liabilities	4,999,718			1,755,183			497,955			(5,189,300		)	2,063,556
Total common shareholders' equity	1,911,309			5,250,426			1,808,169			(7,058,595		)	1,911,309
Noncontrolling interest	—			—			2,390			—			2,390
Total equity	1,911,309			5,250,426			1,810,559			(7,058,595		)	1,913,699
Total liabilities and equity	$	6,911,027		$	7,005,609		$	2,308,514		$	(12,247,895	)	$	3,977,255
	31-Dec-13
	Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
	Company			Subsidiaries			Subsidiaries						Consolidated
	(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents	$	42,749		$	14,500		$	374,735		$	—		$	431,984
Accounts receivable, net	1,822			10,948			279,048			3,472			295,290
Accounts receivable from consolidated subsidiaries	42,865			2,623,314			214,469			(2,880,648		)	—
Inventories, net	—			211,165			138,165			(15,709		)	333,621
Prepaid expenses and other current assets	15,200			6,870			17,740			—			39,810
Prepaid taxes	27,487			—			9,017			—			36,504
Deferred tax assets	20,218			22,472			10,230			(3		)	52,917
Assets held for sale	1,669			3,503			5,256			—			10,428
Total current assets	152,010			2,892,772			1,048,660			(2,892,888		)	1,200,554
Property, plant and equipment, net	14,189			188,455			123,256			—			325,900
Goodwill	—			797,671			556,532			—			1,354,203
Intangibles assets, net	—			962,243			293,354			—			1,255,597
Investments in affiliates	5,489,676			1,478,429			21,382			(6,987,772		)	1,715
Deferred tax assets	35,877			—			4,476			(39,410		)	943
Notes receivable and other amounts due from consolidated subsidiaries	1,049,344			873,105			14,169			(1,936,618		)	—
Other assets	24,574			7,447			38,074			—			70,095
Total assets	$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
LIABILITIES AND EQUITY
Current liabilities
Current borrowings	$	351,587		$	—		$	4,700		$	—		$	356,287
Accounts payable	2,194			45,802			23,971			—			71,967
Accounts payable to consolidated subsidiaries	2,644,296			147,957			88,395			(2,880,648		)	—
Accrued expenses	15,569			21,120			38,179			—			74,868
Current portion of contingent consideration	—			4,131			—			—			4,131
Payroll and benefit-related liabilities	15,976			21,818			35,296			—			73,090
Accrued interest	8,720			—			5			—			8,725
Income taxes payable	—			—			23,821			—			23,821
Other current liabilities	9,646			7,517			5,072			(4		)	22,231
Total current liabilities	3,047,988			248,345			219,439			(2,880,652		)	635,120
Long-term borrowings	930,000			—			—			—			930,000
Deferred tax liabilities	—			496,228			57,896			(39,409		)	514,715
Pension and other postretirement benefit liabilities	57,406			33,777			18,315			—			109,498
Noncurrent liability for uncertain tax positions	11,389			17,241			26,522			—			55,152
Notes payable and other amounts due to consolidated subsidiaries	785,476			957,451			197,173			(1,940,100		)	—
Other liabilities	19,884			16,221			12,401			—			48,506
Total liabilities	4,852,143			1,769,263			531,746			(4,860,161		)	2,292,991
Total common shareholders' equity	1,913,527			5,430,859			1,565,668			(6,996,527		)	1,913,527
Noncontrolling interest	—			—			2,489			—			2,489
Total equity	1,913,527			5,430,859			1,568,157			(6,996,527		)	1,916,016
Total liabilities and equity	$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
	Year Ended December 31, 2014
	Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
	Company			Subsidiaries			Subsidiaries						Consolidated
	(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations	$	(80,651	)	$	322,687		$	123,545		$	(75,340	)	$	290,241
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment	(2,273		)	(30,586		)	(34,712		)	—			(67,571		)
Proceeds from sale of assets and investments	1,669			3,421			161			—			5,251
Payments for businesses and intangibles acquired, net of cash acquired	—			(17,241		)	(28,536		)	—			(45,777		)
Investments in affiliates	(60		)	20			—			—			(40		)
Intercompany dividends received	—			—			229,782			(229,782		)	—
Net cash (used in) provided by investing activities from continuing operations	(664		)	(44,386		)	166,695			(229,782		)	(108,137		)
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings	250,000			—			—			—			250,000
Repayment of long-term borrowings	(480,102		)	—			—			—			(480,102		)
Debt extinguishment, issuance and amendment fees	(4,494		)	—			—			—			(4,494		)
Proceeds from stock compensation plans and related tax impacts	4,245			—			—			—			4,245
Dividends	(56,258		)	—			—			—			(56,258		)
Payments to noncontrolling shareholders				—			(1,094		)	—			(1,094		)
Intercompany transactions	356,847			(292,801		)	(64,046		)	—			—
Intercompany dividends paid	—			—			(305,122		)	305,122			—
Net cash provided by (used in) financing activities from continuing operations	70,238			(292,801		)	(370,262		)	305,122			(287,703		)
Cash Flows from Discontinued Operations:
Net cash used in operating activities	(3,676		)	—			—			—			(3,676		)
Net cash used in discontinued operations	(3,676		)	—			—			—			(3,676		)
Effect of exchange rate changes on cash and cash equivalents	—			—			(19,473		)	—			(19,473		)
Net decrease in cash and cash equivalents	(14,753		)	(14,500		)	(99,495		)	—			(128,748		)
Cash and cash equivalents at the beginning of the period	42,749			14,500			374,735			—			431,984
Cash and cash equivalents at the end of the period	$	27,996		$	—		$	275,240		$	—		$	303,236
	Year Ended December 31, 2013
	Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
	Company			Subsidiaries			Subsidiaries						Consolidated
	(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations	$	(131,031	)	$	205,954		$	304,278		$	(147,902	)	$	231,299
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment	(1,553		)	(47,633		)	(14,394		)	—			(63,580		)
Payments for businesses and intangibles acquired, net of cash acquired	—			(250,912		)	(58,096		)	—			(309,008		)
Investments in affiliates	(50		)	—			—			—			(50		)
Net cash used in investing activities from continuing operations	(1,603		)	(298,545		)	(72,490		)	—			(372,638		)
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings	680,000			—			—			—			680,000
Repayment of long-term borrowings	(375,000		)	—			—			—			(375,000		)
Debt extinguishment, issuance and amendment fees	(6,400		)	—			—			—			(6,400		)
Proceeds from share based compensation plans and the related tax impacts	6,181			—			—			—			6,181
Dividends	(55,917		)	—			—			—			(55,917		)
Payments to noncontrolling shareholders	—			—			(736		)	—			(736		)
Payments for contingent consideration	—			(14,802		)	(2,156		)	—			(16,958		)
Intercompany transactions	(141,614		)	137,304			4,310			—			—
Intercompany dividends paid	—			(17,400		)	(130,502		)	147,902			—
Net cash provided by (used in) financing activities from continuing operations	107,250			105,102			(129,084		)	147,902			231,170
Cash Flows from Discontinued Operations:
Net cash used in operating activities	(2,727		)	—			(600		)	—			(3,327		)
Net cash used in discontinued operations	(2,727		)	—			(600		)	—			(3,327		)
Effect of exchange rate changes on cash and cash equivalents	—			—			8,441			—			8,441
Net (decrease) increase in cash and cash equivalents	(28,111		)	12,511			110,545			—			94,945
Cash and cash equivalents at the beginning of the period	70,860			1,989			264,190			—			337,039
Cash and cash equivalents at the end of the period	$	42,749		$	14,500		$	374,735		$	—		$	431,984
	Year Ended December 31, 2012
	Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
	Company			Subsidiaries			Subsidiaries						Consolidated
	(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations	$	(178,017	)	$	310,736		$	160,802		$	(98,903	)	$	194,618
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment	(7,352		)	(39,118		)	(18,924		)	—			(65,394		)
Proceeds from sales of businesses and assets, net of cash sold	4,301			45,204			17,155			—			66,660
Payments for businesses and intangibles acquired, net of cash acquired	—			(105,195		)	(264,249		)	—			(369,444		)
Investments in affiliates	(80		)	—			—			—			(80		)
Net cash used in investing activities from continuing operations	(3,131		)	(99,109		)	(266,018		)	—			(368,258		)
Cash Flows from Financing Activities of Continuing Operations:
Decrease in notes payable and current borrowings	—			(421		)	(285		)	—			(706		)
Proceeds from share based compensation plans and the related tax impacts	8,238			—			—			—			8,238
Dividends	(55,589		)	—			—			—			(55,589		)
Payments for contingent consideration	—			(16,289		)	(1,307		)	—			(17,596		)
Intercompany transactions	196,850			(177,900		)	(18,950		)	—			—
Intercompany dividends paid	—			(16,900		)	(82,003		)	98,903			—
Net cash provided by (used in) financing activities from continuing operations	149,499			(211,510		)	(102,545		)	98,903			(65,653		)
Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities	(12,022		)	4,223			—			—			(7,799		)
Net cash used in investing activities	—			(2,351		)	—			—			(2,351		)
Net cash (used in) provided by discontinued operations	(12,022		)	1,872			—			—			(10,150		)
Effect of exchange rate changes on cash and cash equivalents	—			—			2,394			—			2,394
Net (decrease) increase in cash and cash equivalents	(43,671		)	1,989			(205,367		)	—			(247,049		)
Cash and cash equivalents at the beginning of the period	114,531			—			469,557			—			584,088
Cash and cash equivalents at the end of the period	$	70,860		$	1,989		$	264,190		$	—		$	337,039

Divestiturerelated_activities

Divestiture-related activities	12 Months Ended
	Dec. 31, 2014
Divestiture-Related Activities [Abstract]
Divestiture-related activities	Divestiture-related activities
	Assets Held for Sale
	The table below provides information regarding assets held for sale at December 31, 2014 and 2013. At December 31, 2014, these assets consisted of two buildings and other assets, which the Company is actively marketing.
		2014			2013
	Assets held for sale:	(Dollars in thousands)
	Property, plant and equipment	$	7,422		$	10,428
	Total assets held for sale	$	7,422		$	10,428
	Discontinued Operations
	The Company has recorded $3.4 million, $2.2 million and $2.7 million of expense during 2014, 2013 and 2012, respectively, associated with retained liabilities related to businesses that have been divested.
	On August 26, 2012, the Company completed the sale of the orthopedic business of its OEM segment for $45.2 million in cash and realized a loss of $39 thousand, net of tax, from the sale of this business.
	The results of the Company’s discontinued operations for the years 2014, 2013 and 2012 were as follows:
		2014			2013			2012
		(Dollars in thousands)
	Net revenues	$	—		$	—		$	16,616
	Costs and other expenses	3,407			2,205			18,328
	Goodwill impairment(1)	—			—			9,700
	Gain on disposition(2)	—			—			2,205
	Loss from discontinued operations before income taxes	(3,407		)	(2,205		)	(9,207		)
	Tax benefit on loss from discontinued operations	(698		)	(1,770		)	(1,887		)
	Loss from discontinued operations	$	(2,709	)	$	(435	)	$	(7,320	)
	-1	During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of its former orthopedic business to its estimated fair value.
	-2	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the Company's former cargo systems and cargo container businesses.

QUARTERLY_DATA_UNAUDITED

QUARTERLY DATA (UNAUDITED)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information	QUARTERLY DATA (UNAUDITED)
		First			Second			Third			Fourth
		Quarter			Quarter			Quarter			Quarter
		(Dollars in thousands, except per share)
	2014:00:00
	Net revenues	$	438,546		$	468,105		$	457,173		$	476,008
	Gross profit	221,159			244,088			236,166			241,015
	Income from continuing operations before interest and taxes	59,020			74,752			81,935			69,155
	Income from continuing operations	35,269			48,830			55,228			52,133
	Loss from discontinued operations	(125		)	(1,125		)	(271		)	(1,188		)
	Net income	35,144			47,705			54,957			50,945
	Less: Income from continuing operations attributable to noncontrolling interest	186			453			126			307
	Net income attributable to common shareholders	34,958			47,252			54,831			50,638
	Earnings per share available to common shareholders — basic(1):
	Income from continuing operations	$	0.85		$	1.17		$	1.33		$	1.25
	Loss from discontinued operations	—			(0.03		)	(0.01		)	(0.03		)
	Net income	$	0.85		$	1.14		$	1.32		$	1.22
	Earnings per share available to common shareholders — diluted(1):
	Income from continuing operations	$	0.77		$	1.04		$	1.18		$	1.1
	Loss from discontinued operations	(0.01		)	(0.02		)	—			(0.03		)
	Net income	$	0.76		$	1.02		$	1.18		$	1.07
	2013:00:00
	Net revenues	$	411,877		$	420,059		$	413,796		$	450,539
	Gross profit	200,520			209,490			203,992			224,943
	Income from continuing operations before interest, loss on extinguishment of debt and taxes	49,404			63,751			66,042			54,064
	Income from continuing operations	27,701			43,401			45,779			35,302
	(Loss) income from discontinued operations	(462		)	(766		)	1,029			(236		)
	Net income	27,239			42,635			46,808			35,066
	Less: Income from continuing operations attributable to noncontrolling interest	201			194			234			238
	Net income attributable to common shareholders	27,038			42,441			46,574			34,828
	Earnings per share available to common shareholders — basic(1):
	Income from continuing operations	$	0.67		$	1.05		$	1.11		$	0.85
	(Loss) income from discontinued operations	(0.01		)	(0.02		)	0.02			—
	Net income	$	0.66		$	1.03		$	1.13		$	0.85
	Earnings per share available to common shareholders — diluted(1):
	Income from continuing operations	$	0.64		$	0.99		$	1.05		$	0.78
	(Loss) income from discontinued operations	(0.01		)	(0.01		)	0.03			(0.01		)
	Net income	$	0.63		$	0.98		$	1.08		$	0.77
	(1) Each quarter is calculated as a discrete period; the sum of the four quarters may not equal the calculated full year amount.

SCHEDULE_II_VALUTAION_AND_QUAL

SCHEDULE II - VALUTAION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
SCHEDULE II - VALUTAION AND QUALIFYING ACCOUNTS	SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
	(Dollars in thousands)
	ALLOWANCE FOR DOUBTFUL ACCOUNTS
		Balance at		Dispositions			Additions			Accounts			Translation			Balance at
		Beginning of					Charged to			Receivable			and Other			End of
		Year					Income			Write-offs						Year
	31-Dec-14	$	10,722	$	—		$	1,882		$	(2,738	)	$	(1,083	)	$	8,783
	31-Dec-13	$	7,818	$	—		$	4,414		$	(1,446	)	$	(64	)	$	10,722
	31-Dec-12	$	6,452	$	—		$	1,730		$	(483	)	$	119		$	7,818
	INVENTORY RESERVE
		Balance at		Dispositions			Additions			Inventory			Translation			Balance at
		Beginning of					Charged to			Write-offs			and Other			End of
		Year					Income									Year
	31-Dec-14
	Raw material	$	5,687	$	—		$	1,840		$	(2,391	)	$	1,755		$	6,891
	Work-in-process	1,729		—			1,239			(1,720		)	(739		)	509
	Finished goods	24,957		—			10,135			(7,317		)	(1,301		)	26,474
		$	32,373	$	—		$	13,214		$	(11,428	)	$	(285	)	$	33,874
	31-Dec-13
	Raw material	$	9,394	$	—		$	1,931		$	(5,774	)	$	136		$	5,687
	Work-in-process	1,646		—			855			(340		)	(432		)	1,729
	Finished goods	20,663		—			11,440			(11,663		)	4,517			24,957
		$	31,703	$	—		$	14,226		$	(17,777	)	$	4,221		$	32,373
	31-Dec-12
	Raw material	$	9,095	$	(504	)	$	5,206		$	(4,346	)	$	(57	)	$	9,394
	Work-in-process	2,742		—			1,107			(2,204		)	1			1,646
	Finished goods	21,082		—			13,175			(12,183		)	(1,411		)	20,663
		$	32,919	$	(504	)	$	19,488		$	(18,733	)	$	(1,467	)	$	31,703
	DEFERRED TAX ASSET VALUATION ALLOWANCE
		Balance at		Additions			Reductions			Translation			Balance at
		Beginning of Year		Charged to			Credited to			and Other			End of Year
				Expense			Expense
	31-Dec-14	$	86,510	$	13,331		$	(3,741	)	$	3,041		$	99,141
	31-Dec-13	$	69,527	$	21,118		$	(1,553	)	$	(2,582	)	$	86,510
	31-Dec-12	$	66,305	$	6,103		$	(4,888	)	$	2,007		$	69,527

Summary_of_significant_account1

Summary of significant accounting policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Consolidation	Consolidation: The consolidated financial statements include the accounts of Teleflex Incorporated and its subsidiaries (the “Company”). Intercompany transactions are eliminated in consolidation. Investments in affiliates over which the Company has significant influence but not a controlling equity interest, including variable interest entities where the Company is not the primary beneficiary, are accounted for using the equity method. Investments in affiliates over which the Company does not have significant influence are accounted for using the cost method of accounting. These consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and include management’s estimates and assumptions that affect the recorded amounts.
	Effective January 1, 2014, the Company realigned its operating segments to reflect changes in the Company's internal financial reporting structure. All prior comparative periods have been restated to reflect these changes. Refer to Note 16 to the consolidated financial statements for additional information on the Company's changed reporting structure.
	The Company’s share-based compensation plan permits employees to elect to have shares withheld by the Company to satisfy their minimum statutory tax withholding obligations arising from the exercise or vesting of share-based awards.  The Company then remits, in cash, the withholding taxes to the appropriate tax authorities on behalf of the employee.  For the year ended December 31, 2014, the Company classified such payments as a cash outflow from financing activities under the line item “Proceeds from share-based compensation plans and the related tax impacts” within the consolidated statement of cash flows (i.e., the payment by the Company of the withholding taxes offsets, in part, increases in cash flow from financing activities resulting from the proceeds of the exercise and vesting of share-based awards and tax benefits related to such exercise and vesting).  The Company views the activity as, in effect, a repurchase of the employee’s shares.  The Company's payments were previously reported as a cash outflow from operating activities; therefore, the Company reclassified the cash outflows of $2.7 million and $1.6 million from operating to financing activities for the years ended December 31, 2013 and 2012, respectively, to conform to the presentation for the year ended December 31, 2014 within the consolidated statement of cash flows and within the condensed consolidating statement of cash flows included in Note 17.
Use of estimates	Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and cash equivalents	Cash and cash equivalents: All highly liquid debt instruments with an original maturity of three months or less are classified as cash equivalents. The carrying value of cash equivalents approximates their current market value.
Accounts receivable	Accounts receivable: Accounts receivable represents amounts due from customers related to the sale of products and provision of services. An allowance for doubtful accounts is maintained and represents the Company’s estimate of the amount of uncollectible receivables. The allowance is provided at such time as management believes reasonable doubt exists that such balances will be collected within a reasonable period of time. The allowance is based on the Company’s historical experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. In addition, the Company maintains a reserve for returns and allowances based on its historical experience.
Inventories	Inventories:  Inventories are valued at the lower of cost or market. The cost of the Company’s inventories is determined using the average cost method. Elements of cost in inventory include raw materials, direct labor, and manufacturing overhead. In estimating market value, the Company evaluates inventory for excess and obsolete quantities based on estimated usage and sales.
Property, plant and equipment	Property, plant and equipment: Property, plant and equipment are stated at cost, net of accumulated depreciation. Costs incurred to develop internal-use computer software during the application development stage generally are capitalized. Costs of enhancements to internal-use computer software are capitalized, provided that these enhancements result in additional functionality. Other additions and those improvements which increase the capacity or lengthen the useful lives of the assets are also capitalized. With minor exceptions, composite useful lives for property, plant and equipment, which are depreciated on a straight-line basis are as follows: land improvements — 5 years; buildings — 30 years; machinery and equipment — 3 to 10 years; computer equipment and software — 3 to 10 years. Leasehold improvements are depreciated over the lesser of the useful lives of the leasehold improvements or the remaining lease periods. Repairs and maintenance costs are expensed as incurred.
Goodwill and other intangible assets	Goodwill and other intangible assets: Goodwill and other intangible assets with indefinite lives are not amortized but are tested for impairment annually during the fourth quarter or more frequently if events or changes in circumstances indicate that an impairment may exist. Impairment losses, if any, are included in income from operations. The goodwill impairment test is applied to each of the Company’s reporting units whose assets include goodwill. For purposes of this assessment, a reporting unit is an operating segment, or a business one level below that operating segment (also known as a component) if discrete financial information is prepared and regularly reviewed by segment management. However, separate components are aggregated as a single reporting unit if they have similar economic characteristics.
	In applying the goodwill impairment test, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors may include, but are not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, and entity specific factors such as strategies and financial performance. If, after completing such assessment, it is determined more likely than not that the fair value of a reporting unit is less than its carrying value, the Company proceeds to a two-step quantitative impairment test. Alternatively, the Company may proceed directly to testing goodwill for impairment through the two-step quantitative impairment test, described below, without conducting the qualitative analysis. In the fourth quarter of 2014, the Company performed a qualitative assessment on five of its reporting units whose assets include goodwill and determined, based on the assessment, that the fair value of each of the reporting units was more likely than not higher than its carrying value. For the three remaining reporting units whose assets include goodwill, the Company elected to forego the qualitative assessment and apply the two-step quantitative impairment test.
	The first step of the two-step impairment test is to quantitatively compare the fair value of a reporting unit, including goodwill, to its carrying value. In performing the first step, the Company calculates the fair value of the reporting unit using equal weighting of two methods; one which estimates the discounted cash flows of the reporting unit based on projected earnings in the future (the Income Approach) and one which is based on sales of similar businesses or assets to those of the reporting unit in actual transactions (the Market Approach). If the reporting unit fair value exceeds the carrying value, there is no impairment. If the reporting unit carrying value exceeds the fair value, the Company would perform the second step of the goodwill impairment test, in which the Company would recognize an impairment loss if the carrying value of goodwill exceeds its implied fair value. The implied fair value of goodwill is determined by deducting the fair value of a reporting unit's identifiable assets and liabilities from the fair value of the reporting unit as a whole, as if that reporting unit had just been acquired and the fair value of the individual assets acquired and liabilities assumed were being determined initially. The Company performed the quantitative goodwill impairment test during the fourth quarter of 2014, on three of its reporting units whose assets include goodwill, and determined that the fair value of each of the reporting units exceeded the carrying value.  As a result, no impairment in the carrying value of any of the Company’s reporting units was evident.
	The Company’s intangible assets consist of customer lists, intellectual property, distribution rights and trade names. The Company tests its indefinite-lived intangible assets for impairment annually, and more frequently if events or changes in circumstances indicate that an impairment may have occurred. Similar to the goodwill impairment test process, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If, after completing the qualitative assessment, the Company determines it is more likely than not that the fair value of the indefinite-lived intangible asset is greater than its carrying amount, the asset is not impaired. If the Company concludes it is more likely than not that the fair value of the indefinite-lived intangible assets is less than the carrying value, the Company then proceeds to a quantitative impairment test, which consists of a comparison of the fair value of the intangible assets to their carrying amounts. Alternatively, the Company may elect to forgo the qualitative analysis and proceed directly to testing the indefinite-lived intangible asset for impairment through the quantitative impairment test. In the fourth quarter of 2014, the Company performed a qualitative assessment on all of its indefinite lived assets, except for two trade names, and determined, based on its assessment, that their fair values were more likely than not higher than their carrying values. For the remaining two trade names, the Company elected to test impairment through the quantitative test and determined that the fair value of the trade names exceeded the respective carrying values. As a result, no impairment in the carrying value of any of the Company's intangible assets was evident. The Company recorded in process research and development (IPR&D) impairment charges of $7.4 million in 2013, following its decision to abandon certain IPR&D projects. See Note 4 to the consolidated financial statements for further information related to these charges.
	Intangible assets consisting of intellectual property, customer lists, distribution rights and trade names that do not have indefinite lives are being amortized over their estimated useful lives, which are as follows: intellectual property, 3 to 20 years; customer lists, 5 to 30 years; distribution rights, 3 to 22 years; trade names, 1 to 30 years. The weighted average amortization period is approximately 13 years. The Company periodically evaluates the reasonableness of the useful lives of these assets.
Long-lived assets	Long-lived assets: The Company assesses the remaining useful life and recoverability of long-lived assets whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. The evaluation is based on various analyses, including undiscounted cash flow and profitability projections that incorporate, as applicable, the impact on the existing business.  Therefore, the evaluation involves significant management judgment. Any impairment loss, if indicated, is measured as the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset.
Foreign currency translation	Foreign currency translation: Assets and liabilities of subsidiaries with non-United States dollar denominated functional currencies are translated into United States dollars at the rates of exchange at the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the year. The translation adjustments are reported as a component of accumulated other comprehensive income.
Derivative financial instruments	Derivative financial instruments: The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in foreign currency exchange rates. All instruments are entered into for other than trading purposes. All derivatives are recognized on the balance sheet at fair value. Changes in the fair value of derivatives are recorded in the consolidated statement of comprehensive income (loss) as other comprehensive income, based on whether the instrument is designated as part of a hedge transaction and, if so, the type of hedge transaction. Gains or losses on derivative instruments reported in other comprehensive income are reclassified to the consolidated statement of income (loss) in the period in which earnings are affected by the underlying hedged item. The ineffective portion of all hedges is recognized in the current period consolidated statement of income (loss). If the hedging relationship ceases to be highly effective or it becomes probable that an expected transaction will no longer occur, gains or losses on the derivative are recorded in the current period consolidated statement of income (loss).
Share-based compensation	Share-based compensation: The Company estimates the fair value of share-based awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods. Share-based compensation expense related to stock options is measured using a Black-Scholes option pricing model that takes into account highly subjective and complex assumptions. The expected life of options granted is derived from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that options granted are expected to be outstanding. Expected volatility is based on a blend of historical volatility and implied volatility derived from publicly traded options to purchase the Company’s common stock, which the Company believes is more reflective of the market conditions and a better indicator of expected volatility than would be the case if the Company only used historical volatility. The risk-free interest rate is the implied yield currently available on United States Treasury zero-coupon issues with a remaining term equal to the expected life of the option.
	Share-based compensation expense recognized is based on the value of the portion of stock-based awards that is ultimately expected to vest during the period less estimated forfeitures. Forfeitures are required to be estimated at the time of grant. To minimize fluctuations in share-based compensation expense, management reviews and revises the estimate of forfeitures for all share-based awards on a quarterly basis based on management’s expectation of the awards that will ultimately vest.
Income taxes	Income taxes: The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized to reflect the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases, and to reflect operating loss and tax credit carryforwards. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Provision has been made for income taxes on unremitted earnings of subsidiaries and affiliates, except for subsidiaries in which earnings are deemed to be permanently reinvested.
	Significant judgment is required in determining income tax provisions and in evaluating tax positions. The Company establishes additional provisions for income taxes when, despite the belief that tax positions are supportable, there remain certain positions that do not meet the minimum probability threshold, which is a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority. In the normal course of business, the Company and its subsidiaries are examined by various federal, state and foreign tax authorities. The Company regularly assesses the potential outcomes of these examinations and any future examinations for the current or prior years in determining the adequacy of its provision for income taxes. Interest accrued with respect to unrecognized tax benefits and income tax related penalties are both included in taxes on income from continuing operations. The Company periodically assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, the current tax liability and deferred taxes in the period in which the facts that give rise to an adjustment become known.
Pensions and other postretirement benefits	Pensions and other postretirement benefits: The Company provides a range of benefits to eligible employees and retired employees, including pensions and postretirement healthcare. The Company records annual amounts relating to these plans based on calculations which include various actuarial assumptions such as discount rates, expected rates of return on plan assets, compensation increases, turnover rates and healthcare cost trend rates. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends when appropriate. The effect of the modifications is generally amortized over future periods.
Restructuring costs	Restructuring costs: Restructuring costs, which include termination benefits, facility closure costs, contract termination costs and other restructuring costs are recorded at estimated fair value. Key assumptions in calculating the restructuring costs include the terms and payments that may be negotiated to terminate certain contractual obligations and the timing of reductions in force.
Contingent consideration related to business acquisitions	Contingent consideration related to business acquisitions: In connection with business acquisitions, the Company may be required to pay future consideration that is contingent upon the achievement of specified objectives such as receipt of regulatory approval, commercialization of a product, achievement of sales targets, or the passage of time (collectively, "milestone payments"). As of the acquisition date, the Company records a contingent liability representing the estimated fair value of the contingent consideration that it expects to pay. The Company is required to reevaluate the fair value of contingent consideration each reporting period based on new developments and record changes in fair value until the contingent consideration obligation either is satisfied through payment upon the achievement of the specified objectives or is no longer payable due to the failure to achieve the specified objectives. The change in the fair value is recorded in the consolidated statement of income (loss). A contingent payment is classified as a financing activity in the consolidated statement of cash flows to the extent it was recorded as a liability as of the acquisition date. Any additional amount paid in excess of the amount initially accrued is classified as an operating activity in the consolidated statement of cash flows.
Revenue recognition	Revenue recognition: The Company recognizes revenues from product sales, including sales to distributors, or services provided when the following revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectability is reasonably assured. This generally occurs when products are shipped, when services are rendered or upon customers’ acceptance. Revenues are net of estimated returns and other allowances including rebates.
	The Company’s normal policy is to accept returns only in cases in which the product is defective and covered under the Company’s standard warranty provisions. However, in the limited cases where an arrangement provides a right of return to the customer, including a distributor, the Company believes it has the ability to reasonably estimate the amount of returns based on its substantial historical experience with respect to these arrangements. The Company accrues any costs or losses that may be expected in connection with any returns in accordance with FASB Accounting Standards Codification (“ASC”) Topic 450, “Contingencies.” Revenues and cost of goods sold are reduced to reflect estimated returns. The reserve for returns and allowances was $4.1 million and $3.3 million as of December 31, 2014 and 2013, respectively.
	Allowances related to customer incentive programs, which include discounts or rebates, are estimated and provided for in the period that the related sales are recorded. These allowances are recorded as a reduction of revenue. The Company also offers rebates to certain distributors and records the estimated rebate as a reduction of revenue at the time of sale. In estimating rebates, the Company considers the lag time between the point of sale and the payment of the distributor’s rebate claim, distributor-specific trend analyses, contractual commitments, including stated rebate rates, historical experience with respect to specific customers and other relevant information. The Company adjusts estimated rebates based on actual experience and records the adjustment as a reduction of sales in the period of adjustment.  The estimated reserve for the customer incentive programs, including distributor rebates, was $10.4 million and $7.8 million at December 31, 2014 and 2013, respectively. The Company expects the estimated rebates as of December 31, 2014 to be paid within 90 days subsequent to year-end.
Recently issued not yet effective	Recently issued not yet effective
	In April 2014, the Financial Accounting Standards Board (FASB) issued guidance for the reporting of discontinued operations. Under the new guidance, only those disposals of components of an entity that represent a strategic shift that has or will have a major effect on an entity's operations and financial results will be reported as discontinued operations in an entity's financial statements. In addition, the new guidance requires additional disclosures for discontinued operations designed to provide users of financial statements with more information about the assets, liabilities, revenues and expenses of discontinued operations. The new guidance also requires disclosures regarding disposals of a significant component of an entity that does not qualify for discontinued operations reporting.This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014 with early adoption permitted. The Company does not believe the adoption of this guidance will have a material impact on the Company’s results of operations, cash flows or financial position.
	In May 2014, the FASB, in a joint effort with the International Accounting Standards Board, issued new accounting guidance to clarify the principles for recognizing revenue.  The new guidance is designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, and will affect any entity that enters into contracts with customers or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards.  The new guidance establishes principles for reporting information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity's contracts with customers.  The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new guidance is effective prospectively for annual periods beginning after December 15, 2016, and interim periods within those years.  Early application is not permitted. The Company is currently evaluating this guidance to determine the impact on the Company’s results of operations, cash flows, and financial position.
	From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has assessed these recently issued standards that are not yet effective and believes the new standards will not have a material impact on the Company’s results of operations, cash flows or financial position.

Acquisitions_Tables

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table presents the preliminary fair value determination of the assets acquired and liabilities assumed in the acquisitions that occurred during 2014:
		(Dollars in thousands)
	Assets
	Current assets	$	10,512
	Property, plant and equipment	344
	Intangible assets:
	Intellectual property	37,000
	Trade name	300
	Customer list	9,335
	Goodwill	16,392
	Total assets acquired	73,883
	Less:
	Current liabilities	4,769
	Deferred tax liabilities	2,800
	Liabilities assumed	7,569
	Net assets acquired	$	66,314

Restructuring_and_other_impair1

Restructuring and other impairment charges (Tables)	12 Months Ended
	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring and Other Impairment Charges	Restructuring and other impairment charges by reportable segment for the twelve months ended December 31, 2014, 2013, and 2012 are set forth in the following table:
		2014			2013			2012
		(Dollars in thousands)
	Restructuring and other impairment charges
	Vascular North America	$	7,069		$	5,348		$	(1,120	)
	Anesthesia/Respiratory North America	1,379			3,207			983
	Surgical North America	—			6,525			278
	EMEA	6,375			16,122			1,995
	Asia	1,305			603			442
	OEM	—			588			83
	All other	1,741			6,059			376
	Total restructuring and other impairment charges	$	17,869		$	38,452		$	3,037
	The following table provides a summary of the Company’s current cost estimates by major type of expense associated with the 2014 Manufacturing Footprint Realignment Plan:
	Type of expense	Total estimated amount expected to be incurred
	Termination benefits	$11 million to $13 million
	Facility closure and other exit costs (1)	$2 million to $3 million
	Accelerated depreciation charges	$10 million to $11 million
	Other (2)	$14 million to $17 million
		$37 million to $44 million
	-1	Includes costs to transfer product lines among facilities and outplacement and employee relocation costs.
	-2	Consists of other costs directly related to the Plan, including project management, legal and regulatory costs.
LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Changes in Accrued Liability Associated with Restructuring Program	A reconciliation of the changes in accrued liabilities associated with the LMA Restructuring Program from December 31, 2012 through December 31, 2014 is set forth in the following table:
		Termination			Facility Closure Costs			Contract			Other			Total
		benefits						Termination			Restructuring
								Costs			Costs
		(Dollars in thousands)
	Balance at December 31, 2012	$	1,744		$	—		$	277		$	12		$	2,033
	Subsequent accruals	3,282			788			7,906			176			12,152
	Cash payments	(4,461		)	(362		)	(4,560		)	(164		)	(9,547		)
	Foreign currency translation	(13		)	1			63			(8		)	43
	Balance at December 31, 2013	552			427			3,686			16			4,681
	Subsequent accruals (reversals)	(29		)	(112		)	(3,188		)	—			(3,329		)
	Cash payments	(503		)	(317		)	(260		)	(4		)	(1,084		)
	Foreign currency translation	(20		)	2			(26		)	—			(44		)
	Balance at December 31, 2014	$	—		$	—		$	212		$	12		$	224
2014 Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Restructuring and Other Impairment Charges	The restructuring and other impairment charges recognized for the twelve months ended December 31, 2014, 2013 and 2012 consisted of the following:
		2014
	(in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs			Total
	2014 Manufacturing footprint realignment plan	$	9,200		$	—		$	—		$	60		$	9,260
	2014 European restructuring plan	7,237			1			345			225			7,808
	Other 2014 restructuring programs	552			—			2,754			244			3,550
	2013 Restructuring programs	562			—			249			22			833
	LMA restructuring program	(29		)	(112		)	(3,188		)	—			(3,329		)
	2012 Restructuring program	(619		)	354			—			—			(265		)
	2011 Restructuring program	—			12			—			—			12
	Total restructuring and other impairment charges	$	16,903		$	255		$	160		$	551		$	17,869
2013 Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Restructuring and Other Impairment Charges
		2013
	(in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs			Total
	2013 Restructuring programs	4,787			—			3,326			2,117			10,230
	LMA restructuring program	3,282			788			7,906			176			12,152
	2012 Restructuring program	2,993			935			296			5			4,229
	2011 Restructuring	—			42			728			—			770
	2007 Arrow integration program	—			230			—			—			230
		11,062			1,995			12,256			2,298			27,611
	Impairment charges	—			—			—			10,841			10,841
	Total restructuring and other impairment charges	$	11,062		$	1,995		$	12,256		$	13,139		$	38,452
2012 Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Restructuring and Other Impairment Charges
		2012
	(in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs			Total
	LMA restructuring program	$	2,229		$	—		$	274		$	12		2,515
	2012 Restructuring program	1,681			—			758			20			2,459
	2007 Arrow integration program	20			230			(2,166		)	(21		)	(1,937		)
	Total restructuring and other impairment charges	$	3,930		$	230		$	(1,134	)	$	11		$	3,037

Inventories_Tables

Inventories (Tables)	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventories	Inventories at December 31, 2014 and 2013 consisted of the following:
		2014			2013
		(Dollars in thousands)
	Raw materials	$	68,191		$	70,209
	Work-in-process	58,526			53,672
	Finished goods	242,750			242,113
		369,467			365,994
	Less: Inventory reserves	(33,874		)	(32,373		)
	Inventories, net	$	335,593		$	333,621

Property_plant_and_equipment_T

Property, plant and equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Major Classes of Property, Plant and Equipment at Cost	The major classes of property, plant and equipment, at cost, at December 31, 2014 and 2013 are as follows:
		2014			2013
		(Dollars in thousands)
	Land, buildings and leasehold improvements	$	194,923		$	199,741
	Machinery and equipment	320,999			322,060
	Computer equipment and software	107,743			102,527
	Construction in progress	51,834			55,092
		675,499			679,420
	Less: Accumulated depreciation	(358,064		)	(353,520		)
	Property, plant and equipment, net	$	317,435		$	325,900

Goodwill_and_other_intangible_1

Goodwill and other intangible assets (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill, by Reporting Segment	Changes in the carrying amount of goodwill, by reporting segment, for the twelve months ended December 31, 2014 and 2013 are as follows:
		Vascular North America			Anesthesia/Respiratory North America			Surgical North America			EMEA			Asia			All Other			Total
		(Dollars in thousands)
	Balance as of December 31, 2013
	Goodwill	$	459,696		$	167,195		$	250,506		$	373,417		$	136,946		$	298,571		$	1,686,331
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		240,169			60,122			250,506			373,417			136,946			293,043			1,354,203
	Goodwill related to acquisitions	—			—			406						15,986			—			$	16,392
	Translation adjustment	—			(681		)	—			(34,388		)	(8,220		)	(3,753		)	(47,042		)
	Balance as of December 31, 2014
	Goodwill	459,696			166,514			250,912			339,029			144,712			294,818			1,655,681
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		$	240,169		$	59,441		$	250,912		$	339,029		$	144,712		$	289,290		$	1,323,553
		Vascular North America			Anesthesia/Respiratory North America			Surgical North America			EMEA			Asia			All Other			Total
		(Dollars in thousands)
	Balance as of December 31, 2012
	Goodwill	$	407,090		$	167,942		$	245,794		$	353,282		$	139,469		$	257,003		1,570,580
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		187,563			60,869			245,794			353,282			139,469			251,475			1,238,452
	Goodwill related to acquisitions	52,606			—			4,712			17,922			6,394			41,650			123,284
	Translation adjustment	—			(747		)	—			2,213			(8,917		)	(82		)	(7,533		)
	Balance as of December 31, 2013
	Goodwill	459,696			167,195			250,506			373,417			136,946			298,571			1,686,331
	Accumulated impairment losses	(219,527		)	(107,073		)	—			—			—			(5,528		)	(332,128		)
		$	240,169		$	60,122		$	250,506		$	373,417		$	136,946		$	293,043		$	1,354,203
Components of Intangible Assets	Intangible assets at December 31, 2014 and 2013 consisted of the following:
		Gross Carrying Amount						Accumulated Amortization
		2014			2013			2014			2013
		(Dollars in thousands)
	Customer lists	$	624,574		$	628,020		$	(192,876	)	$	(168,223	)
	In-process research and development	68,694			68,786			—			—
	Intellectual property	467,068			435,869			(146,131		)	(118,086		)
	Distribution rights	16,101			16,797			(14,243		)	(14,592		)
	Trade names	396,269			407,879			(2,764		)	(1,148		)
	Noncompete agreements	337			337			(309		)	(42		)
		$	1,573,043		$	1,557,688		$	(356,323	)	$	(302,091	)
Estimated Annual Amortization Expense	Amortization expense related to intangible assets was $60.9 million, $50.6 million, and $44.3 million for the twelve months ended December 31, 2014, 2013 and 2012, respectively. Estimated annual amortization expense for each of the five succeeding years is as follows:
		(Dollars in thousands)
	2015	$	55,750
	2016	55,400
	2017	54,950
	2018	54,700
	2019	54,500

Borrowings_Tables

Borrowings (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Components of Long-Term Debt	The Company's debt obligations at December 31, 2014 and 2013 are set forth in the following table:
		2014			2013
		(Dollars in thousands)
	Senior Credit Facility:
	Revolving credit facility, at a rate of 1.92% at December 31, 2014 and 2013, due July 16, 2018	$	200,000		$	680,000
	3.875% Convertible Senior Subordinated Notes due 2017	399,898			400,000
	6.875% Senior Subordinated Notes due 2019	250,000			250,000
	5.25% Senior Notes due 2024	250,000			—
	Securitization program, at a rate of 0.92% at December 31, 2014 and 2013	4,700			4,700
		1,104,598			1,334,700
	Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017	(36,197		)	(48,413		)
		1,068,401			1,286,287
	Current borrowings	(368,401		)	(356,287		)
	Long-term borrowings	$	700,000		$	930,000
Interest Expense Amounts Related to Convertible Notes	The following table provides interest expense amounts related to the Convertible Notes for the periods presented:
	(in millions)	Year Ended December 31, 2014			Year Ended December 31, 2013			Year Ended December 31, 2012
	Interest cost related to contractual interest coupon	$	15.5		$	15.5		$	15.5
	Interest cost related to amortization of the discount	$	12.2		$	11.3		$	10.5
Carrying Value of Convertible Notes	The following table provides the carrying value of the Convertible Notes as of December 31, 2014 and 2013:
	(in millions)	31-Dec-14			31-Dec-13
	Principal amount of the Convertible Notes	$	399.9		$	400
	Unamortized discount	(36.2		)	(48.4		)
	Net carrying amount	$	363.7		$	351.6
Fair Value of Debt	The following table provides the fair value of the Company’s debt by fair value hierarchy level (see Note 10 to the consolidated financial statements for further information) as of December 31, 2014 and 2013:
		Fair value of debt
		31-Dec-14			31-Dec-13
		(Dollars in thousands)
	Level 1	$	1,024,806		$	899,390
	Level 2	455,222			648,712
	Total	$	1,480,028		$	1,548,102
Aggregate Amounts of Long-Term Debt	As of December 31, 2014, the aggregate amounts of long-term debt, demand loans and debt under the Company’s securitization program that will mature during each of the next four fiscal years and thereafter were as follows:
		(Dollars in thousands)
	2015(1)	$	404,598
	2016	—
	2017	—
	2018	200,000
	2019 and thereafter	500,000
	-1	The Convertible Notes are included in amounts that will mature in 2015 because, at December 31, 2014, they were convertible in accordance with their terms, which are described in more detail above in this section under “Convertible Notes.”

Financial_instruments_Tables

Financial instruments (Tables)	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
After Tax Gain/(Loss) Recognized in OCI	The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (“OCI”) for the years ended December 31, 2014, 2013 and 2012:
		After Tax Gain/(Loss)
		Recognized in OCI
		2014			2013			2012
		(Dollars in thousands)
	Interest rate swap	$	—		$	—		$	7,032
	Foreign currency exchange contracts	—			381			(156		)
	Total	$	—		$	381		$	6,876
Aggregate Accounts Receivable, Net of Allowance for Doubtful Accounts	The aggregate net current and long-term accounts receivable for customers in Spain, Italy, Greece and Portugal and the percentage of the Company’s total net current and long-term accounts receivable represented by the net current and long-term accounts receivables for customers in those countries at December 31, 2014 and 2013 are as follows:
		31-Dec-14			31-Dec-13
		(Dollars in thousands)
	Current and long-term accounts receivable (net of allowances of $8.1 million and $7.9 million in 2014 and 2013, respectively) in Spain, Italy, Greece and Portugal (1)	$	76,190		$	97,852
	Percentage of total net current and long-term accounts receivables	27.3		%	31		%
	(1)    The long-term portion of accounts receivable, net from customers in Spain, Italy, Greece and Portugal at December 31, 2014 and 2013 was $11.3 million and $17.6 million, respectively, and is reported in other assets.

Fair_value_measurement_Tables

Fair value measurement (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis	The following tables provide information regarding the financial assets and liabilities reported at fair value and measured on a recurring basis as of December 31, 2014 and 2013:
		Total carrying			Quoted prices in			Significant		Significant
		value at			active markets			other		unobservable
		December 31,			(Level 1)			observable		inputs (Level 3)
		2014						inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	6,863		$	6,863		$	—	$	—
	Contingent consideration liabilities	33,433			—			—		33,433
		Total carrying			Quoted prices in			Significant		Significant
		value at			active markets			other		unobservable
		December 31,			(Level 1)			observable		inputs (Level 3)
		2013						inputs (Level 2)
		(Dollars in thousands)
	Investments in marketable securities	$	6,150		$	6,150		$	—	$	—
	Contingent consideration liabilities	20,313			—			—		20,313
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis	The following table provides information regarding changes in financial liabilities, the fair value of which is based on Level 3 inputs, related to contingent consideration in connection with various Company acquisitions, including those described in Note 3 to the consolidated financial statements, during the twelve months ended December 31, 2014 and 2013:
		Contingent consideration
		2014			2013
		(Dollars in thousands)
	Beginning balance – January 1	$	20,313		$	51,196
	Initial estimate upon acquisition	20,538			—
	Payment	—			(18,880		)
	Revaluations	(7,418		)	(11,982		)
	Translation adjustment	—			(21		)
	Ending balance – December 31	$	33,433		$	20,313
Valuation Technique and Inputs Used to Determine Fair Value of Assets or Liabilities	The following table provides information regarding the valuation techniques and inputs used in determining the fair value of the contingent consideration liabilities measured by Level 3 inputs:
		Valuation Technique		Unobservable Input	Range (Weighted Average)
	Contingent consideration	Discounted cash flow		Discount rate	2.3% - 10% (7.0%)
				Probability of payment	0% - 100% (52.6%)

Shareholders_equity_Tables

Shareholders' equity (Tables)	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Schedule of Weighted Average Number of Shares	The following table provides a reconciliation of basic to diluted weighted average shares outstanding:
		2014			2013			2012
		(Shares in thousands)
	Basic	41,366			41,105			40,859
	Dilutive effect of share based awards	450			410			—
	Dilutive effect of 3.875% Convertible Notes and warrants	4,654			2,178			—
	Diluted	46,470			43,693			40,859
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables provide information relating to the changes in accumulated other comprehensive income (loss), net of tax, for the twelve months ended December 31, 2014 and 2013:
		Cash Flow				Pension and			Foreign			Accumulated
		Hedges				Other			Currency			Other
						Postretirement			Translation			Comprehensive
						Benefit Plans			Adjustment			Income (Loss)
		(Dollars in thousands)
	Balance at December 31, 2012	$	(381	)		$	(127,257	)	$	(4,410	)	$	(132,048	)
	Other comprehensive income (loss) before reclassifications	(549		)		25,464			(9,408		)	15,507
	Amounts reclassified from accumulated other comprehensive income (loss)	930				4,756			—			5,686
	Net current-period other comprehensive income (loss)	381				30,220			(9,408		)	21,193
	Balance at December 31, 2013	—				(97,037		)	(13,818		)	(110,855		)
	Other comprehensive income (loss) before reclassifications	594				(47,536		)	(105,333		)	(152,275		)
	Amounts reclassified from accumulated other comprehensive income (loss)	(594		)		2,829			—			2,235
	Net current-period other comprehensive loss	—				(44,707		)	(105,333		)	(150,040		)
	Balance at December 31, 2014	$	—			$	(141,744	)	$	(119,151	)	$	(260,895	)
Reclassification out of Accumulated Other Comprehensive Income	The following table provides information relating to the reclassifications of losses/(gain) in accumulated other comprehensive income into expense/(income), net of tax, for the twelve months ended December 31, 2014 and 2013:
		31-Dec-14				31-Dec-13
		(Dollars in thousands)
	Gains and losses on foreign exchange contracts:
	Cost of goods sold	(705		)		884
	Total before tax	(705		)		884
	Taxes	111				46
	Net of tax	$	(594	)		$	930
	Amortization of pension and other postretirement benefits items (1):
	Actuarial losses	$	4,385			$	7,211
	Prior-service costs	(21		)		(21		)
	Transition obligation	—				5
	Total before tax	4,364				7,195
	Tax benefit	(1,535		)		(2,439		)
	Net of tax	$	2,829			$	4,756
	Total reclassifications, net of tax	$	2,235			$	5,686
	-1	These accumulated other comprehensive income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 14 to the consolidated financial statements  for additional information).

Stock_compensation_plans_Table

Stock compensation plans (Tables)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation [Abstract]
Weighted-Average Assumptions used to Estimate Fair Value of Options Granted	The fair value of options granted in 2014, 2013 and 2012 was estimated at the date of grant using a multiple point Black-Scholes option pricing model. The following weighted-average assumptions were used:
		2014		2013		2012
	Risk-free interest rate	1.45	%	0.75	%	0.81	%
	Expected life of option	4.89 years		4.87 years		4.85 years
	Expected dividend yield	1.34	%	1.73	%	2.28	%
	Expected volatility	21.44	%	24.65	%	28.46	%
Weighted-Average Assumptions used to Estimate Fair Value of Non-Vested Shares Granted	The following weighted-average assumptions were used:
		2014		2013		2012
	Risk-free interest rate	0.65	%	0.36	%	0.37	%
	Expected dividend yield	1.34	%	1.71	%	2.24	%
Summary of Stock Option Activity	The following table summarizes the option activity during 2014:
		Shares Subject to Options		Weighted Average Exercise Price			Weighted Average Remaining Contractual Life In Years	Aggregate
								Intrinsic
								Value
								(Dollars in thousands)
	Outstanding, beginning of the year	1,279,480		$	65.05
	Granted	343,580		101.45
	Exercised	(362,719	)	60.86
	Forfeited or expired	(26,669	)	87.37
	Outstanding, end of the year	1,233,672		75.93			7.3	$	47,974
	Exercisable, end of the year	647,425		$	64.82		6.1	$	32,373
Summary of Non-Vested Restricted Stock Unit Activity	The Company recorded $4.6 million of expense related to the portion of the shares underlying options

Income_taxes_Tables

Income taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Components of Provision for Income Taxes from Continuing Operations	The following table summarizes the components of the provision for income taxes from continuing operations:
		2014				2013				2012
		(Dollars in thousands)
	Current:
	Federal	$	12,348			$	(2,996	)		$	21,046
	State	1,912				1,736				3,623
	Foreign	30,748				36,422				30,389
	Deferred:
	Federal	(6,593		)		(9,565		)		(34,629		)
	State	3,435				(1,825		)		(720		)
	Foreign	(13,200		)		(225		)		(3,296		)
		$	28,650			$	23,547			$	16,413
Summaries of U.S. and Non-U.S. Components of Income from Continuing Operations Before Taxes	The following table summarizes the United States and non-United States components of income from continuing operations before taxes:
		2014				2013				2012
		(Dollars in thousands)
	United States	$	(23,875	)		$	(3,323	)		$	(315,707	)
	Other	243,985				179,053				150,338
		$	220,110			$	175,730			$	(165,369	)
Reconciliations Between Statutory Federal Income Tax Rate and Effective Income Tax Rate	Reconciliations between the statutory federal income tax rate and the effective income tax rate are as follows:
		2014			2013			2012
	Federal statutory rate	35	%		35	%		35	%
	Goodwill impairment	—			—			(60.84	)
	Tax effect of International items	(22.54	)		(14.83	)		11.28
	State taxes, net of federal benefit	2.1			(0.32	)		(0.90	)
	Uncertain tax contingencies	(0.83	)		(4.06	)		4.85
	Contingent consideration reversals	(1.18	)		(2.04	)		—
	Other, net	0.47			(0.35	)		0.68
		13.02	%		13.4	%		(9.93	)%
Deferred Tax Assets and Liabilities	The following table summarizes significant components of the Company’s deferred tax assets and liabilities at December 31, 2014 and 2013:
		2014				2013
		(Dollars in thousands)
	Deferred tax assets:
	Tax loss and credit carryforwards	$	112,796			$	104,043
	Pension	63,669				39,310
	Reserves and accruals	42,296				38,684
	Other	28,416				27,886
	Less: valuation allowances	(99,141		)		(86,510		)
	Total deferred tax assets	148,036				123,413
	Deferred tax liabilities:
	Property, plant and equipment	31,143				26,550
	Intangibles — stock acquisitions	384,734				400,297
	Unremitted foreign earnings	116,595				147,326
	Other	10,756				12,030
	Total deferred tax liabilities	543,228				586,203
	Net deferred tax liability	$	(395,192	)		$	(462,790	)
Uncertain Tax Positions for Liabilities Associated with Unrecognized Tax Benefits	Uncertain Tax Positions: The following table is a reconciliation of the beginning and ending balances for liabilities associated with unrecognized tax benefits for the twelve month periods ending December 31, 2014, 2013 and 2012:
		2014				2013				2012
		(Dollars in thousands)
	Balance at January 1	$	55,771			$	62,108			$	75,026
	Increase in unrecognized tax benefits related to prior years	—				—				1,110
	Decrease in unrecognized tax benefits related to prior years	—				—				(6,134		)
	Unrecognized tax benefits related to the current year	910				1,838				4,256
	Reductions in unrecognized tax benefits due to settlements	(132		)		—				(8,816		)
	Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations	(3,235		)		(8,433		)		(3,503		)
	Increase (decrease) in unrecognized tax benefits due to foreign currency translation	(2,230		)		258				169
	Balance at December 31	$	51,084			$	55,771			$	62,108
Examinations by Major Tax Jurisdictions	The taxable years that remain subject to examination by major tax jurisdictions are as follows:
		Beginning		Ending
	United States	2010		2014
	Canada	2005		2014
	China	2009		2014
	Czech Republic	2011		2014
	France	2012		2014
	Germany	2007		2014
	India	2008		2014
	Ireland	2010		2014
	Italy	2010		2014
	Malaysia	2010		2014
	Singapore	2010		2014

Pension_and_other_postretireme1

Pension and other postretirement benefits (Tables)	12 Months Ended
	Dec. 31, 2014
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Net Benefit Cost of Pension and Postretirement Benefit Plans	The following table provides information regarding the net benefit cost of pension and postretirement benefit plans for continuing operations:
		Pension											Other Benefits
		2014				2013				2012			2014				2013			2012
		(Dollars in thousands)
	Service cost	$	1,794			$	1,819			$	2,331		$	424			$	663		$	704
	Interest cost	18,000				16,842				16,561			2,169				2,707			2,122
	Expected return on plan assets	(25,006		)		(23,122		)		(20,245		)	—				—			—
	Net amortization and deferral	4,371				5,847				6,474			(7		)		1,348			761
	Curtailment gain	—				—				(197		)	—				—			—
	Settlement loss	—				—				106			—				—			—
	Net benefit cost	$	(841	)		$	1,386			$	5,030		$	2,586			$	4,718		$	3,587
Weighted Average Assumptions used in Determining Net Periodic Benefit Cost	The following table provides the weighted average assumptions for United States and foreign plans used in determining net benefit cost:
		Pension									Other Benefits
		2014			2013			2012			2014		2013			2012
	Discount rate	5	%		4.3	%		4.3	%		4.7	%	3.8	%		4	%
	Rate of return	8.3	%		8.3	%		8.3	%		—	%	—	%		—	%
	Initial healthcare trend rate	—	%		—	%		—	%		7.5	%	8.2	%		8.5	%
	Ultimate healthcare trend rate	—	%		—	%		—	%		5	%	5	%		5	%
	The following table provides the weighted average assumptions for United States and foreign plans used in determining benefit obligations:
		Pension						Other Benefits
		2014			2013			2014			2013
	Discount rate	4.1	%		5	%		4	%		4.7	%
	Rate of compensation increase	3	%		3	%		—			—
	Initial healthcare trend rate	—			—			7.3	%		7	%
	Ultimate healthcare trend rate	—			—			5	%		5	%
Pension and Postretirement Benefit Plans	The following table provides summarized information with respect to the Company’s pension and postretirement benefit plans, measured as of December 31, 2014 and 2013:
		Pension								Other Benefits
		2014				2013				2014			2013
		Under Funded								Under Funded
		(Dollars in thousands)
	Benefit obligation, beginning of year	$	367,731			$	397,184			$	52,448		$	55,609
	Service cost	1,794				1,819				424			663
	Interest cost	18,000				16,842				2,169			2,707
	Actuarial loss (gain)	82,922				(30,755		)		1,273			(3,833		)
	Currency translation	(2,973		)		861				—			—
	Benefits paid	(17,988		)		(17,004		)		(3,287		)	(2,860		)
	Medicare Part D reimbursement	—				—				127			162
	Administrative costs	(1,522		)		(1,216		)		—			—
	Projected benefit obligation, end of year	447,964				367,731				53,154			52,448
	Fair value of plan assets, beginning of year	305,481				276,863				—			—
	Actual return on plan assets	34,332				28,813				—			—
	Contributions	9,539				17,724				—			—
	Benefits paid	(17,988		)		(17,004		)		—			—
	Settlements paid	—				—				—			—
	Administrative costs	(1,522		)		(1,216		)		—			—
	Currency translation	(1,012		)		301				—			—
	Fair value of plan assets, end of year	328,830				305,481				—			—
	Funded status, end of year	$	(119,134	)		$	(62,250	)		$	(53,154	)	$	(52,448	)
Amounts Recognized in the Consolidated Balance Sheet	The following table sets forth the amounts recognized in the consolidated balance sheet with respect to the plans:
		Pension								Other Benefits
		2014				2013				2014			2013
		(Dollars in thousands)
	Payroll and benefit-related liabilities	$	(1,779	)		$	(1,819	)		$	(3,268	)	$	(3,381	)
	Pension and postretirement benefit liabilities	(117,355		)		(60,431		)		(49,886		)	(49,067		)
	Accumulated other comprehensive loss	213,117				144,866				8,353			7,073
		$	93,983			$	82,616			$	(44,801	)	$	(45,375	)
Amounts Recognized in Accumulated Other Comprehensive (Income) Loss	The following tables set forth the amounts recognized in accumulated other comprehensive income (loss) with respect to the plans:
		Pension
		Prior Service				Net (Gain)				Deferred			Accumulated
		Cost (Credit)				or Loss				Taxes			Other
													Comprehensive
													(Income) Loss,
													Net of Tax
		(Dollars in thousands)
	Balance at December 31, 2012	$	216			$	186,700			$	(67,567	)	$	119,349
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net amortization and deferral	(34		)		(5,813		)		1,947			(3,900		)
	Amounts arising during the period:
	Actuarial changes in benefit obligation	—				(36,446		)		13,206			(23,240		)
	Impact of currency translation	—				243				(66		)	177
	Balance at December 31, 2013	182				144,684				(52,480		)	92,386
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net amortization and deferral	(34		)		(4,337		)		1,539			(2,832		)
	Amounts arising during the period:
	Actuarial changes in benefit obligation	—				73,596				(26,131		)	47,465
	Impact of currency translation	—				(974		)		265			(709		)
	Balance at December 31, 2014	$	148			$	212,969			$	(76,807	)	$	136,310
		Other Benefits
		Prior Service				Initial				Net (Gain) or			Deferred				Accumulated
		Cost (Credit)				Obligation				Loss			Taxes				Other
																	Comprehensive
																	(Income) Loss,
																	Net of Tax
		(Dollars in thousands)
	Balance at December 31, 2012	$	(38	)		$	5			$	12,287		$	(4,346	)		$	7,908
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net Amortization and deferral	55				(5		)		(1,398		)	492				(856		)
	Amounts Arising During the period:
	Actuarial changes in benefit obligation	—				—				(3,833		)	1,432				(2,401		)
	Balance at December 31, 2013	17				—				7,056			(2,422		)		4,651
	Reclassification adjustments related to components of Net Periodic Benefit Cost recognized during the period:
	Net Amortization and deferral	55				—				(48		)	(4		)		3
	Amounts Arising During the period:
	Actuarial changes in benefit obligation	—				—				1,273			(493		)		780
	Balance at December 31, 2014	$	72			$	—			$	8,281		$	(2,919	)		$	5,434
Fair Values of Pension Plan Assets	The following table provides the fair values of the Company’s pension plan assets at December 31, 2014 by asset category:
			Fair Value Measurements
	Asset Category (a)		Total				Quoted Prices in				Significant			Significant
							Active Markets for				Observable			Unobservable
							Identical Assets				Inputs			Inputs
							(Level 1)				(Level 2)			(Level 3)
			(Dollars in thousands)
	Cash		$	659			$	659			$	—		$	—
	Money market funds		31				31				—			—
	Equity securities:
	Managed volatility (b)		83,068				83,068				—			—
	United States small/mid-cap equity (c)		20,312				20,312				—			—
	World Equity (excluding United States) (d)		26,064				26,064				—			—
	Common Equity Securities – Teleflex Incorporated		13,422				13,422				—			—
	Diversified United Kingdom Equity		875				875				—			—
	Diversified Global		2,884				2,884				—			—
	Emerging Markets		1,266				1,266				—			—
	Fixed income securities:
	Long duration bond fund (e)		92,553				92,553				—			—
	UK corporate bond fund		2,719				2,719				—			—
	UK Government bond fund		5,078				5,078				—			—
	High yield bond fund (f)		11,618				11,618				—			—
	Emerging markets debt fund (g)		8,531								8,531			—
	Corporate, government and foreign bonds		81								81			—
	Asset backed – home loans		782								782			—
	Other types of investments:
	Structured credit (h)		31,176								—			31,176
	Hedge fund of funds (i)		23,171								—			23,171
	UK Property Fund (j)		1,549								1,549			—
	Multi asset fund  (k)		2,986				2,986				—			—
	Other		5				—				—			5
	Total		$	328,830			$	263,535			$	10,943		$	54,352
	The following table provides the fair values of the Company’s pension plan assets at December 31, 2013 by asset category:
			Fair Value Measurements
	Asset Category (a)		Total				Quoted Prices in				Significant			Significant
							Active Markets for				Observable			Unobservable
							Identical Assets				Inputs			Inputs
							(Level 1)				(Level 2)			(Level 3)
			(Dollars in thousands)
	Cash		$	472			$	472			$	—		$	—
	Money market funds		310				310				—			—
	Equity securities:
	Managed volatility (b)		77,140				77,140				—			—
	United States small/mid-cap equity (c)		19,760				19,760				—			—
	World Equity (excluding United States) (d)		30,183				30,183				—			—
	Common Equity Securities – Teleflex Incorporated		10,972				10,972				—			—
	Diversified United Kingdom Equity		928				928				—			—
	Diversified Global		2,319				2,319				—			—
	Emerging Markets		1,270				1,270				—			—
	Fixed income securities:
	Long duration bond fund (e)		76,608				76,608				—			—
	UK corporate bond fund		2,569				2,569				—			—
	UK Government bond fund		4,455				4,455				—			—
	High yield bond fund (f)		12,754				12,754				—			—
	Emerging markets debt fund (g)		9,003				—				9,003			—
	Corporate, government and foreign bonds		87				—				87			—
	Asset backed – home loans		847				—				847			—
	Other types of investments:
	Structured credit (h)		29,109				—				—			29,109
	Hedge fund of funds (i)		22,540				—				—			22,540
	UK Property Fund (j)		1,402				—				1,402			—
	Multi asset fund  (k)		2,748				2,748				—			—
	Other		5				—				—			5
	Total		$	305,481			$	242,488			$	11,339		$	51,654
(a)	Information on asset categories described in notes (b)-(k) is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.
(b)	This category comprises mutual funds that invest in securities of United States and non-United States companies of all capitalization ranges that exhibit relatively low volatility.
(c)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of small and mid-sized companies. The fund invests in common stocks or exchange traded funds holding common stock of United States companies with market capitalizations in the range of companies in the Russell 2500 Index.
(d)	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of foreign companies. These securities may include common stocks, preferred stocks, warrants, exchange traded funds based on an international equity index and derivative instruments whose value is based on an international equity index and derivative instruments whose value is based on an underlying equity security or a basket of equity securities. The fund invests in securities of foreign issuers located in developed and emerging market countries. However, the fund will not invest more than 30% of its assets in the common stocks or other equity securities of issuers located in emerging market countries.
(e)	This category comprises a mutual fund that invests in instruments or derivatives having economic characteristics similar to fixed income securities. The fund invests in investment grade fixed income instruments, including securities issued or guaranteed by the United States Government and its agencies and instrumentalities, corporate bonds, asset-backed securities, exchange traded funds, mortgage-backed securities and collateralized mortgage-backed securities. The fund invests primarily in long duration government and corporate fixed income securities, and uses derivative instruments, including interest rate swap agreements and Treasury futures contracts, for the purpose of managing the overall duration and yield curve exposure of the Fund’s portfolio of fixed income securities.
(f)	This category comprises a mutual fund that invests at least 80% of its net assets in higher-yielding fixed income securities, including corporate bonds and debentures, convertible and preferred securities and zero coupon obligations.
(g)	This category comprises a mutual fund that invests at least 80% of its net assets in fixed income securities of emerging market issuers, primarily in United States dollar-denominated debt of foreign governments, government-related and corporate issuers in emerging market countries and entities organized to restructure the debt of those issuers.
(h)	This category comprises a fund that invests primarily in collateralized debt obligations (“CDOs”) and other structured credit vehicles. The fund investments may include fixed income securities, loan participants, credit-linked notes, medium-term notes, pooled investment vehicles and derivative instruments.
(i)	This category comprises a hedge fund that invests in various other hedge funds. As of December 31, 2014 and 2013:
•	approximately 33% and 28%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;
•	approximately 10% and 18%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;
•	approximately 24% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;
•	approximately 33% and 23%, respectively, of the assets were held in funds with an event driven strategy; and
•	approximately 6% of the assets were held in cash as of December 31, 2013.
(j)	This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
(k)	This category comprises a mutual fund that invests primarily in equities, bonds and alternatives.
Reconciliation of Changes in Level 3 Pension Assets Measured at Fair Value on Recurring Basis	The following table provides a reconciliation of changes in pension assets measured at fair value on a recurring basis, using Level 3 inputs, from December 31, 2012 through December 31, 2014:
		(Dollars in thousands)
	Balance at December 31, 2012	$	48,198
	Unrealized gain on assets	3,456
	Balance at December 31, 2013	51,654
	Unrealized gain on assets	2,698
	Balance at December 31, 2014	$	54,352
Expected Benefit Payments	The following table provides information about the Company’s expected benefit payments for U.S. and foreign plans for each of the five succeeding years and the aggregate of the five years thereafter, net of the annual average Medicare Part D subsidy of approximately $0.2 million:
		Pension				Other Benefits
		(Dollars in thousands)
	2015	$	17,841			$	3,268
	2016	18,449				3,362
	2017	19,023				3,334
	2018	19,653				3,367
	2019	20,472				3,416
	Years 2020 — 2024	114,185				18,229

Commitments_and_contingent_lia1

Commitments and contingent liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Future Minimum Lease Payments Under Noncancelable Operating Leases	Future minimum lease payments as of December 31, 2014 under noncancelable operating leases are as follows:
		Future Lease Payments
		(Dollars in thousands)
	2015	$	27,706
	2016	23,292
	2017	18,846
	2018	15,474
	2019 and thereafter	32,182

Business_segments_and_other_in1

Business segments and other information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Business segments and other information	The following tables present the Company’s segment results for the twelve months ended December 31, 2014, 2013 and 2012:
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Revenue
	Vascular North America	$	259,227		$	231,112		$	222,749
	Anesthesia/Respiratory North America	222,650			228,485			180,363
	Surgical North America	150,121			146,058			143,875
	EMEA	593,065			557,427			510,248
	Asia	237,696			207,207			173,721
	OEM	143,966			131,173			140,230
	All other	233,107			194,809			179,823
	Consolidated net revenues	$	1,839,832		$	1,696,271		$	1,551,009
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Operating Profit
	Vascular North America	$	41,079		$	23,798		$	26,048
	Anesthesia/Respiratory North America	26,574			21,910			14,048
	Surgical North America	49,592			50,334			50,615
	EMEA	114,650			87,902			65,822
	Asia	62,152			63,822			52,541
	OEM	30,635			27,328			31,664
	All other	40,482			27,191			18,759
	Total segment operating profit (1)	365,164			302,285			259,497
	Unallocated expenses (2)	(80,302		)	(69,024		)	(356,872		)
	Income from continuing operations before interest, loss on extinguishments of debt and taxes	$	284,862		$	233,261		$	(97,375	)
	-1	Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for certain manufacturing variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
	-2	Unallocated expenses primarily include manufacturing variances and fixed manufacturing costs, with the exception of certain manufacturing variances allocated to the segments as noted above, as well as net gain on sales of assets, goodwill impairment and restructuring and other impairment charges.
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Depreciation and Amortization
	Vascular North America	$	31,782		$	28,719		$	23,063
	Anesthesia/Respiratory North America	17,109			13,162			7,955
	Surgical North America	6,316			10,549			3,646
	EMEA	38,062			29,947			22,975
	Asia	8,515			4,960			3,653
	OEM	6,175			4,876			4,083
	All other	19,071			15,722			29,509
	Consolidated depreciation and amortization	$	127,030		$	107,935		$	94,884
	Business segments and other information
	An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The Company does not evaluate its operating segments using discrete asset information.
	Effective January 1, 2014, the Company realigned its operating segments due to changes in the Company’s internal financial reporting structure. The Company’s North American Vascular, Anesthesia/Respiratory and Surgical businesses, which previously comprised much of the former Americas reportable segment, are now separate reportable segments.  As a result, the Company now has six reportable segments: Vascular North America, Anesthesia/Respiratory North America, Surgical North America, EMEA, Asia and OEM. Certain operating segments are not material and are therefore included in the “All other” line item in tabular presentations of segment information. Additionally, the Company changed the allocation methodology for certain corporate costs, including manufacturing variances and research and development costs, among its businesses to improve accountability, which resulted in changes to the previously reported segment operating profit. All prior comparative periods have been restated to reflect these changes.
	The Company’s reportable segments other than the OEM segment design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care and generally serve two end markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers.
	The following tables present the Company’s segment results for the twelve months ended December 31, 2014, 2013 and 2012:
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Revenue
	Vascular North America	$	259,227		$	231,112		$	222,749
	Anesthesia/Respiratory North America	222,650			228,485			180,363
	Surgical North America	150,121			146,058			143,875
	EMEA	593,065			557,427			510,248
	Asia	237,696			207,207			173,721
	OEM	143,966			131,173			140,230
	All other	233,107			194,809			179,823
	Consolidated net revenues	$	1,839,832		$	1,696,271		$	1,551,009
		Year Ended December 31:
		2014			2013			2012
		(Dollars in thousands)
	Operating Profit
	Vascular North America	$	41,079		$	23,798		$	26,048
	Anesthesia/Respiratory North America	26,574			21,910			14,048
Surgical North America	49,592			50,334			50,615
EMEA	114,650			87,902			65,822
Asia	62,152			63,822			52,541
OEM	30,635			27,328			31,664
All other	40,482			27,191			18,759
Total segment operating profit (1)	365,164			302,285			259,497
Unallocated expenses (2)	(80,302		)	(69,024		)	(356,872		)
Income from continuing operations before interest, loss on extinguishments of debt and taxes	$	284,862		$	233,261		$	(97,375	)
-1	Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for certain manufacturing variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
-2	Unallocated expenses primarily include manufacturing variances and fixed manufacturing costs, with the exception of certain manufacturing variances allocated to the segments as noted above, as well as net gain on sales of assets, goodwill impairment and restructuring and other impairment charges.
	Year Ended December 31:
	2014			2013			2012
	(Dollars in thousands)
Depreciation and Amortization
Vascular North America	$	31,782		$	28,719		$	23,063
Anesthesia/Respiratory North America	17,109			13,162			7,955
Surgical North America	6,316			10,549			3,646
EMEA	38,062			29,947			22,975
Asia	8,515			4,960			3,653
OEM	6,175			4,876			4,083
All other	19,071			15,722			29,509
Consolidated depreciation and amortization	$	127,030		$	107,935		$	94,884
The following table provides total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2014, 2013 and 2012:
	Year Ended
	2014			2013			2012
	(Dollars in thousands)
Net revenues (based on the Company's selling location):
United States	$	916,619		$	844,884		$	789,771
Other Americas	60,736			57,098			53,665
Europe	664,982			568,559			516,982
All Other	197,495			225,730			190,591
	$	1,839,832		$	1,696,271		$	1,551,009
Net property, plant and equipment:
United States	$	174,893		$	203,985		$	180,833
Malaysia	36,427			29,313			27,764
Czech Republic	35,655			41,607			45,884
All Other	70,460			50,995			43,464
	$	317,435		$	325,900		$	297,945
Total Net Revenues and Total Net Property, Plant and Equipment by Geographic Region	The following table provides total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2014, 2013 and 2012:
		Year Ended
		2014			2013			2012
		(Dollars in thousands)
	Net revenues (based on the Company's selling location):
	United States	$	916,619		$	844,884		$	789,771
	Other Americas	60,736			57,098			53,665
	Europe	664,982			568,559			516,982
	All Other	197,495			225,730			190,591
		$	1,839,832		$	1,696,271		$	1,551,009
	Net property, plant and equipment:
	United States	$	174,893		$	203,985		$	180,833
	Malaysia	36,427			29,313			27,764
	Czech Republic	35,655			41,607			45,884
	All Other	70,460			50,995			43,464
		$	317,435		$	325,900		$	297,945

Condensed_consolidating_guaran1

Condensed consolidating guarantor financial information (Tables)	12 Months Ended
	Dec. 31, 2014
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed Consolidating Statements of Income (Loss) and Comprehensive Income (Loss)	CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
		Year Ended December 31, 2014
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net revenues	$	—		$	1,078,851		$	1,132,152		$	(371,171	)	$	1,839,832
	Cost of goods sold	—			652,742			608,256			(363,594		)	897,404
	Gross profit	—			426,109			523,896			(7,577		)	942,428
	Selling, general and administrative expenses	42,829			326,282			209,930			(384		)	578,657
	Research and development expenses	—			40,546			20,494			—			61,040
	Restructuring and other impairment charges	—			10,189			7,680			—			17,869
	Income (loss) from continuing operations before interest and taxes	(42,829		)	49,092			285,792			(7,193		)	284,862
	Interest expense	144,869			(85,885		)	6,474			—			65,458
	Interest income	—			(1		)	(705		)	—			(706		)
	Income (loss) from continuing operations before taxes	(187,698		)	134,978			280,023			(7,193		)	220,110
	Taxes (benefit) on income (loss) from continuing operations	(68,307		)	68,690			28,159			108			28,650
	Equity in net income of consolidated subsidiaries	308,396			233,827			252			(542,475		)	—
	Income from continuing operations	189,005			300,115			252,116			(549,776		)	191,460
	Operating loss from discontinued operations	(2,196		)	—			(1,211		)	—			(3,407		)
	Taxes (benefit) on loss from discontinued operations	(870		)	—			172			—			(698		)
	Loss from discontinued operations	(1,326		)	—			(1,383		)	—			(2,709		)
	Net income	187,679			300,115			250,733			(549,776		)	188,751
	Less: Income from continuing operations attributable to noncontrolling interests	—			—			1,072			—			1,072
	Net income attributable to common shareholders	187,679			300,115			249,661			(549,776		)	187,679
	Other comprehensive loss attributable to common shareholders	(150,040		)	(130,691		)	(126,317		)	257,008			(150,040		)
	Comprehensive income attributable to common shareholders	$	37,639		$	169,424		$	123,344		$	(292,768	)	$	37,639
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net revenues	$	—		$	1,001,404		$	963,184		$	(268,317	)	$	1,696,271
	Cost of goods sold	—			582,110			543,717			(268,501		)	857,326
	Gross profit	—			419,294			419,467			184			838,945
	Selling, general and administrative expenses	39,176			284,960			178,358			(307		)	502,187
	Research and development expenses	—			55,694			9,351			—			65,045
	Restructuring and other impairment charges	935			15,288			22,229			—			38,452
	Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	(40,111		)	63,352			209,529			491			233,261
	Interest expense	134,879			(85,058		)	7,084			—			56,905
	Interest income	(15		)	(5		)	(604		)	—			(624		)
	Loss on extinguishments of debt	1,250			—			—			—			1,250
	Income (loss) from continuing operations before taxes	(176,225		)	148,415			203,049			491			175,730
	Taxes (benefit) on income (loss) from continuing operations	(63,857		)	42,804			45,354			(754		)	23,547
	Equity in net income of consolidated subsidiaries	263,469			141,773			288			(405,530		)	—
	Income from continuing operations	151,101			247,384			157,983			(404,285		)	152,183
	Operating loss from discontinued operations	(1,947		)	—			(258		)	—			(2,205		)
	Taxes (benefit) on loss from discontinued operations	(1,727		)	(170		)	127			—			(1,770		)
	Income (loss) from discontinued operations	(220		)	170			(385		)	—			(435		)
	Net income	150,881			247,554			157,598			(404,285		)	151,748
	Less: Income from continuing operations attributable to noncontrolling interests	—			—			867			—			867
	Net income attributable to common shareholders	150,881			247,554			156,731			(404,285		)	150,881
	Other comprehensive income attributable to common shareholders	21,193			1,960			5,442			(7,402		)	21,193
	Comprehensive income attributable to common shareholders	$	172,074		$	249,514		$	162,173		$	(411,687	)	$	172,074
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net revenues	$	—		$	950,888		$	833,903		$	(233,782	)	$	1,551,009
	Cost of goods sold	—			552,726			482,881			(232,823		)	802,784
	Gross profit	—			398,162			351,022			(959		)	748,225
	Selling, general and administrative expenses	34,657			259,476			160,089			267			454,489
	Research and development expenses	—			48,649			7,629			—			56,278
	Goodwill impairment	—			331,779			349			—			332,128
	Restructuring and other impairment charges	—			598			2,439			—			3,037
	Net gain on sales of businesses and assets	(116,193		)	(149,240		)	(332		)	265,433			(332		)
Income (loss) from continuing operations before interest and taxes	81,536			(93,100		)	180,848			(266,659		)	(97,375		)
Interest expense	143,653			(81,328		)	7,240			—			69,565
Interest income	(372		)	(23		)	(1,176		)	—			(1,571		)
Income (loss) from continuing operations before taxes	(61,745		)	(11,749		)	174,784			(266,659		)	(165,369		)
Taxes (benefit) on income (loss) from continuing operations	(63,806		)	45,068			35,670			(519		)	16,413
Equity in net income (loss) of consolidated subsidiaries	(190,742		)	124,918			—			65,824			—
Income (loss) from continuing operations	(188,681		)	68,101			139,114			(200,316		)	(181,782		)
Operating income (loss) from discontinued operations	(2,647		)	(9,179		)	2,619			—			(9,207		)
Tax benefit on income (loss) from discontinued operations	(1,271		)	(129		)	(487		)	—			(1,887		)
Income (loss) from discontinued operations	(1,376		)	(9,050		)	3,106			—			(7,320		)
Net income (loss)	(190,057		)	59,051			142,220			(200,316		)	(189,102		)
Less: Income from continuing operations attributable to noncontrolling interests	—			—			955			—			955
Net income (loss) attributable to common shareholders	(190,057		)	59,051			141,265			(200,316		)	(190,057		)
Other comprehensive income attributable to common shareholders	27,305			10,475			8,907			(19,382		)	27,305
Comprehensive income (loss) attributable to common shareholders	$	(162,752	)	$	69,526		$	150,172		$	(219,698	)	$	(162,752	)
Condensed Consolidating Balance Sheets
		31-Dec-14
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	ASSETS
	Current assets
	Cash and cash equivalents	$	27,996		$	—		$	275,240		$	—		$	303,236
	Accounts receivable, net	2,346			2,422			265,081			3,855			273,704
	Accounts receivable from consolidated subsidiaries	37,378			2,303,284			272,811			(2,613,473		)	—
	Inventories, net	—			204,335			154,544			(23,286		)	335,593
	Prepaid expenses and other current assets	14,301			4,786			16,610			—			35,697
	Prepaid taxes	23,493			—			16,763			—			40,256
	Deferred tax assets	30,248			17,387			9,666			—			57,301
	Assets held for sale	2,901			—			4,521			—			7,422
	Total current assets	138,663			2,532,214			1,015,236			(2,632,904		)	1,053,209
	Property, plant and equipment, net	3,489			170,054			143,892			—			317,435
	Goodwill	—			703,663			619,890			—			1,323,553
	Intangibles assets, net	—			743,222			473,498			—			1,216,720
	Investments in affiliates	5,662,773			1,359,661			21,253			(7,042,537		)	1,150
	Deferred tax assets	52,244			—			5,535			(56,601		)	1,178
	Notes receivable and other amounts due from consolidated subsidiaries	1,025,859			1,489,994			—			(2,515,853		)	—
	Other assets	27,999			6,801			29,210			—			64,010
	Total assets	$	6,911,027		$	7,005,609		$	2,308,514		$	(12,247,895	)	$	3,977,255
	LIABILITIES AND EQUITY
	Current liabilities
	Current borrowings	$	363,701		$	—		$	4,700		$	—		$	368,401
	Accounts payable	1,449			32,692			29,959			—			64,100
	Accounts payable to consolidated subsidiaries	2,259,891			188,908			163,291			(2,612,090		)	—
	Accrued expenses	17,149			21,479			33,755			—			72,383
	Current portion of contingent consideration	—			11,276			—			—			11,276
	Payroll and benefit-related liabilities	20,693			27,228			37,521			—			85,442
	Accrued interest	9,152			—			17			—			9,169
	Income taxes payable	—			—			13,768			—			13,768
	Other current liabilities	5			3,065			7,290			—			10,360
	Total current liabilities	2,672,040			284,648			290,301			(2,612,090		)	634,899
	Long-term borrowings	700,000			—			—			—			700,000
	Deferred tax liabilities	—			462,274			45,867			(56,600		)	451,541
	Pension and other postretirement benefit liabilities	110,830			35,074			21,337			—			167,241
	Noncurrent liability for uncertain tax positions	11,431			15,569			23,884			—			50,884
	Notes payable and other amounts due to consolidated subsidiaries	1,483,984			932,718			103,908			(2,520,610		)	—
	Other liabilities	21,433			24,900			12,658			—			58,991
	Total liabilities	4,999,718			1,755,183			497,955			(5,189,300		)	2,063,556
	Total common shareholders' equity	1,911,309			5,250,426			1,808,169			(7,058,595		)	1,911,309
	Noncontrolling interest	—			—			2,390			—			2,390
	Total equity	1,911,309			5,250,426			1,810,559			(7,058,595		)	1,913,699
	Total liabilities and equity	$	6,911,027		$	7,005,609		$	2,308,514		$	(12,247,895	)	$	3,977,255
		31-Dec-13
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	ASSETS
	Current assets
	Cash and cash equivalents	$	42,749		$	14,500		$	374,735		$	—		$	431,984
	Accounts receivable, net	1,822			10,948			279,048			3,472			295,290
	Accounts receivable from consolidated subsidiaries	42,865			2,623,314			214,469			(2,880,648		)	—
	Inventories, net	—			211,165			138,165			(15,709		)	333,621
	Prepaid expenses and other current assets	15,200			6,870			17,740			—			39,810
	Prepaid taxes	27,487			—			9,017			—			36,504
	Deferred tax assets	20,218			22,472			10,230			(3		)	52,917
	Assets held for sale	1,669			3,503			5,256			—			10,428
	Total current assets	152,010			2,892,772			1,048,660			(2,892,888		)	1,200,554
	Property, plant and equipment, net	14,189			188,455			123,256			—			325,900
	Goodwill	—			797,671			556,532			—			1,354,203
Intangibles assets, net	—			962,243			293,354			—			1,255,597
Investments in affiliates	5,489,676			1,478,429			21,382			(6,987,772		)	1,715
Deferred tax assets	35,877			—			4,476			(39,410		)	943
Notes receivable and other amounts due from consolidated subsidiaries	1,049,344			873,105			14,169			(1,936,618		)	—
Other assets	24,574			7,447			38,074			—			70,095
Total assets	$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
LIABILITIES AND EQUITY
Current liabilities
Current borrowings	$	351,587		$	—		$	4,700		$	—		$	356,287
Accounts payable	2,194			45,802			23,971			—			71,967
Accounts payable to consolidated subsidiaries	2,644,296			147,957			88,395			(2,880,648		)	—
Accrued expenses	15,569			21,120			38,179			—			74,868
Current portion of contingent consideration	—			4,131			—			—			4,131
Payroll and benefit-related liabilities	15,976			21,818			35,296			—			73,090
Accrued interest	8,720			—			5			—			8,725
Income taxes payable	—			—			23,821			—			23,821
Other current liabilities	9,646			7,517			5,072			(4		)	22,231
Total current liabilities	3,047,988			248,345			219,439			(2,880,652		)	635,120
Long-term borrowings	930,000			—			—			—			930,000
Deferred tax liabilities	—			496,228			57,896			(39,409		)	514,715
Pension and other postretirement benefit liabilities	57,406			33,777			18,315			—			109,498
Noncurrent liability for uncertain tax positions	11,389			17,241			26,522			—			55,152
Notes payable and other amounts due to consolidated subsidiaries	785,476			957,451			197,173			(1,940,100		)	—
Other liabilities	19,884			16,221			12,401			—			48,506
Total liabilities	4,852,143			1,769,263			531,746			(4,860,161		)	2,292,991
Total common shareholders' equity	1,913,527			5,430,859			1,565,668			(6,996,527		)	1,913,527
Noncontrolling interest	—			—			2,489			—			2,489
Total equity	1,913,527			5,430,859			1,568,157			(6,996,527		)	1,916,016
Total liabilities and equity	$	6,765,670		$	7,200,122		$	2,099,903		$	(11,856,688	)	$	4,209,007
Condensed Consolidating Statements of Cash Flows
		Year Ended December 31, 2014
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net cash (used in) provided by operating activities from continuing operations	$	(80,651	)	$	322,687		$	123,545		$	(75,340	)	$	290,241
	Cash Flows from Investing Activities of Continuing Operations:
	Expenditures for property, plant and equipment	(2,273		)	(30,586		)	(34,712		)	—			(67,571		)
	Proceeds from sale of assets and investments	1,669			3,421			161			—			5,251
	Payments for businesses and intangibles acquired, net of cash acquired	—			(17,241		)	(28,536		)	—			(45,777		)
	Investments in affiliates	(60		)	20			—			—			(40		)
	Intercompany dividends received	—			—			229,782			(229,782		)	—
	Net cash (used in) provided by investing activities from continuing operations	(664		)	(44,386		)	166,695			(229,782		)	(108,137		)
	Cash Flows from Financing Activities of Continuing Operations:
	Proceeds from new borrowings	250,000			—			—			—			250,000
	Repayment of long-term borrowings	(480,102		)	—			—			—			(480,102		)
	Debt extinguishment, issuance and amendment fees	(4,494		)	—			—			—			(4,494		)
	Proceeds from stock compensation plans and related tax impacts	4,245			—			—			—			4,245
	Dividends	(56,258		)	—			—			—			(56,258		)
	Payments to noncontrolling shareholders				—			(1,094		)	—			(1,094		)
	Intercompany transactions	356,847			(292,801		)	(64,046		)	—			—
	Intercompany dividends paid	—			—			(305,122		)	305,122			—
	Net cash provided by (used in) financing activities from continuing operations	70,238			(292,801		)	(370,262		)	305,122			(287,703		)
	Cash Flows from Discontinued Operations:
	Net cash used in operating activities	(3,676		)	—			—			—			(3,676		)
	Net cash used in discontinued operations	(3,676		)	—			—			—			(3,676		)
	Effect of exchange rate changes on cash and cash equivalents	—			—			(19,473		)	—			(19,473		)
	Net decrease in cash and cash equivalents	(14,753		)	(14,500		)	(99,495		)	—			(128,748		)
	Cash and cash equivalents at the beginning of the period	42,749			14,500			374,735			—			431,984
	Cash and cash equivalents at the end of the period	$	27,996		$	—		$	275,240		$	—		$	303,236
		Year Ended December 31, 2013
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net cash (used in) provided by operating activities from continuing operations	$	(131,031	)	$	205,954		$	304,278		$	(147,902	)	$	231,299
	Cash Flows from Investing Activities of Continuing Operations:
	Expenditures for property, plant and equipment	(1,553		)	(47,633		)	(14,394		)	—			(63,580		)
	Payments for businesses and intangibles acquired, net of cash acquired	—			(250,912		)	(58,096		)	—			(309,008		)
	Investments in affiliates	(50		)	—			—			—			(50		)
	Net cash used in investing activities from continuing operations	(1,603		)	(298,545		)	(72,490		)	—			(372,638		)
	Cash Flows from Financing Activities of Continuing Operations:
	Proceeds from new borrowings	680,000			—			—			—			680,000
	Repayment of long-term borrowings	(375,000		)	—			—			—			(375,000		)
	Debt extinguishment, issuance and amendment fees	(6,400		)	—			—			—			(6,400		)
	Proceeds from share based compensation plans and the related tax impacts	6,181			—			—			—			6,181
	Dividends	(55,917		)	—			—			—			(55,917		)
	Payments to noncontrolling shareholders	—			—			(736		)	—			(736		)
	Payments for contingent consideration	—			(14,802		)	(2,156		)	—			(16,958		)
	Intercompany transactions	(141,614		)	137,304			4,310			—			—
	Intercompany dividends paid	—			(17,400		)	(130,502		)	147,902			—
	Net cash provided by (used in) financing activities from continuing operations	107,250			105,102			(129,084		)	147,902			231,170
	Cash Flows from Discontinued Operations:
	Net cash used in operating activities	(2,727		)	—			(600		)	—			(3,327		)
	Net cash used in discontinued operations	(2,727		)	—			(600		)	—			(3,327		)
	Effect of exchange rate changes on cash and cash equivalents	—			—			8,441			—			8,441
	Net (decrease) increase in cash and cash equivalents	(28,111		)	12,511			110,545			—			94,945
	Cash and cash equivalents at the beginning of the period	70,860			1,989			264,190			—			337,039
	Cash and cash equivalents at the end of the period	$	42,749		$	14,500		$	374,735		$	—		$	431,984
		Year Ended December 31, 2012
		Parent			Guarantor			Non-Guarantor			Eliminations			Condensed
		Company			Subsidiaries			Subsidiaries						Consolidated
		(Dollars in thousands)
	Net cash (used in) provided by operating activities from continuing operations	$	(178,017	)	$	310,736		$	160,802		$	(98,903	)	$	194,618
	Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment	(7,352		)	(39,118		)	(18,924		)	—			(65,394		)
Proceeds from sales of businesses and assets, net of cash sold	4,301			45,204			17,155			—			66,660
Payments for businesses and intangibles acquired, net of cash acquired	—			(105,195		)	(264,249		)	—			(369,444		)
Investments in affiliates	(80		)	—			—			—			(80		)
Net cash used in investing activities from continuing operations	(3,131		)	(99,109		)	(266,018		)	—			(368,258		)
Cash Flows from Financing Activities of Continuing Operations:
Decrease in notes payable and current borrowings	—			(421		)	(285		)	—			(706		)
Proceeds from share based compensation plans and the related tax impacts	8,238			—			—			—			8,238
Dividends	(55,589		)	—			—			—			(55,589		)
Payments for contingent consideration	—			(16,289		)	(1,307		)	—			(17,596		)
Intercompany transactions	196,850			(177,900		)	(18,950		)	—			—
Intercompany dividends paid	—			(16,900		)	(82,003		)	98,903			—
Net cash provided by (used in) financing activities from continuing operations	149,499			(211,510		)	(102,545		)	98,903			(65,653		)
Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities	(12,022		)	4,223			—			—			(7,799		)
Net cash used in investing activities	—			(2,351		)	—			—			(2,351		)
Net cash (used in) provided by discontinued operations	(12,022		)	1,872			—			—			(10,150		)
Effect of exchange rate changes on cash and cash equivalents	—			—			2,394			—			2,394
Net (decrease) increase in cash and cash equivalents	(43,671		)	1,989			(205,367		)	—			(247,049		)
Cash and cash equivalents at the beginning of the period	114,531			—			469,557			—			584,088
Cash and cash equivalents at the end of the period	$	70,860		$	1,989		$	264,190		$	—		$	337,039

Divestiturerelated_activities_

Divestiture-related activities (Tables)	12 Months Ended
	Dec. 31, 2014
Divestiture-Related Activities [Abstract]
Assets Held for Sale	The table below provides information regarding assets held for sale at December 31, 2014 and 2013. At December 31, 2014, these assets consisted of two buildings and other assets, which the Company is actively marketing.
		2014			2013
	Assets held for sale:	(Dollars in thousands)
	Property, plant and equipment	$	7,422		$	10,428
	Total assets held for sale	$	7,422		$	10,428
Operating Results of Operations Treated as Discontinued Operations	The results of the Company’s discontinued operations for the years 2014, 2013 and 2012 were as follows:
		2014			2013			2012
		(Dollars in thousands)
	Net revenues	$	—		$	—		$	16,616
	Costs and other expenses	3,407			2,205			18,328
	Goodwill impairment(1)	—			—			9,700
	Gain on disposition(2)	—			—			2,205
	Loss from discontinued operations before income taxes	(3,407		)	(2,205		)	(9,207		)
	Tax benefit on loss from discontinued operations	(698		)	(1,770		)	(1,887		)
	Loss from discontinued operations	$	(2,709	)	$	(435	)	$	(7,320	)
	-1	During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of its former orthopedic business to its estimated fair value.
	-2	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the Company's former cargo systems and cargo container businesses.

Summary_of_significant_account2

Summary of significant accounting policies - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	tradename
	unit
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units	5
Number of reporting units, two-step quantitative impairment test	3
Number of trade names	2
Asset Impairment Charges			$10,841,000
Weighted average amortization period of intangible assets, in years		13 years
Reserve for returns and allowances		4,100,000	3,300,000
Reserve for estimated rebates		10,400,000	7,800,000
In-process Research and Development Asset
Summary Of Significant Accounting Policies [Line Items]
Asset Impairment Charges			7,400,000
Minimum | Intellectual property
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		3 years
Minimum | Customer Lists
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		5 years
Minimum | Distribution rights
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		3 years
Minimum | Trade Names
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		1 year
Maximum | Intellectual property
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		20 years
Maximum | Customer Lists
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		30 years
Maximum | Distribution rights
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		22 years
Maximum | Trade Names
Summary Of Significant Accounting Policies [Line Items]
Useful life of Intangible assets, in years		30 years
Land Improvements
Summary Of Significant Accounting Policies [Line Items]
Useful life of plant and equipment, in years		5 years
Building
Summary Of Significant Accounting Policies [Line Items]
Useful life of plant and equipment, in years		30 years
Machinery and Equipment | Minimum
Summary Of Significant Accounting Policies [Line Items]
Useful life of plant and equipment, in years		3 years
Machinery and Equipment | Maximum
Summary Of Significant Accounting Policies [Line Items]
Useful life of plant and equipment, in years		10 years
Computer Equipment and Software | Minimum
Summary Of Significant Accounting Policies [Line Items]
Useful life of plant and equipment, in years		3 years
Computer Equipment and Software | Maximum
Summary Of Significant Accounting Policies [Line Items]
Useful life of plant and equipment, in years		10 years
Previously Reported
Summary Of Significant Accounting Policies [Line Items]
Payments related to tax withholding for share-based compensation			$2,700,000	$1,600,000

Acquisitions_Additional_Inform

Acquisitions - Additional Information (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Acquisition [Line Items]
Estimated fair value of contingent consideration	$33,433,000				$20,313,000				$33,433,000	$20,313,000
Revenue	476,008,000	457,173,000	468,105,000	438,546,000	450,539,000	413,796,000	420,059,000	411,877,000	1,839,832,000	1,696,271,000	1,551,009,000
Segment operating profit	69,155,000	81,935,000	74,752,000	59,020,000	54,064,000	66,042,000	63,751,000	49,404,000	284,862,000	233,261,000	-97,375,000
2014 Acquisition
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	66,314,000								66,314,000
Initial payment									46,300,000
Estimated fair value of contingent consideration	20,500,000								20,500,000
Working capital adjustment									500,000
Transaction expenses									500,000
Revenue									27,200,000
Segment operating profit									3,600,000
2014 Acquisition | Intellectual property
Business Acquisition [Line Items]
Useful life of intangible assets acquired, years									15 years
2014 Acquisition | Customer Lists
Business Acquisition [Line Items]
Useful life of intangible assets acquired, years									10 years
2013 Acquisition
Business Acquisition [Line Items]
Fair value of the consideration at the date of acquisition					$307,000,000					$307,000,000

Acquisitions_fair_values_deter

Acquisitions - fair values determination of assets acquired and liabilities assumed in acquisition (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Business Acquisition [Line Items]
Goodwill	$1,323,553	$1,354,203	$1,238,452
2014 Acquisition
Business Acquisition [Line Items]
Current assets	10,512
Property, plant and equipment	344
Goodwill	16,392
Total assets acquired	73,883
Current liabilities	4,769
Deferred tax liabilities	2,800
Liabilities assumed	7,569
Net assets acquired	66,314
2014 Acquisition | Intellectual property
Business Acquisition [Line Items]
Intangible Assets	37,000
2014 Acquisition | Trade Names
Business Acquisition [Line Items]
Intangible Assets	300
2014 Acquisition | Customer Lists
Business Acquisition [Line Items]
Intangible Assets	$9,335

Restructuring_and_other_impair2

Restructuring and other impairment charges - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended				3 Months Ended	24 Months Ended	12 Months Ended	3 Months Ended
	Sep. 29, 2013	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2011	Dec. 31, 2013
								facility
Restructuring Cost and Reserve [Line Items]
Restructuring charges				$27,611,000
Restructuring and other impairment charges		17,869,000		38,452,000	3,037,000
Impairment of long-lived assets	3,500,000	0		3,460,000	0
Asset impairment charges				10,841,000
Axiom Technology Partners L L C
Restructuring Cost and Reserve [Line Items]
In-process research and development impairment						4,500,000
Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges				11,062,000
Restructuring and other impairment charges		16,903,000		11,062,000	3,930,000
Asset impairment charges				0
Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges				1,995,000
Restructuring and other impairment charges		255,000		1,995,000	230,000
Asset impairment charges				0
Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges				2,298,000
Restructuring and other impairment charges		551,000		13,139,000	11,000
Asset impairment charges				10,841,000
2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring expenses		14,200,000
Restructuring charges		9,260,000
Restructuring reserve		9,100,000					9,100,000
2014 Manufacturing footprint realignment plan | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		9,200,000
2014 Manufacturing footprint realignment plan | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		4,900,000
2014 Manufacturing footprint realignment plan | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0
2014 Manufacturing footprint realignment plan | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges		60,000
2014 Manufacturing footprint realignment plan | Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		37,000,000
Restructuring costs expected cash payment		26,000,000
2014 Manufacturing footprint realignment plan | Minimum | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		11,000,000
2014 Manufacturing footprint realignment plan | Minimum | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		2,000,000	[1]
2014 Manufacturing footprint realignment plan | Minimum | Accelerated Depreciation Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		10,000,000
2014 Manufacturing footprint realignment plan | Minimum | Other
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		14,000,000	[2]
2014 Manufacturing footprint realignment plan | Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		44,000,000
Restructuring costs expected cash payment		31,000,000
2014 Manufacturing footprint realignment plan | Maximum | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		13,000,000
2014 Manufacturing footprint realignment plan | Maximum | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		3,000,000	[1]
2014 Manufacturing footprint realignment plan | Maximum | Accelerated Depreciation Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		11,000,000
2014 Manufacturing footprint realignment plan | Maximum | Other
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		17,000,000	[2]
2014 European restructuring plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges		7,808,000
Restructuring reserve		400,000					400,000
2014 European restructuring plan | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		7,237,000
2014 European restructuring plan | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1,000
2014 European restructuring plan | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges		225,000
2014 Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		4,000,000
Restructuring charges		3,550,000
Restructuring reserve		900,000					900,000
2014 Restructuring Charges | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		552,000
2014 Restructuring Charges | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0
2014 Restructuring Charges | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges		244,000
2013 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		833,000		10,230,000
Restructuring reserve		900,000					900,000
Restructuring charges cumulative		11,000,000
2013 Restructuring programs | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		562,000		4,787,000
2013 Restructuring programs | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0		0
2013 Restructuring programs | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges		22,000		2,117,000
2013 Restructuring programs | Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		11,000,000
2013 Restructuring programs | Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		12,000,000
LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		-3,329,000		12,152,000	2,515,000		11,400,000
Restructuring reserve		224,000		4,681,000	2,033,000		224,000		4,681,000
Contract termination costs		3,200,000
LMA Restructuring Program | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		-29,000		3,282,000	2,229,000
Restructuring reserve		0		552,000	1,744,000		0		552,000
LMA Restructuring Program | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		-112,000		788,000	0
Restructuring reserve		0		427,000	0		0		427,000
LMA Restructuring Program | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0		176,000	12,000
2012 Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges		6,300,000
Restructuring reserve		600,000					600,000
Number of facilities under restructuring program					3
2011 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		12,000		770,000
Contract termination costs				800,000				2,600,000
Number of facilities under restructuring program								3
Percentage of premises eliminated								50.00%
Termination benefits								400,000
2011 Restructuring program | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0		0
2011 Restructuring program | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		12,000		42,000
2011 Restructuring program | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0		0
2007 Arrow integration program
Restructuring Cost and Reserve [Line Items]
Restructuring charges				230,000	-1,937,000
Contract termination costs					1,900,000
In-process research and development impairment									2,900,000
2007 Arrow integration program | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges				0	20,000
2007 Arrow integration program | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges				230,000	230,000
2007 Arrow integration program | Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges				$0	($21,000)
[1]	Includes costs to transfer product lines among facilities and outplacement and employee relocation costs.
[2]	Consists of other costs directly related to the Plan, including project management, legal and regulatory costs.

Restructuring_and_other_impair3

Restructuring and other impairment charges - reconciliation of changes in accrued liabilities associated with restructuring program (Detail) (LMA Restructuring Program, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Restructuring Reserve [Roll Forward]
Balance, beginning	$4,681	$2,033
Subsequent accruals	-3,329	12,152
Cash payments	-1,084	-9,547
Foreign currency translation	-44	43
Balance, ending	224	4,681
Termination Benefits
Restructuring Reserve [Roll Forward]
Balance, beginning	552	1,744
Subsequent accruals	-29	3,282
Cash payments	-503	-4,461
Foreign currency translation	-20	-13
Balance, ending	0	552
Facility Closure Costs
Restructuring Reserve [Roll Forward]
Balance, beginning	427	0
Subsequent accruals	-112	788
Cash payments	-317	-362
Foreign currency translation	2	1
Balance, ending	0	427
Contract Termination Costs
Restructuring Reserve [Roll Forward]
Balance, beginning	3,686	277
Subsequent accruals	-3,188	7,906
Cash payments	-260	-4,560
Foreign currency translation	-26	63
Balance, ending	212	3,686
Other Restructuring Costs
Restructuring Reserve [Roll Forward]
Balance, beginning	16	12
Subsequent accruals	0	176
Cash payments	-4	-164
Foreign currency translation	0	-8
Balance, ending	$12	$16

Restructuring_and_other_impair4

Restructuring and other impairment charges - restructuring program (Detail) (USD $)	12 Months Ended			24 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$27,611
Asset Impairment Charges		10,841
Total restructuring and other impairment charges	17,869	38,452	3,037
2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	9,260
2014 European restructuring plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	7,808
Other 2014 restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3,550
2013 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	833	10,230
LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	-3,329	12,152	2,515	11,400
2012 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	-265	4,229	2,459
2011 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	12	770
2007 Arrow integration program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		230	-1,937
Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		11,062
Asset Impairment Charges		0
Total restructuring and other impairment charges	16,903	11,062	3,930
Termination Benefits | 2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	9,200
Termination Benefits | 2014 European restructuring plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	7,237
Termination Benefits | Other 2014 restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	552
Termination Benefits | 2013 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	562	4,787
Termination Benefits | LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	-29	3,282	2,229
Termination Benefits | 2012 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	-619	2,993	1,681
Termination Benefits | 2011 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0
Termination Benefits | 2007 Arrow integration program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0	20
Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1,995
Asset Impairment Charges		0
Total restructuring and other impairment charges	255	1,995	230
Facility Closure Costs | 2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
Facility Closure Costs | 2014 European restructuring plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1
Facility Closure Costs | Other 2014 restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
Facility Closure Costs | 2013 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0
Facility Closure Costs | LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	-112	788	0
Facility Closure Costs | 2012 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	354	935	0
Facility Closure Costs | 2011 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	12	42
Facility Closure Costs | 2007 Arrow integration program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		230	230
Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		12,256
Asset Impairment Charges		0
Total restructuring and other impairment charges	160	12,256	-1,134
Contract Termination Costs | 2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
Contract Termination Costs | 2014 European restructuring plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	345
Contract Termination Costs | Other 2014 restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2,754
Contract Termination Costs | 2013 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	249	3,326
Contract Termination Costs | LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	-3,188	7,906	274
Contract Termination Costs | 2012 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	296	758
Contract Termination Costs | 2011 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	728
Contract Termination Costs | 2007 Arrow integration program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		0	-2,166
Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		2,298
Asset Impairment Charges		10,841
Total restructuring and other impairment charges	551	13,139	11
Other Exit Costs | 2014 Manufacturing footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	60
Other Exit Costs | 2014 European restructuring plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	225
Other Exit Costs | Other 2014 restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	244
Other Exit Costs | 2013 Restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	22	2,117
Other Exit Costs | LMA Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	176	12
Other Exit Costs | 2012 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	5	20
Other Exit Costs | 2011 Restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0
Other Exit Costs | 2007 Arrow integration program
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$0	($21)

Restructuring_and_other_impair5

Restructuring and other impairment charges - by segment (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	$17,869	$38,452	$3,037
Vascular North America
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	7,069	5,348	-1,120
Anesthesia Respiratory North America
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	1,379	3,207	983
Surgical North America
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	0	6,525	278
EMEA Segment
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	6,375	16,122	1,995
Asia Segment
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	1,305	603	442
OEM Segment
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	0	588	83
All Other
Restructuring Cost and Reserve [Line Items]
Restructuring and other impairment charges	$1,741	$6,059	$376

Inventories_Detail

Inventories (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]
Raw materials	$68,191	$70,209
Work-in-process	58,526	53,672
Finished goods	242,750	242,113
Inventories, gross	369,467	365,994
Less: Inventory reserves	-33,874	-32,373
Inventories, net	$335,593	$333,621

Property_plant_equipment_Detai

Property, plant, equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Property, Plant and Equipment [Abstract]
Land, buildings and leasehold improvements	$194,923	$199,741
Machinery and equipment	320,999	322,060
Computer equipment and software	107,743	102,527
Construction in progress	51,834	55,092
Property, plant and equipment, gross	675,499	679,420
Less: Accumulated depreciation	-358,064	-353,520
Property, plant and equipment, net	$317,435	$325,900	$297,945

Goodwill_and_other_intangible_2

Goodwill and other intangible assets - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Amortization expense of intangible assets	$60,926,000	$50,608,000	$44,264,000
Semprus Technology
Finite-Lived Intangible Assets [Line Items]
Net assets	41,000,000
Trade Names
Finite-Lived Intangible Assets [Line Items]
Indefinite lived intangible assets	$359,300,000

Goodwill_and_other_intangible_3

Goodwill and other intangible assets - changes in carrying amount by reporting segment (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Goodwill [Roll Forward]
Goodwill gross, beginning balance	$1,686,331	$1,570,580
Accumulated impairment losses	-332,128	-332,128	-332,128
Goodwill net	1,323,553	1,354,203	1,238,452
Goodwill related to acquisitions	16,392	123,284
Translation adjustment	-47,042	-7,533
Goodwill gross, ending balance	1,655,681	1,686,331
Vascular North America
Goodwill [Roll Forward]
Goodwill gross, beginning balance	459,696	407,090
Accumulated impairment losses	-219,527	-219,527	-219,527
Goodwill net	240,169	240,169	187,563
Goodwill related to acquisitions	0	52,606
Translation adjustment	0	0
Goodwill gross, ending balance	459,696	459,696
Anesthesia Respiratory North America
Goodwill [Roll Forward]
Goodwill gross, beginning balance	167,195	167,942
Accumulated impairment losses	-107,073	-107,073	-107,073
Goodwill net	59,441	60,122	60,869
Goodwill related to acquisitions	0	0
Translation adjustment	-681	-747
Goodwill gross, ending balance	166,514	167,195
Surgical North America
Goodwill [Roll Forward]
Goodwill gross, beginning balance	250,506	245,794
Accumulated impairment losses	0	0	0
Goodwill net	250,912	250,506	245,794
Goodwill related to acquisitions	406	4,712
Translation adjustment	0	0
Goodwill gross, ending balance	250,912	250,506
EMEA Segment
Goodwill [Roll Forward]
Goodwill gross, beginning balance	373,417	353,282
Accumulated impairment losses	0	0	0
Goodwill net	339,029	373,417	353,282
Goodwill related to acquisitions		17,922
Translation adjustment	-34,388	2,213
Goodwill gross, ending balance	339,029	373,417
Asia Segment
Goodwill [Roll Forward]
Goodwill gross, beginning balance	136,946	139,469
Accumulated impairment losses	0	0	0
Goodwill net	144,712	136,946	139,469
Goodwill related to acquisitions	15,986	6,394
Translation adjustment	-8,220	-8,917
Goodwill gross, ending balance	144,712	136,946
All Other
Goodwill [Roll Forward]
Goodwill gross, beginning balance	298,571	257,003
Accumulated impairment losses	-5,528	-5,528	-5,528
Goodwill net	289,290	293,043	251,475
Goodwill related to acquisitions	0	41,650
Translation adjustment	-3,753	-82
Goodwill gross, ending balance	$294,818	$298,571

Goodwill_and_other_intangible_4

Goodwill and other intangible assets - components of intangible assets (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$1,573,043	$1,557,688
Accumulated Amortization	-356,323	-302,091
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	624,574	628,020
Accumulated Amortization	-192,876	-168,223
In-process Research and Development Asset
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	68,694	68,786
Accumulated Amortization	0	0
Intellectual property
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	467,068	435,869
Accumulated Amortization	-146,131	-118,086
Distribution rights
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	16,101	16,797
Accumulated Amortization	-14,243	-14,592
Trade Names
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	396,269	407,879
Accumulated Amortization	-2,764	-1,148
Noncompete Agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	337	337
Accumulated Amortization	($309)	($42)

Goodwill_and_other_intangible_5

Goodwill and other intangible assets - estimated annual amortization expense (Detail) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Goodwill and Intangible Assets Disclosure [Abstract]
2015	$55,750
2016	55,400
2017	54,950
2018	54,700
2019	$54,500

Borrowings_Components_of_LongT

Borrowings - Components of Long-Term Debt (Detail) (USD $)	12 Months Ended		0 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Jun. 13, 2011	Dec. 31, 2012	Aug. 09, 2010
Line Of Credit Facility [Line Items]
Long-term debt, Gross	$1,104,598	$1,334,700
Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017	-36,197	-48,413
Total long-term debt	1,068,401	1,286,287
Debt, Current	368,401	356,287
Long-term borrowings	700,000	930,000
Interest rate	3.88%	3.88%		3.88%
Revolving Credit Facility
Line Of Credit Facility [Line Items]
Revolving credit facility, at a rate of 1.92% at December 31, 2014 and 2013, due July 16, 2018	200,000	680,000
Senior credit facility interest rate	1.92%	1.92%
Debt maturity date	16-Jul-18
3.875% Convertible Senior Subordinated Notes
Line Of Credit Facility [Line Items]
3.875% Convertible Senior Subordinated Notes due 2017	399,898	400,000			400,000
Interest rate	3.88%	3.88%			3.88%
6.875% Senior Subordinated Notes Due 2019
Line Of Credit Facility [Line Items]
6.875% Senior Subordinated Notes due 2019	250,000	250,000	250,000
Interest rate	6.88%	6.88%	6.88%
Debt instrument maturity date	2019	2019	2019
5.25% Senior Subordinated Notes Due 2024
Line Of Credit Facility [Line Items]
5.25% Senior Notes due 2024	250,000	0
Interest rate	5.25%	5.25%
Securitization Program
Line Of Credit Facility [Line Items]
Other Short-term Borrowings	$4,700	$4,700
Interest rate	0.92%	0.92%

Borrowings_Additional_Informat

Borrowings - Additional Information (Detail) (USD $)	12 Months Ended				0 Months Ended	9 Months Ended	1 Months Ended	3 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010	21-May-14	Sep. 28, 2014	Jul. 16, 2013	Dec. 31, 2013	Sep. 29, 2013	Jun. 13, 2011	Aug. 09, 2010
Debt Instrument [Line Items]
Amortization of debt issuance costs	$0	($1,250,000)	$0
Interest rate	3.88%	3.88%	3.88%					3.88%
Convertible notes, latest date of termination	28-Jul-17
Convertible note hedge transactions, purchased call options	88,000,000
Convertible note hedge transactions, net of tax	56,000,000
Conversion of convertible notes, shares issued upon conversion	1,900,000	600,000		7,981,422
Warrants expiration period				180 days
Warrants expiration date				1-Nov-17
Strike price of warrants	$74.65			$74.65
Proceeds from sale of warrants				59,400,000
Convertible debt, fair value	316,300,000
Proceeds from Convertible Debt	400,000,000
Initial equity component	83,700,000
Convertible notes, carrying value, net of tax	53,300,000
Debt discount	83,700,000
Remaining life of the convertible notes	2 years 7 months 6 days
Effective interest rate	7.81%
Ownership percentage of subsidiaries	50.00%
Debt Instrument, Basis Spread on Variable Rate	50.00%
Total Long-term Debt	1,068,401,000	1,286,287,000						1,286,287,000
5.25% Senior Subordinated Notes Due 2024
Debt Instrument [Line Items]
Repayment of Debt					245,000,000
Interest rate	5.25%	5.25%						5.25%
Senior notes	250,000,000	0						0
Senior Notes
Debt Instrument [Line Items]
Interest rate					5.25%
Senior notes					250,000,000
Fee amount					4,500,000
Proceed from senior notes used to repay revolving line of credit					245,000,000
Ownership percentage of subsidiaries	100.00%
Senior Notes | Minimum
Debt Instrument [Line Items]
Declining percent of redemption price to principal amount	0.88%
Senior Notes | Maximum
Debt Instrument [Line Items]
Percent of redemption price to principal amount	102.63%
Declining percent of redemption price to principal amount						100.00%
Senior Notes | Debt Instrument Redemption Prior To June 15, 2019
Debt Instrument [Line Items]
Percent of redemption price to principal amount on redemption	100.00%
Make whole premium as percentage of principal amount of notes subject to redemption						1.00%
Senior Notes | Debt Instrument Redemption Prior To June Fifteen Twenty Seventeen
Debt Instrument [Line Items]
Percent of redemption price to principal amount on redemption	105.25%
Percent of principal amount of notes redeemable	35.00%
Senior Credit Facility
Debt Instrument [Line Items]
Maximum amount available for borrowing							775,000,000
Senior Credit Facility | Term Loan
Debt Instrument [Line Items]
Maximum amount available for borrowing							375,000,000		375,000,000
Senior Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum amount available for borrowing							400,000,000
New Senior Credit Facility
Debt Instrument [Line Items]
Maximum amount available for borrowing	850,000,000						850,000,000
Transaction fees recorded as Deferred asset		6,400,000
Amortization of debt issuance costs									1,300,000
Borrowing under revolving credit							382,000,000	298,000,000
Federal funds effective rate plus							0.50%
Prime rate or one month LIBOR plus							1.00%
Senior credit facility interest rate	1.92%
New Senior Credit Facility | Prime Rate | Minimum
Debt Instrument [Line Items]
Applicable margin							0.25%
New Senior Credit Facility | Prime Rate | Maximum
Debt Instrument [Line Items]
Applicable margin							1.00%
New Senior Credit Facility | Libor Rate Plus
Debt Instrument [Line Items]
Senior credit facility interest rate	0.17%
New Senior Credit Facility | Libor Rate Plus | Minimum
Debt Instrument [Line Items]
Applicable margin							1.25%
New Senior Credit Facility | Libor Rate Plus | Maximum
Debt Instrument [Line Items]
Applicable margin							2.00%
New Senior Credit Facility | Rate Spread
Debt Instrument [Line Items]
Senior credit facility interest rate	1.75%
Standby Letters of Credit
Debt Instrument [Line Items]
Line of credit facility amount outstanding	6,000,000
3.875% Convertible Senior Subordinated Notes
Debt Instrument [Line Items]
Interest rate	3.88%	3.88%						3.88%			3.88%
Convertible subordinated debt	399,898,000	400,000,000						400,000,000			400,000,000
Number of trading days	20 days
Number of consecutive trading days	30 days
Percentage of conversion price of applicable trading day	130.00%
Number of business days	5 days
Principal amount of convertible notes	1,000
Percentage of the product of the last reported sale price of the common stock	98.00%
Convertible notes conversion rate	16.3084
Conversion price, per share	$61.32
6.875% Senior Subordinated Notes Due 2019
Debt Instrument [Line Items]
Interest rate	6.88%	6.88%						6.88%		6.88%
Senior subordinated notes	250,000,000	250,000,000						250,000,000		250,000,000
Debt instrument maturity date	2019	2019								2019
Percent of redemption price to principal amount	103.44%
Declining percent of redemption price to principal amount	1.72%
Debt instrument, earliest date of redemption	1-Jun-15
Percent of redemption price to principal amount on redemption	100.00%
Make-whole premium as percentage of principal amount of Notes subject to redemption	1.00%
Debt Instrument, Basis Spread on Variable Rate	0.50%
6.875% Senior Subordinated Notes Due 2019 | Minimum
Debt Instrument [Line Items]
Percent of redemption price to principal amount	100.00%
Securitization Program
Debt Instrument [Line Items]
Maximum amount available for borrowing	45,300,000
Other Short-term Borrowings	4,700,000	4,700,000						4,700,000
Interest rate	0.92%	0.92%						0.92%
Maximum amount available under receivable securitization	$50,000,000

Borrowings_Interest_Expense_Am

Borrowings - Interest Expense Amounts Related to Convertible Notes (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Debt Disclosure [Abstract]
Interest cost related to contractual interest coupon	$15.50	$15.50	$15.50
Interest cost related to amortization of the discount	$12.20	$11.30	$10.50

Borrowings_Carrying_Value_of_C

Borrowings - Carrying Value of Convertible Notes (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Debt Disclosure [Abstract]
Principal amount of the Convertible Notes	$399,900,000	$400,000,000
Unamortized discount	-36,197,000	-48,413,000
Net carrying amount	$363,700,000	$351,600,000

Borrowings_Fair_Value_of_Debt_

Borrowings - Fair Value of Debt (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value Measurements [Line Items]
Fair value of debt	$1,480,028	$1,548,102
Level 1
Fair Value Measurements [Line Items]
Fair value of debt	1,024,806	899,390
Level 2
Fair Value Measurements [Line Items]
Fair value of debt	$455,222	$648,712

Borrowings_Aggregate_Amounts_o

Borrowings - Aggregate Amounts of Long-Term Debt (Detail) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]
2015	$404,598	[1]
2016	0
2017	0
2018	200,000
2019 and thereafter	$500,000
[1]	The Convertible Notes are included in amounts that will mature in 2015 because, at December 31, 2014, they were convertible in accordance with their terms, which are described in more detail above in this section under bConvertible Notes.b

Financial_instruments_Addition

Financial instruments - Additional Information (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivatives Fair Value [Line Items]
Pre-tax loss on foreign currency forward exchange contracts											$7,600,000
Allowance for doubtful accounts	8,800,000				10,700,000				8,800,000	10,700,000
Current portion of allowance for doubtful accounts	2,400,000				5,200,000				2,400,000	5,200,000
Noncurrent portion of allowance for doubtful accounts	6,400,000				5,500,000				6,400,000	5,500,000
Net revenues	476,008,000	457,173,000	468,105,000	438,546,000	450,539,000	413,796,000	420,059,000	411,877,000	1,839,832,000	1,696,271,000	1,551,009,000
Spain, Italy, Portugal, and Greece
Derivatives Fair Value [Line Items]
Current portion of allowance for doubtful accounts	8,100,000				7,900,000				8,100,000	7,900,000
Long-term portion of accounts receivable net	11,300,000				17,600,000				11,300,000	17,600,000
Net revenues									150,500,000	142,600,000	132,500,000
Interest Rate Swap | Cash Flow Hedging
Derivatives Fair Value [Line Items]
Total notional amount for all open foreign currency forward contracts												$350,000,000

Financial_instruments_after_ta

Financial instruments - after tax (gain)/loss reclassified from accumulated other comprehensive income into income (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Derivatives Fair Value [Line Items]
Derivatives qualifying as hedges, net of tax	$0	$381	$6,876
Interest Rate Swap
Derivatives Fair Value [Line Items]
Derivatives qualifying as hedges, net of tax	0	0	7,032
Foreign Currency Exchange Contracts
Derivatives Fair Value [Line Items]
Derivatives qualifying as hedges, net of tax	$0	$381	($156)

Financial_instruments_aggregat

Financial instruments - aggregate accounts receivable, net of allowance for doubtful accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Derivatives Fair Value [Line Items]
Accounts receivable, net	$273,704		$295,290
Spain, Italy, Portugal, and Greece
Derivatives Fair Value [Line Items]
Accounts receivable, net	$76,190	[1]	$97,852	[1]
Percentage of total net current and long-term accounts receivables	27.30%		31.00%
[1]	The long-term portion of accounts receivable, net from customers in Spain, Italy, Greece and Portugal at DecemberB 31, 2014 and 2013 was $11.3 million and $17.6 million, respectively, and is reported in other assets.

Fair_value_measurement_Additio

Fair value measurement - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Fair Value Measurements [Line Items]
Reversal of contingent consideration	$8,200,000	$12,300,000
Contingent consideration	33,433,000	20,313,000	51,196,000
Current portion of contingent consideration	11,276,000	4,131,000
Other liabilities	22,100,000
Minimum
Fair Value Measurements [Line Items]
Fair value of contingent consideration liability associated with future milestone	15,000,000
Maximum
Fair Value Measurements [Line Items]
Fair value of contingent consideration liability associated with future milestone	$83,000,000

Fair_value_measurment_financia

Fair value measurment - financial assets and liabilities carried at fair value measured on recurring basis (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	$6,863	$6,150
Estimated fair value of contingent consideration	33,433	20,313
Quoted Prices In Active Markets (Level 1)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	6,863	6,150
Estimated fair value of contingent consideration	0	0
Significant Other Observable Inputs (Level 2)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Estimated fair value of contingent consideration	0	0
Significant Unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Estimated fair value of contingent consideration	$33,433	$20,313

Fair_value_measurement_reconci

Fair value measurement - reconciliation of changes in three financial liabilities measured at fair value on recurring (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Changes in Level 3 Financial Liabilities Related to Contingent Consideration [Roll Forward]
Beginning balance	$20,313	$51,196
Initial estimate upon acquisition	20,538	0
Payment	0	-18,880
Revaluations	-7,418	-11,982
Translation adjustment	0	-21
Ending balance	$33,433	$20,313

Fair_value_measuremnt_valuatio

Fair value measuremnt - valuation technique and inputs used to determine fair value of assets or liabilities (Detail)	12 Months Ended
	Dec. 31, 2014
Discount Rate
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Fair Value Inputs, Discount Rate	7.00%
Probability of Payment
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration, weighted average	52.60%
Minimum | Discount Rate
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Fair Value Inputs, Discount Rate	2.30%
Minimum | Probability of Payment
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	0.00%
Maximum | Discount Rate
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Fair Value Inputs, Discount Rate	10.00%
Maximum | Probability of Payment
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	100.00%

Shareholders_equity_Additional

Shareholders' equity - Additional Information (Detail) (USD $)	1 Months Ended	12 Months Ended
	Jun. 30, 2007	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2010	Dec. 31, 2012
Shareholders Equity [Line Items]
Common shares, authorized		200,000,000
Common shares, par value		$1	$1
Preference shares, authorized		500,000
Repurchase of outstanding common stock, authorized amount	$300,000,000
Per share market price of common stock		$61.32
Strike price of warrants		$74.65		$74.65
Conversion of convertible notes, shares issued upon conversion		1,900,000	600,000	7,981,422
Convertible senior notes percentage		3.88%	3.88%		3.88%
Stock Option
Shareholders Equity [Line Items]
Weighted average antidilutive which were not included in the calculation of earnings per share		6,300,000	7,700,000		9,000,000
Convertible Note
Shareholders Equity [Line Items]
Weighted average antidilutive which were not included in the calculation of earnings per share		2,700,000	1,600,000		300,000

Shareholders_equity_reconcilia

Shareholders' equity - reconciliation of basic to diluted weighted average common shares outstanding (Detail)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]
Basic (in shares)	41,366	41,105	40,859
Dilutive effect of share based awards (in shares)	450	410	0
Dilutive effect of 3.875% Convertible Notes and warrants (in shares)	4,654	2,178	0
Diluted (in shares)	46,470	43,693	40,859

Shareholders_equity_change_in_

Shareholders' equity - change in accumulated other comprehensive income (loss), net of tax (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, accumulated other comprehensive income (loss), net of tax	($110,855)	($132,048)
Other comprehensive income (loss) before reclassifications	-152,275	15,507
Amounts reclassified from accumulated other comprehensive income (loss)	2,235	5,686
Net current-period other comprehensive income (loss)	-150,040	21,193
Ending balance, accumulated other comprehensive income (loss), net of tax	-260,895	-110,855
Cash Flow Hedges
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, accumulated other comprehensive income (loss), net of tax	0	-381
Other comprehensive income (loss) before reclassifications	594	-549
Amounts reclassified from accumulated other comprehensive income (loss)	-594	930
Net current-period other comprehensive income (loss)	0	381
Ending balance, accumulated other comprehensive income (loss), net of tax	0	0
Pension and Other Postretirement Benefits Plans
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, accumulated other comprehensive income (loss), net of tax	-97,037	-127,257
Other comprehensive income (loss) before reclassifications	-47,536	25,464
Amounts reclassified from accumulated other comprehensive income (loss)	2,829	4,756
Net current-period other comprehensive income (loss)	-44,707	30,220
Ending balance, accumulated other comprehensive income (loss), net of tax	-141,744	-97,037
Foreign Currency Translation Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, accumulated other comprehensive income (loss), net of tax	-13,818	-4,410
Other comprehensive income (loss) before reclassifications	-105,333	-9,408
Amounts reclassified from accumulated other comprehensive income (loss)	0	0
Net current-period other comprehensive income (loss)	-105,333	-9,408
Ending balance, accumulated other comprehensive income (loss), net of tax	($119,151)	($13,818)

Shareholders_equity_accumulate

Shareholders' equity - accumulated other comprehensive income (loss) into income expense (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold									$897,404		$857,326		$802,784
Total before tax									220,110		175,730		-165,369
Taxes on income (loss) from continuing operations									28,650		23,547		16,413
Income (loss) from continuing operations	52,133	55,228	48,830	35,269	35,302	45,779	43,401	27,701	191,460		152,183		-181,782
Reclassification out of Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total reclassifications, net of tax									2,235		5,686
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax									-705		884
Taxes on income (loss) from continuing operations									111		46
Income (loss) from continuing operations									-594		930
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Commodity Contract
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold									-705		884
Reclassification out of Accumulated Other Comprehensive Income | Pension and Other Postretirement Benefits Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax									4,364		7,195
Taxes on income (loss) from continuing operations									-1,535		-2,439
Income (loss) from continuing operations									2,829		4,756
Actuarial losses									4,385	[1]	7,211	[1]
Prior-service costs									-21	[1]	-21	[1]
Transition obligation									$0	[1]	$5	[1]
[1]	These accumulated other comprehensive income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 14 to the consolidated financial statements for additional information).

Stock_compensation_plans_Addit

Stock compensation plans - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of common stock authorized to be issued under plan	5,300,000
Number of options granted	343,580
Unrecognized compensation expense	$17,600,000
Shares available for future grants	4,903,018
Stock-based compensation	12,227,000	11,871,000	8,623,000
Tax benefit from compensation expense	3,300,000	3,800,000	2,700,000
Stock option granted, weighted average grant date fair value	$18.01	$14.30	$11.78
Stock option granted, weighted average grant date fair value	15,400,000	4,100,000	2,700,000
Stock option expenses including selling general and administrative expenses	4,600,000
Non-vested restricted stock units issued	116,258	148,191	178,690
Non vested restricted stock expense including selling general and administrative expense	7,600,000
Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation expense	5,400,000
Period for recognition	1 year 9 months 29 days
Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of options granted	343,580
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant of restricted stock awards	116,258
Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation expense	$10,400,000
Period for recognition	1 year 9 months 11 days
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant of restricted stock awards	116,258
Weighted average grant date fair value	$97.87	$75.60	$56.95
2014 Plan | Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Award Shares	1
2014 Plan | Stock Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Award Shares	1.8
Prior Plans Before December 31, 2013 | Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Award Shares	1
Prior Plans Before December 31, 2013 | Stock Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Award Shares	1.8
Prior Plans After January 1, 2014 | Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Award Shares	1
Prior Plans After January 1, 2014 | Stock Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Award Shares	1.8

Stock_compensation_plans_weigh

Stock compensation plans - weighted-average assumptions used to estimate fair value of options granted (Detail) (Stock Options)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Weighted Average Fair Values [Line Items]
Risk-free interest rate	1.45%	0.75%	0.81%
Expected life of option	4 years 10 months 21 days	4 years 10 months 13 days	4 years 10 months 6 days
Expected dividend yield	1.34%	1.73%	2.28%
Expected volatility	21.44%	24.65%	28.46%

Stock_compensation_plans_weigh1

Stock compensation plans - weighted-average assumptions used to estimate fair value of non-vested shares granted (Detail) (Stock Options)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Weighted Average Fair Values [Line Items]
Risk-free interest rate	0.65%	0.36%	0.37%
Expected dividend yield	1.34%	1.71%	2.24%

Stock_compensation_plans_summa

Stock compensation plans- summary of stock option activity (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options, Outstanding, beginning of year	1,279,480
Number of Options, Granted	343,580
Number of Options, Exercised	-362,719
Number of Options, Forfeited or Expired	-26,669
Number of Options, Outstanding, ending of year	1,233,672
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted Average Exercise Price, Outstanding, beginning of year	$65.05
Weighted Average Exercise Price, Granted	$101.45
Weighted Average Exercise Price, Exercised	$60.86
Weighted Average Exercise Price, Forfeited or Expired	$87.37
Weighted Average Exercise Price, Outstanding, beginning of year	$75.93
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Number of Options, Exercisable, end of year	647,425
Weighted Average Exercise Price, Exercisable, end of year	$64.82
Weighted Average Remaining Contractual Life in Years, Exercisable, end of year	6 years 1 month 17 days
Aggregate Intrinsic Value, Exercisable, end of year	$32,373
Weighted Average Remaining Contractual Life in Years, Outstanding, end of year	7 years 3 months 18 days
Aggregate Intrinsic Value, Outstanding, end of year	$47,974

Stock_compensation_plans_summa1

Stock compensation plans - summary of non vested restricted stock unit activity (Detail) (Restricted Stock Units, USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Non-Vested Shares, Outstanding, beginning of the year	353,357
Number of Non-Vested Shares, Granted	116,258
Number of Non-Vested Shares, Vested	-128,101
Number of Non-Vested Shares, Forfeited	-27,811
Number of Non-Vested Shares, Outstanding, end of the year	313,703	353,357
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value, Outstanding, beginning of the year	$62.49
Weighted Average Grant Date Fair Value, Granted	$97.87	$75.60	$56.95
Weighted Average Grant Date Fair Value, Vested	$57.57
Weighted Average Grant Date Fair Value, Forfeited	$71.63
Weighted Average Grant Date Fair Value, Outstanding, end of the year	$76.80	$62.49
Weighted Average Remaining Contractual Life In Years, Outstanding, end of the year	1 year 2 months 12 days
Aggregate Intrinsic Value, Outstanding, end of the year	$36,019

Income_taxes_Additional_Inform

Income taxes - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Contingency [Line Items]
Cumulative unremitted earnings, non-permanently reinvested	$545,500,000
Cumulative unremitted earnings	966,200,000
Effective income tax rate, total	13.02%	13.40%	-9.93%
Realized net benefit as result of reducing our reserves with respect to uncertain tax positions	1,800,000	7,100,000	8,000,000
Tax effect, carry forwards	112,800,000
Percentage of change in ownership	50.00%
Deferred tax assets, valuation allowance	99,141,000	86,510,000
Unrecognized tax benefits that would impact effective tax rate	21,600,000
Unrecognized tax benefits, interest (benefit) expense	1,000,000	1,300,000	800,000
Unrecognized tax benefits, penalties	-800,000	-800,000	200,000
Unrecognized tax benefits, interest (benefit) expense accrued	6,200,000	5,700,000
Unrecognized tax benefits, penalties accrued	5,000,000	6,000,000
Unrecognized tax benefits change within next twelve months due to potential for resolution of foreign and U.S. examinations	-2,230,000	258,000	169,000
Minimum
Income Tax Contingency [Line Items]
Unrecognized tax benefits change within next twelve months due to potential for resolution of foreign and U.S. examinations	0
Maximum
Income Tax Contingency [Line Items]
Unrecognized tax benefits change within next twelve months due to potential for resolution of foreign and U.S. examinations	2,600,000
No Expiration Date
Income Tax Contingency [Line Items]
Tax effect, carry forwards	12,600,000
After 2013 but before the end of 2018
Income Tax Contingency [Line Items]
Tax effect, carry forwards	300,000
After 2018
Income Tax Contingency [Line Items]
Tax effect, carry forwards	$99,900,000
Excess Tax Deductions
Income Tax Contingency [Line Items]
Effective income tax rate, total	13.00%	13.40%

Income_taxes_components_of_pro

Income taxes - components of provision for income taxes from continuing operations (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Federal, Current	$12,348	($2,996)	$21,046
State, Current	1,912	1,736	3,623
Foreign, Current	30,748	36,422	30,389
Federal, Deferred	-6,593	-9,565	-34,629
State, Deferred	3,435	-1,825	-720
Foreign, Deferred	-13,200	-225	-3,296
Provision for income taxes from continuing operations	$28,650	$23,547	$16,413

Income_taxes_summary_of_US_and

Income taxes - summary of U.S. and non-U.S. components of income from continuing operations before taxes (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
United States	($23,875)	($3,323)	($315,707)
Other	243,985	179,053	150,338
Income (loss) from continuing operations before taxes	$220,110	$175,730	($165,369)

Income_taxes_reconciliations_b

Income taxes - reconciliations between statutory federal income tax rate and effective income tax rate (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Federal statutory rate	35.00%	35.00%	35.00%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent	0.00%	0.00%	-60.84%
Tax effect of International items	-22.54%	-14.83%	11.28%
State taxes, net of federal benefit	2.10%	-0.32%	-0.90%
Uncertain tax contingencies	-0.83%	-4.06%	4.85%
Contingent consideration reversals	-1.18%	-2.04%	0.00%
Other, net	0.47%	-0.35%	0.68%
Effective income tax rate, total	13.02%	13.40%	-9.93%

Income_taxes_deferred_tax_asse

Income taxes - deferred tax assets and liabilities (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred tax assets:
Tax loss and credit carryforwards	$112,796	$104,043
Pension	63,669	39,310
Reserves and accruals	42,296	38,684
Other	28,416	27,886
Less: valuation allowances	-99,141	-86,510
Total deferred tax assets	148,036	123,413
Deferred tax liabilities:
Property, plant and equipment	31,143	26,550
Intangibles b stock acquisitions	384,734	400,297
Unremitted foreign earnings	116,595	147,326
Other	10,756	12,030
Total deferred tax liabilities	543,228	586,203
Net deferred tax liability	($395,192)	($462,790)

Income_taxes_uncertain_tax_pos

Income taxes - uncertain tax positions for liabilities associated with unrecognized tax benefits (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance	$55,771	$62,108	$75,026
Increase in unrecognized tax benefits related to prior years	0	0	1,110
Decrease in unrecognized tax benefits related to prior years	0	0	-6,134
Unrecognized tax benefits related to the current year	910	1,838	4,256
Reductions in unrecognized tax benefits due to settlements	-132	0	-8,816
Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations	-3,235	-8,433	-3,503
Increase (decrease) in unrecognized tax benefits due to foreign currency translation	-2,230	258	169
Ending balance	$51,084	$55,771	$62,108

Income_taxes_examination_by_ma

Income taxes - examination by major tax jurisdictions (Detail)	12 Months Ended
	Dec. 31, 2014
United States | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2010
United States | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Canada | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2005
Canada | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
China | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2009
China | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Czech Republic | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2011
Czech Republic | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
France | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2012
France | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Germany | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2007
Germany | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
India | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2008
India | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Ireland | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2010
Ireland | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Italy | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2010
Italy | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Malaysia | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2010
Malaysia | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014
Singapore | Beginning
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2010
Singapore | Ending
Income Tax Examination [Line Items]
Taxable years remain subject to examination	2014

Pension_and_other_postretireme2

Pension and other postretirement benefits - Additional Information (Detail) (USD $)	12 Months Ended			2 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Feb. 20, 2015
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Increase in projected benefit obligation	9.00%
Increase trend rate by 1%, increase the benefit expenses	$4.40
Increase trend rate by 1%, increase the benefit obligation	0.2
Decrease trend rate by 1%, decrease the benefit expenses	3.8
Decrease trend rate by 1%, decrease the benefit obligation	0.2
Defined benefit plans, annual average Medicare part D subsidy	0.2
Defined contribution plans, costs	11.5	12.1	10.1
Equity Securities
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Target allocation percentage of securities	45.00%
Fixed Income Securities
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Target allocation percentage of securities	35.00%
Other Securities
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Target allocation percentage of securities	20.00%
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	4.24%
Rate of return	8.50%
United States Postretirement Benefit Plans of US Entity, Defined Benefit
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	3.97%
Pension
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	4.10%	5.00%
Rate of return	8.30%	8.30%	8.30%
Accumulated benefit obligation	447.4	367.3
Expected employer contribution for year 2011	2.9
Postretirement Health Care Plans
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	4.00%	4.70%
Rate of return	0.00%	0.00%	0.00%
Expected employer contribution for year 2011	$3.30
Subsequent Event | United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Rate of return				8.25%

Pension_and_other_postretireme3

Pension and other postretirement benefits - net benefit cost of pension and postretirement benefit plans (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pension
Defined Benefit Plan Disclosure [Line Items]
Service cost	$1,794	$1,819	$2,331
Interest cost	18,000	16,842	16,561
Expected return on plan assets	-25,006	-23,122	-20,245
Net amortization and deferral	4,371	5,847	6,474
Curtailment gain	0	0	-197
Settlement loss (gain)	0	0	106
Net benefit cost	-841	1,386	5,030
Other Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	424	663	704
Interest cost	2,169	2,707	2,122
Expected return on plan assets	0	0	0
Net amortization and deferral	-7	1,348	761
Curtailment gain	0	0	0
Settlement loss (gain)	0	0	0
Net benefit cost	$2,586	$4,718	$3,587

Pension_and_other_postretireme4

Pension and other postretirement benefits - weighted average assumptions used in determining net periodic benefit cost (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pension
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.00%	4.30%	4.30%
Rate of return	8.30%	8.30%	8.30%
Initial healthcare trend rate	0.00%	0.00%	0.00%
Ultimate healthcare trend rate	0.00%	0.00%	0.00%
Other Benefits
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.70%	3.80%	4.00%
Rate of return	0.00%	0.00%	0.00%
Initial healthcare trend rate	7.50%	8.20%	8.50%
Ultimate healthcare trend rate	5.00%	5.00%	5.00%

Pension_and_other_postretireme5

Pension and other postretirement benefits - (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, end of year	$328,830	[1]	$305,481	[1]
Pension
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning of year	367,731		397,184
Service cost	1,794		1,819		2,331
Interest cost	18,000		16,842		16,561
Actuarial loss (gain)	82,922		-30,755
Currency translation, benefit obligation	-2,973		861
Benefits paid	-17,988		-17,004
Medicare Part D reimbursement	0		0
Administrative costs	-1,522		-1,216
Projected benefit obligation, end of year	447,964		367,731		397,184
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning of year	305,481		276,863
Actual return on plan assets	34,332		28,813
Contributions	9,539		17,724
Settlements paid	0		0
Currency translation, fair value of plan assets	-1,012		301
Fair value of plan assets, end of year	328,830		305,481		276,863
Funded status, end of year	-119,134		-62,250
Other Benefits
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning of year	52,448		55,609
Service cost	424		663		704
Interest cost	2,169		2,707		2,122
Actuarial loss (gain)	1,273		-3,833
Currency translation, benefit obligation	0		0
Benefits paid	-3,287		-2,860
Defined Benefit Plan Benefits Paid Plan Assets	0		0
Medicare Part D reimbursement	127		162
Administrative costs	0		0
Projected benefit obligation, end of year	53,154		52,448		55,609
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning of year	0		0
Actual return on plan assets	0		0
Contributions	0		0
Settlements paid	0		0
Currency translation, fair value of plan assets	0		0
Fair value of plan assets, end of year	0		0		0
Funded status, end of year	($53,154)		($52,448)
[1]	Information on asset categories described in notes (b)-(k)B is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.

Pension_and_other_postretireme6

Pension and other postretirement benefits - amounts recognized in consolidated balance sheet (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Defined Benefit Plan Disclosure [Line Items]
Payroll and benefit-related liabilities	($85,442)	($73,090)
Pension and postretirement benefit liabilities	-167,241	-109,498
Pension
Defined Benefit Plan Disclosure [Line Items]
Payroll and benefit-related liabilities	-1,779	-1,819
Pension and postretirement benefit liabilities	-117,355	-60,431
Accumulated other comprehensive loss	213,117	144,866
Amounts recognized in balance sheet	93,983	82,616
Other Benefits
Defined Benefit Plan Disclosure [Line Items]
Payroll and benefit-related liabilities	-3,268	-3,381
Pension and postretirement benefit liabilities	-49,886	-49,067
Accumulated other comprehensive loss	8,353	7,073
Amounts recognized in balance sheet	($44,801)	($45,375)

Pension_and_other_postretireme7

Pension and other postretirement benefits - amounts recognized in accumulated other comprehensive (income) loss (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan, Chance in Amounts Recognized in Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance, accumulated other comprehensive (income) loss, net of tax	$110,855	$132,048
Impact of currency translation, accumulated other comprehensive (income) loss, net of tax	105,410	9,637	-13,071
Ending balance, accumulated other comprehensive (income) loss, net of tax	260,895	110,855	132,048
Pension
Defined Benefit Plan, Chance in Amounts Recognized in Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance, prior service cost (credit)	182	216
Net Amortization and deferral	-34	-34
Actuarial gain (loss) obligation, prior service cost (credit)	0	0
Impact of currency translation, prior service cost (credit)	0	0
Ending balance, prior service cost (credit)	148	182
Beginning balance, net (gain) or loss	144,684	186,700
Net amortization and deferral, net (gain) or loss	-4,337	-5,813
Actuarial changes in benefit obligation, net gain (loss)	73,596	-36,446
Impact of currency translation, net (gain) or loss	-974	243
Ending balance, net (gain) or loss	212,969	144,684
Beginning balance, deferred taxes	-52,480	-67,567
Net amortization and deferral, deferred taxes	1,539	1,947
Actuarial changes in benefit obligation, deferred taxes	-26,131	13,206
Impact of currency translation, deferred taxes	265	-66
Ending balance, deferred taxes	-76,807	-52,480
Beginning balance, accumulated other comprehensive (income) loss, net of tax	92,386	119,349
Net amortization and deferral, accumulated other comprehensive (income) loss, net of tax	-2,832	-3,900
Actuarial changes in benefit obligation, accumulated other comprehensive income (loss), net of tax	47,465	-23,240
Impact of currency translation, accumulated other comprehensive (income) loss, net of tax	-709	177
Ending balance, accumulated other comprehensive (income) loss, net of tax	136,310	92,386
Other Benefits
Defined Benefit Plan, Chance in Amounts Recognized in Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance, prior service cost (credit)	17	-38
Net Amortization and deferral	55	55
Actuarial gain (loss) obligation, prior service cost (credit)	0	0
Ending balance, prior service cost (credit)	72	17
Beginning balance, net (gain) or loss	7,056	12,287
Net amortization and deferral, net (gain) or loss	-48	-1,398
Actuarial changes in benefit obligation, net gain (loss)	1,273	-3,833
Ending balance, net (gain) or loss	8,281	7,056
Beginning balance, deferred taxes	-2,422	-4,346
Net amortization and deferral, deferred taxes	-4	492
Actuarial changes in benefit obligation, deferred taxes	-493	1,432
Ending balance, deferred taxes	-2,919	-2,422
Beginning balance, accumulated other comprehensive (income) loss, net of tax	4,651	7,908
Net amortization and deferral, accumulated other comprehensive (income) loss, net of tax	-3	856
Actuarial changes in benefit obligation, accumulated other comprehensive income (loss), net of tax	780	-2,401
Ending balance, accumulated other comprehensive (income) loss, net of tax	5,434	4,651
Beginning balance, gain (loss) initial obligation	0	5
Net amortization and deferral, initial obligation	0	-5
Actuarial changes in benefit obligation, initial obligation	0	0
Ending balance, gain (loss) initial obligation	$0	$0

Pension_and_other_postretireme8

Pension and other postretirement benefits - weighted average assumptions used in determining benefit obligations (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pension
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	4.10%	5.00%
Rate of compensation increase	3.00%	3.00%
Initial healthcare trend rate	0.00%	0.00%
Ultimate healthcare trend rate	0.00%	0.00%	0.00%
Other Benefits
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	4.00%	4.70%
Rate of compensation increase	0.00%	0.00%
Initial healthcare trend rate	7.30%	7.00%
Ultimate healthcare trend rate	5.00%	5.00%	5.00%

Pension_and_other_postretireme9

Pension and other postretirement benefits - fair values of pension plan assets (Detail) (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	$328,830	[1]	$305,481	[1]
Cash
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	659	[1]	472	[1]
Money Market Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	31	[1]	310	[1]
Equity Securities | Managed Volatility
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	83,068	[1],[2]	77,140	[1],[2]
Equity Securities | U.S. Small/Mid-Cap Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	20,312	[1],[3]	19,760	[1],[3]
Equity Securities | World Equity Exclude United States
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	26,064	[1],[4]	30,183	[1],[4]
Equity Securities | Common Equity Securities - Teleflex Incorporated
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	13,422	[1]	10,972	[1]
Equity Securities | Diversified United Kingdom Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	875	[1]	928	[1]
Equity Securities | Diversified Global Exclude United Kingdom
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	2,884	[1]	2,319	[1]
Equity Securities | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	1,266	[1]	1,270	[1]
Fixed Income Investments | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	8,531	[1],[5]	9,003	[1],[5]
Fixed Income Investments | Long Duration Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	92,553	[1],[6]	76,608	[1],[6]
Fixed Income Investments | U K Corporate Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	2,719	[1]	2,569	[1]
Fixed Income Investments | U K Government Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	5,078	[1]	4,455	[1]
Fixed Income Investments | High Yield Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	11,618	[1],[7]	12,754	[1],[7]
Fixed Income Investments | Corporate, Government And Foreign Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	81	[1]	87	[1]
Fixed Income Investments | Asset Backed - Home Loans
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	782	[1]	847	[1]
Other Investments | Structured Credit
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	31,176	[1],[8]	29,109	[1],[8]
Other Investments | Hedge Fund Of Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	23,171	[1],[9]	22,540	[1],[9]
Other Investments | UK Property Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	1,549	[1],[10]	1,402	[1],[10]
Other Investments | Multi Asset Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	2,986	[1],[11]	2,748	[1],[11]
Other Investments | Other Credit Derivatives
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	5	[1]	5	[1]
Quoted Prices In Active Markets (Level 1)
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	263,535	[1]	242,488	[1]
Quoted Prices In Active Markets (Level 1) | Cash
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	659	[1]	472	[1]
Quoted Prices In Active Markets (Level 1) | Money Market Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	31	[1]	310	[1]
Quoted Prices In Active Markets (Level 1) | Equity Securities | Managed Volatility
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	83,068	[1],[2]	77,140	[1],[2]
Quoted Prices In Active Markets (Level 1) | Equity Securities | U.S. Small/Mid-Cap Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	20,312	[1],[3]	19,760	[1],[3]
Quoted Prices In Active Markets (Level 1) | Equity Securities | World Equity Exclude United States
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	26,064	[1],[4]	30,183	[1],[4]
Quoted Prices In Active Markets (Level 1) | Equity Securities | Common Equity Securities - Teleflex Incorporated
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	13,422	[1]	10,972	[1]
Quoted Prices In Active Markets (Level 1) | Equity Securities | Diversified United Kingdom Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	875	[1]	928	[1]
Quoted Prices In Active Markets (Level 1) | Equity Securities | Diversified Global Exclude United Kingdom
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	2,884	[1]	2,319	[1]
Quoted Prices In Active Markets (Level 1) | Equity Securities | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	1,266	[1]	1,270	[1]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets		[1],[5]	0	[1],[5]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Long Duration Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	92,553	[1],[6]	76,608	[1],[6]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | U K Corporate Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	2,719	[1]	2,569	[1]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | U K Government Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	5,078	[1]	4,455	[1]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | High Yield Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	11,618	[1],[7]	12,754	[1],[7]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Corporate, Government And Foreign Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets		[1]	0	[1]
Quoted Prices In Active Markets (Level 1) | Fixed Income Investments | Asset Backed - Home Loans
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets		[1]	0	[1]
Quoted Prices In Active Markets (Level 1) | Other Investments | Structured Credit
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets		[1],[8]	0	[1],[8]
Quoted Prices In Active Markets (Level 1) | Other Investments | Hedge Fund Of Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets		[1],[9]	0	[1],[9]
Quoted Prices In Active Markets (Level 1) | Other Investments | UK Property Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets		[1],[10]	0	[1],[10]
Quoted Prices In Active Markets (Level 1) | Other Investments | Multi Asset Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	2,986	[1],[11]	2,748	[1],[11]
Quoted Prices In Active Markets (Level 1) | Other Investments | Other Credit Derivatives
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2)
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	10,943	[1]	11,339	[1]
Significant Other Observable Inputs (Level 2) | Cash
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Money Market Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Equity Securities | Managed Volatility
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[2]	0	[1],[2]
Significant Other Observable Inputs (Level 2) | Equity Securities | U.S. Small/Mid-Cap Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[3]	0	[1],[3]
Significant Other Observable Inputs (Level 2) | Equity Securities | World Equity Exclude United States
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[4]	0	[1],[4]
Significant Other Observable Inputs (Level 2) | Equity Securities | Common Equity Securities - Teleflex Incorporated
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Equity Securities | Diversified United Kingdom Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Equity Securities | Diversified Global Exclude United Kingdom
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Equity Securities | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	8,531	[1],[5]	9,003	[1],[5]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Long Duration Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[6]	0	[1],[6]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | U K Corporate Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | U K Government Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | High Yield Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[7]	0	[1],[7]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Corporate, Government And Foreign Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	81	[1]	87	[1]
Significant Other Observable Inputs (Level 2) | Fixed Income Investments | Asset Backed - Home Loans
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	782	[1]	847	[1]
Significant Other Observable Inputs (Level 2) | Other Investments | Structured Credit
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[8]	0	[1],[8]
Significant Other Observable Inputs (Level 2) | Other Investments | Hedge Fund Of Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[9]	0	[1],[9]
Significant Other Observable Inputs (Level 2) | Other Investments | UK Property Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	1,549	[1],[10]	1,402	[1],[10]
Significant Other Observable Inputs (Level 2) | Other Investments | Multi Asset Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[11]	0	[1],[11]
Significant Other Observable Inputs (Level 2) | Other Investments | Other Credit Derivatives
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3)
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	54,352	[1]	51,654	[1]
Significant Unobservable Inputs (Level 3) | Cash
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Money Market Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Equity Securities | Managed Volatility
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[2]	0	[1],[2]
Significant Unobservable Inputs (Level 3) | Equity Securities | U.S. Small/Mid-Cap Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[3]	0	[1],[3]
Significant Unobservable Inputs (Level 3) | Equity Securities | World Equity Exclude United States
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[4]	0	[1],[4]
Significant Unobservable Inputs (Level 3) | Equity Securities | Common Equity Securities - Teleflex Incorporated
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Equity Securities | Diversified United Kingdom Equity
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Equity Securities | Diversified Global Exclude United Kingdom
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Equity Securities | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Emerging Markets Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[5]	0	[1],[5]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Long Duration Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[6]	0	[1],[6]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | U K Corporate Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | U K Government Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | High Yield Bond Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[7]	0	[1],[7]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Corporate, Government And Foreign Bonds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Fixed Income Investments | Asset Backed - Home Loans
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) | Other Investments | Structured Credit
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	31,176	[1],[8]	29,109	[1],[8]
Significant Unobservable Inputs (Level 3) | Other Investments | Hedge Fund Of Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	23,171	[1],[9]	22,540	[1],[9]
Significant Unobservable Inputs (Level 3) | Other Investments | UK Property Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[10]	0	[1],[10]
Significant Unobservable Inputs (Level 3) | Other Investments | Multi Asset Fund
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	0	[1],[11]	0	[1],[11]
Significant Unobservable Inputs (Level 3) | Other Investments | Other Credit Derivatives
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Fair value of plan assets	$5	[1]	$5	[1]
[1]	Information on asset categories described in notes (b)-(k)B is derived from prospectuses and other material provided by the respective funds comprising the respective asset categories.
[2]	This category comprises mutual funds that invest in securities of United States and non-United States companies of all capitalization ranges that exhibit relatively low volatility.
[3]	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of small and mid-sized companies. The fund invests in common stocks or exchange traded funds holding common stock of United States companies with market capitalizations in the range of companies in the Russell 2500 Index.
[4]	This category comprises a mutual fund that invests at least 80% of its net assets in equity securities of foreign companies. These securities may include common stocks, preferred stocks, warrants, exchange traded funds based on an international equity index and derivative instruments whose value is based on an international equity index and derivative instruments whose value is based on an underlying equity security or a basket of equity securities. The fund invests in securities of foreign issuers located in developed and emerging market countries. However, the fund will not invest more than 30% of its assets in the common stocks or other equity securities of issuers located in emerging market countries.
[5]	This category comprises a mutual fund that invests at least 80% of its net assets in fixed income securities of emerging market issuers, primarily in United States dollar-denominated debt of foreign governments, government-related and corporate issuers in emerging market countries and entities organized to restructure the debt of those issuers.
[6]	This category comprises a mutual fund that invests in instruments or derivatives having economic characteristics similar to fixed income securities. The fund invests in investment grade fixed income instruments, including securities issued or guaranteed by the United States Government and its agencies and instrumentalities, corporate bonds, asset-backed securities, exchange traded funds, mortgage-backed securities and collateralized mortgage-backed securities. The fund invests primarily in long duration government and corporate fixed income securities, and uses derivative instruments, including interest rate swap agreements and Treasury futures contracts, for the purpose of managing the overall duration and yield curve exposure of the Fundbs portfolio of fixed income securities.
[7]	This category comprises a mutual fund that invests at least 80% of its net assets in higher-yielding fixed income securities, including corporate bonds and debentures, convertible and preferred securities and zero coupon obligations.
[8]	This category comprises a fund that invests primarily in collateralized debt obligations (bCDOsb) and other structured credit vehicles. The fund investments may include fixed income securities, loan participants, credit-linked notes, medium-term notes, pooled investment vehicles and derivative instruments.
[9]	This category comprises a hedge fund that invests in various other hedge funds.B As of DecemberB 31, 2014 and 2013:b"approximately 33% and 28%, respectively, of the assets of the hedge fund were invested in equity hedge based funds, including equity long/short and equity market neutral strategies;b"approximately 10% and 18%, respectively, of the assets were held in tactical/directional based funds, including global macro, long/short equity, commodity and systematic quantitative strategies;b"approximately 24% and 25%, respectively, of the assets were held in relative value based funds, including convertible and fixed income arbitrage, credit long/short and volatility arbitrage strategies;b"approximately 33% and 23%, respectively, of the assets were held in funds with an event driven strategy; andb"approximately 6% of the assets were held in cash as of December 31, 2013.
[10]	This category comprises a fund that invests primarily in UK freehold and leasehold property. The fund does not invest in higher risk activities such as developments. The fund may invest in indirect vehicles and property derivatives.
[11]	This category comprises a mutual fund that invests primarily in equities, bonds and alternatives.

Recovered_Sheet1

Pension and other postretirement benefits - fair values of pension plan assets footnote (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Maximum percentage of net assets invested in emerging market	30.00%
Equity Hedge Based Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested in funds	33.00%	28.00%
Tactical Directional Based Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested in funds	10.00%	18.00%
Relative Value Based Funds
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested in funds	24.00%	25.00%
Event Driven Strategy
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested in funds	33.00%	23.00%
Foreign Companies
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested in foreign equity securities	80.00%
High Yield Fixed Income
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested	80.00%
Fixed Income Securities
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested	80.00%
Cash
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested in funds		6.00%
U.S. Russell 2500 Index | Small and Mid-Sized Companies | Equity Securities
Schedule Of Pension Plan Assets By Fair Value [Line Items]
Percentage of net assets invested	80.00%

Recovered_Sheet2

Pension and other postretirement benefits - reconciliation of changes in level three pension assets measured at fair value on recurring basis (Detail) (Hedge Fund Of Funds, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Hedge Fund Of Funds
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Balance at beginning of year	$51,654	$48,198
Unrealized gain on assets	2,698	3,456
Balance at end of year	$54,352	$51,654

Recovered_Sheet3

Pension and other postretirement benefits - expected benefit payments (Detail) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Pension
Schedule Of Pension Expected Future Benefit Payments [Line Items]
2015	$17,841
2016	18,449
2017	19,023
2018	19,653
2019	20,472
Years 2020 b 2024	114,185
Other Benefits
Schedule Of Pension Expected Future Benefit Payments [Line Items]
2015	3,268
2016	3,362
2017	3,334
2018	3,367
2019	3,416
Years 2020 b 2024	$18,229

Commitments_and_contingent_lia2

Commitments and contingent liabilities - Additional Information (Detail) (USD $)	12 Months Ended			0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 05, 2014	Aug. 31, 2013
Loss Contingencies [Line Items]
Operating leases, rental expense	$29,400,000	$26,400,000	$24,000,000
Estimated fair value of the costs to construct buildings	51,834,000	55,092,000
Discontinued Operations
Loss Contingencies [Line Items]
Contingency reserve for litigation	2,400,000	1,400,000
Minimum
Loss Contingencies [Line Items]
Time-frame over which the accrued amounts may be paid out, in years	P15Y
Maximum
Loss Contingencies [Line Items]
Time-frame over which the accrued amounts may be paid out, in years	P20Y
Accrued Liabilities
Loss Contingencies [Line Items]
Waste disposed accrued liability	1,300,000	2,500,000
Contingency reserve for litigation	6,000,000	6,800,000
Other Liability
Loss Contingencies [Line Items]
Waste disposed accrued liability	6,500,000	5,800,000
Property, Plant and Equipment | Build To Suit Lease
Loss Contingencies [Line Items]
Estimated fair value of the costs to construct buildings					28,300,000
Parish of Calcasieu | Judicial Ruling | Compensatory Damages
Loss Contingencies [Line Items]
Damages awarded to plaintiff				125,000
Parish of Calcasieu | Judicial Ruling | Punitive Damages
Loss Contingencies [Line Items]
Damages awarded to plaintiff				23,000,000
Parish of Calcasieu | Judicial Ruling | Unfavorable Regulatory Action
Loss Contingencies [Line Items]
Loss Contingency, Range of Possible Loss, Maximum	$10,000,000

Commitments_and_contingent_lia3

Commitments and contingent liabilities - future minimum lease payments under noncancelable operating leases (Detail) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]
2015	$27,706
2016	23,292
2017	18,846
2018	15,474
2019 and thereafter	$32,182

Business_segments_and_other_in2

Business segments and other information - segment result (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
									segment
Revenues From External Customers And Long Lived Assets [Line Items]
Number of reportable segments									6
Revenue	$476,008	$457,173	$468,105	$438,546	$450,539	$413,796	$420,059	$411,877	$1,839,832		$1,696,271		$1,551,009
Segment operating profit									284,862		233,261		-97,375
Depreciation and amortization									127,030		107,935		94,884
Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									365,164	[1]	302,285	[1]	259,497	[1]
Segment Reconciling Items
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									-80,302	[2]	-69,024	[2]	-356,872	[2]
Vascular North America
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									259,227		231,112		222,749
Depreciation and amortization									31,782		28,719		23,063
Vascular North America | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									41,079		23,798		26,048
Anesthesia Respiratory North America
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									222,650		228,485		180,363
Depreciation and amortization									17,109		13,162		7,955
Anesthesia Respiratory North America | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									26,574		21,910		14,048
Surgical North America
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									150,121		146,058		143,875
Depreciation and amortization									6,316		10,549		3,646
Surgical North America | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									49,592		50,334		50,615
EMEA Segment
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									593,065		557,427		510,248
Depreciation and amortization									38,062		29,947		22,975
EMEA Segment | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									114,650		87,902		65,822
Asia Segment
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									237,696		207,207		173,721
Depreciation and amortization									8,515		4,960		3,653
Asia Segment | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									62,152		63,822		52,541
OEM Segment
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									143,966		131,173		140,230
Depreciation and amortization									6,175		4,876		4,083
OEM Segment | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									30,635		27,328		31,664
All Other
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue									233,107		194,809		179,823
Depreciation and amortization									19,071		15,722		29,509
All Other | Operating Segments
Revenues From External Customers And Long Lived Assets [Line Items]
Segment operating profit									$40,482		$27,191		$18,759
[1]	Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for certain manufacturing variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
[2]	Unallocated expenses primarily include manufacturing variances and fixed manufacturing costs, with the exception of certain manufacturing variances allocated to the segments as noted above, as well as net gain on sales of assets, goodwill impairment and restructuring and other impairment charges.

Business_segments_and_other_in3

Business segments and other information - total net revenues and total net property, plant and equipment by geographic region (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Net revenues	$476,008	$457,173	$468,105	$438,546	$450,539	$413,796	$420,059	$411,877	$1,839,832	$1,696,271	$1,551,009
Property, plant and equipment, net	317,435				325,900				317,435	325,900	297,945
United States
Segment Reporting Information [Line Items]
Net revenues									916,619	844,884	789,771
Property, plant and equipment, net	174,893				203,985				174,893	203,985	180,833
Other Americas
Segment Reporting Information [Line Items]
Net revenues									60,736	57,098	53,665
Europe
Segment Reporting Information [Line Items]
Net revenues									664,982	568,559	516,982
Malaysia
Segment Reporting Information [Line Items]
Property, plant and equipment, net	36,427				29,313				36,427	29,313	27,764
Czech Republic
Segment Reporting Information [Line Items]
Property, plant and equipment, net	35,655				41,607				35,655	41,607	45,884
All Other
Segment Reporting Information [Line Items]
Net revenues									197,495	225,730	190,591
Property, plant and equipment, net	$70,460				$50,995				$70,460	$50,995	$43,464

Condensed_consolidating_guaran2

Condensed consolidating guarantor financial information - Additional Information (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jun. 26, 2011
In Thousands, unless otherwise specified
Condensed Financial Statements Captions [Line Items]
Interest rate	3.88%	3.88%	3.88%
Ownership percentage of subsidiaries	100.00%
6.875% Senior Subordinated Notes Due 2019
Condensed Financial Statements Captions [Line Items]
Senior subordinated notes				$250,000
Interest rate				6.88%

Condensed_consolidating_guaran3

Condensed consolidating guarantor financial information - income (loss) and comprehensive income (loss) (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Condensed Consolidating Statement Of Operations [Line Items]
Net revenues	$476,008	$457,173	$468,105	$438,546	$450,539	$413,796	$420,059	$411,877	$1,839,832	$1,696,271	$1,551,009
Cost of goods sold									897,404	857,326	802,784
Gross profit	241,015	236,166	244,088	221,159	224,943	203,992	209,490	200,520	942,428	838,945	748,225
Selling, general and administrative expenses									578,657	502,187	454,489
Research and development expenses									61,040	65,045	56,278
Goodwill impairment									0	0	332,128
Restructuring and other impairment charges									17,869	38,452	3,037
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	69,155	81,935	74,752	59,020	54,064	66,042	63,751	49,404	284,862	233,261	-97,375
Net (gain) loss on sales of businesses and assets									0	0	-332
Income (loss) from continuing operations before interest and taxes											-97,375
Interest expense									65,458	56,905	69,565
Interest income									-706	-624	-1,571
Loss on extinguishments of debt									0	1,250	0
Income (loss) from continuing operations before taxes									220,110	175,730	-165,369
Taxes (benefit) on income (loss) from continuing operations									28,650	23,547	16,413
Equity in net income of consolidated subsidiaries									0	0	0
Income (loss) from continuing operations	52,133	55,228	48,830	35,269	35,302	45,779	43,401	27,701	191,460	152,183	-181,782
Operating loss from discontinued operations									-3,407	-2,205	-9,207
Taxes (benefit) on income (loss) from discontinued operations									-698	-1,770	-1,887
Loss from discontinued operations	-1,188	-271	-1,125	-125	-236	1,029	-766	-462	-2,709	-435	-7,320
Net income (loss)	50,945	54,957	47,705	35,144	35,066	46,808	42,635	27,239	188,751	151,748	-189,102
Less: Income from continuing operations attributable to noncontrolling interest	307	126	453	186	238	234	194	201	1,072	867	955
Net income (loss)	50,638	54,831	47,252	34,958	34,828	46,574	42,441	27,038	187,679	150,881	-190,057
Other comprehensive loss attributable to common shareholders									-150,040	21,193	27,305
Comprehensive income attributable to common shareholders									37,639	172,074	-162,752
Eliminations
Schedule Of Condensed Consolidating Statement Of Operations [Line Items]
Net revenues									-371,171	-268,317	-233,782
Cost of goods sold									-363,594	-268,501	-232,823
Gross profit									-7,577	184	-959
Selling, general and administrative expenses									-384	-307	267
Research and development expenses									0	0	0
Goodwill impairment											0
Restructuring and other impairment charges									0	0	0
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes									-7,193	491
Net (gain) loss on sales of businesses and assets											265,433
Income (loss) from continuing operations before interest and taxes											-266,659
Interest expense									0	0	0
Interest income									0	0	0
Loss on extinguishments of debt										0
Income (loss) from continuing operations before taxes									-7,193	491	-266,659
Taxes (benefit) on income (loss) from continuing operations									108	-754	-519
Equity in net income of consolidated subsidiaries									-542,475	-405,530	65,824
Income (loss) from continuing operations									-549,776	-404,285	-200,316
Operating loss from discontinued operations									0	0	0
Taxes (benefit) on income (loss) from discontinued operations									0	0	0
Loss from discontinued operations									0	0	0
Net income (loss)									-549,776	-404,285	-200,316
Less: Income from continuing operations attributable to noncontrolling interest									0	0	0
Net income (loss)									-549,776	-404,285	-200,316
Other comprehensive loss attributable to common shareholders									257,008	-7,402	-19,382
Comprehensive income attributable to common shareholders									-292,768	-411,687	-219,698
Parent Company
Schedule Of Condensed Consolidating Statement Of Operations [Line Items]
Net revenues									0	0	0
Cost of goods sold									0	0	0
Gross profit									0	0	0
Selling, general and administrative expenses									42,829	39,176	34,657
Research and development expenses									0	0	0
Goodwill impairment											0
Restructuring and other impairment charges									0	935	0
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes									-42,829	-40,111
Net (gain) loss on sales of businesses and assets											-116,193
Income (loss) from continuing operations before interest and taxes											81,536
Interest expense									144,869	134,879	143,653
Interest income									0	-15	-372
Loss on extinguishments of debt										1,250
Income (loss) from continuing operations before taxes									-187,698	-176,225	-61,745
Taxes (benefit) on income (loss) from continuing operations									-68,307	-63,857	-63,806
Equity in net income of consolidated subsidiaries									308,396	263,469	-190,742
Income (loss) from continuing operations									189,005	151,101	-188,681
Operating loss from discontinued operations									-2,196	-1,947	-2,647
Taxes (benefit) on income (loss) from discontinued operations									-870	-1,727	-1,271
Loss from discontinued operations									-1,326	-220	-1,376
Net income (loss)									187,679	150,881	-190,057
Less: Income from continuing operations attributable to noncontrolling interest									0	0	0
Net income (loss)									187,679	150,881	-190,057
Other comprehensive loss attributable to common shareholders									-150,040	21,193	27,305
Comprehensive income attributable to common shareholders									37,639	172,074	-162,752
Guarantor Subsidiaries
Schedule Of Condensed Consolidating Statement Of Operations [Line Items]
Net revenues									1,078,851	1,001,404	950,888
Cost of goods sold									652,742	582,110	552,726
Gross profit									426,109	419,294	398,162
Selling, general and administrative expenses									326,282	284,960	259,476
Research and development expenses									40,546	55,694	48,649
Goodwill impairment											331,779
Restructuring and other impairment charges									10,189	15,288	598
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes									49,092	63,352
Net (gain) loss on sales of businesses and assets											-149,240
Income (loss) from continuing operations before interest and taxes											-93,100
Interest expense									-85,885	-85,058	-81,328
Interest income									-1	-5	-23
Loss on extinguishments of debt										0
Income (loss) from continuing operations before taxes									134,978	148,415	-11,749
Taxes (benefit) on income (loss) from continuing operations									68,690	42,804	45,068
Equity in net income of consolidated subsidiaries									233,827	141,773	124,918
Income (loss) from continuing operations									300,115	247,384	68,101
Operating loss from discontinued operations									0	0	-9,179
Taxes (benefit) on income (loss) from discontinued operations									0	-170	-129
Loss from discontinued operations									0	170	-9,050
Net income (loss)									300,115	247,554	59,051
Less: Income from continuing operations attributable to noncontrolling interest									0	0	0
Net income (loss)									300,115	247,554	59,051
Other comprehensive loss attributable to common shareholders									-130,691	1,960	10,475
Comprehensive income attributable to common shareholders									169,424	249,514	69,526
Non-Guarantor Subsidiaries
Schedule Of Condensed Consolidating Statement Of Operations [Line Items]
Net revenues									1,132,152	963,184	833,903
Cost of goods sold									608,256	543,717	482,881
Gross profit									523,896	419,467	351,022
Selling, general and administrative expenses									209,930	178,358	160,089
Research and development expenses									20,494	9,351	7,629
Goodwill impairment											349
Restructuring and other impairment charges									7,680	22,229	2,439
Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes									285,792	209,529
Net (gain) loss on sales of businesses and assets											-332
Income (loss) from continuing operations before interest and taxes											180,848
Interest expense									6,474	7,084	7,240
Interest income									-705	-604	-1,176
Loss on extinguishments of debt										0
Income (loss) from continuing operations before taxes									280,023	203,049	174,784
Taxes (benefit) on income (loss) from continuing operations									28,159	45,354	35,670
Equity in net income of consolidated subsidiaries									252	288	0
Income (loss) from continuing operations									252,116	157,983	139,114
Operating loss from discontinued operations									-1,211	-258	2,619
Taxes (benefit) on income (loss) from discontinued operations									172	127	-487
Loss from discontinued operations									-1,383	-385	3,106
Net income (loss)									250,733	157,598	142,220
Less: Income from continuing operations attributable to noncontrolling interest									1,072	867	955
Net income (loss)									249,661	156,731	141,265
Other comprehensive loss attributable to common shareholders									-126,317	5,442	8,907
Comprehensive income attributable to common shareholders									$123,344	$162,173	$150,172

Condensed_consolidating_guaran4

Condensed consolidating guarantor financial information - balance sheets (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Current assets
Cash and cash equivalents	$303,236	$431,984	$337,039	$584,088
Accounts receivable, net	273,704	295,290
Accounts receivable from consolidated subsidiaries	0	0
Inventories, net	335,593	333,621
Prepaid expenses and other current assets	35,697	39,810
Prepaid taxes	40,256	36,504
Deferred tax assets	57,301	52,917
Assets held for sale	7,422	10,428
Total current assets	1,053,209	1,200,554
Property, plant and equipment, net	317,435	325,900	297,945
Goodwill	1,323,553	1,354,203	1,238,452
Intangibles assets, net	1,216,720	1,255,597
Investments in affiliates	1,150	1,715
Deferred tax assets	1,178	943
Notes receivable and other amounts due from consolidated subsidiaries	0	0
Other assets	64,010	70,095
Total assets	3,977,255	4,209,007
Current liabilities
Current borrowings	368,401	356,287
Accounts payable	64,100	71,967
Accounts payable to consolidated subsidiaries	0	0
Accrued expenses	72,383	74,868
Current portion of contingent consideration	11,276	4,131
Payroll and benefit-related liabilities	85,442	73,090
Accrued interest	9,169	8,725
Income taxes payable	13,768	23,821
Other current liabilities	10,360	22,231
Total current liabilities	634,899	635,120
Long-term borrowings	700,000	930,000
Deferred tax liabilities	451,541	514,715
Pension and other postretirement benefit liabilities	167,241	109,498
Noncurrent liability for uncertain tax positions	50,884	55,152
Notes payable and other amounts due to consolidated subsidiaries	0	0
Other liabilities	58,991	48,506
Total liabilities	2,063,556	2,292,991
Total common shareholdersb equity	1,911,309	1,913,527
Noncontrolling interest	2,390	2,489
Total equity	1,913,699	1,916,016	1,781,537	1,982,783
Total liabilities and equity	3,977,255	4,209,007
Eliminations
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	3,855	3,472
Accounts receivable from consolidated subsidiaries	-2,613,473	-2,880,648
Inventories, net	-23,286	-15,709
Prepaid expenses and other current assets	0	0
Prepaid taxes	0	0
Deferred tax assets	0	-3
Assets held for sale	0	0
Total current assets	-2,632,904	-2,892,888
Property, plant and equipment, net	0	0
Goodwill	0	0
Intangibles assets, net	0	0
Investments in affiliates	-7,042,537	-6,987,772
Deferred tax assets	-56,601	-39,410
Notes receivable and other amounts due from consolidated subsidiaries	-2,515,853	-1,936,618
Other assets	0	0
Total assets	-12,247,895	-11,856,688
Current liabilities
Current borrowings	0	0
Accounts payable	0	0
Accounts payable to consolidated subsidiaries	-2,612,090	-2,880,648
Accrued expenses	0	0
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	0	0
Accrued interest	0	0
Income taxes payable	0	0
Other current liabilities	0	-4
Total current liabilities	-2,612,090	-2,880,652
Long-term borrowings	0	0
Deferred tax liabilities	-56,600	-39,409
Pension and other postretirement benefit liabilities	0	0
Noncurrent liability for uncertain tax positions	0	0
Notes payable and other amounts due to consolidated subsidiaries	-2,520,610	-1,940,100
Other liabilities	0	0
Total liabilities	-5,189,300	-4,860,161
Total common shareholdersb equity	-7,058,595	-6,996,527
Noncontrolling interest	0	0
Total equity	-7,058,595	-6,996,527
Total liabilities and equity	-12,247,895	-11,856,688
Parent Company
Current assets
Cash and cash equivalents	27,996	42,749	70,860	114,531
Accounts receivable, net	2,346	1,822
Accounts receivable from consolidated subsidiaries	37,378	42,865
Inventories, net	0	0
Prepaid expenses and other current assets	14,301	15,200
Prepaid taxes	23,493	27,487
Deferred tax assets	30,248	20,218
Assets held for sale	2,901	1,669
Total current assets	138,663	152,010
Property, plant and equipment, net	3,489	14,189
Goodwill	0	0
Intangibles assets, net	0	0
Investments in affiliates	5,662,773	5,489,676
Deferred tax assets	52,244	35,877
Notes receivable and other amounts due from consolidated subsidiaries	1,025,859	1,049,344
Other assets	27,999	24,574
Total assets	6,911,027	6,765,670
Current liabilities
Current borrowings	363,701	351,587
Accounts payable	1,449	2,194
Accounts payable to consolidated subsidiaries	2,259,891	2,644,296
Accrued expenses	17,149	15,569
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	20,693	15,976
Accrued interest	9,152	8,720
Income taxes payable	0	0
Other current liabilities	5	9,646
Total current liabilities	2,672,040	3,047,988
Long-term borrowings	700,000	930,000
Deferred tax liabilities	0	0
Pension and other postretirement benefit liabilities	110,830	57,406
Noncurrent liability for uncertain tax positions	11,431	11,389
Notes payable and other amounts due to consolidated subsidiaries	1,483,984	785,476
Other liabilities	21,433	19,884
Total liabilities	4,999,718	4,852,143
Total common shareholdersb equity	1,911,309	1,913,527
Noncontrolling interest	0	0
Total equity	1,911,309	1,913,527
Total liabilities and equity	6,911,027	6,765,670
Guarantor Subsidiaries
Current assets
Cash and cash equivalents	0	14,500	1,989	0
Accounts receivable, net	2,422	10,948
Accounts receivable from consolidated subsidiaries	2,303,284	2,623,314
Inventories, net	204,335	211,165
Prepaid expenses and other current assets	4,786	6,870
Prepaid taxes	0	0
Deferred tax assets	17,387	22,472
Assets held for sale	0	3,503
Total current assets	2,532,214	2,892,772
Property, plant and equipment, net	170,054	188,455
Goodwill	703,663	797,671
Intangibles assets, net	743,222	962,243
Investments in affiliates	1,359,661	1,478,429
Deferred tax assets	0	0
Notes receivable and other amounts due from consolidated subsidiaries	1,489,994	873,105
Other assets	6,801	7,447
Total assets	7,005,609	7,200,122
Current liabilities
Current borrowings	0	0
Accounts payable	32,692	45,802
Accounts payable to consolidated subsidiaries	188,908	147,957
Accrued expenses	21,479	21,120
Current portion of contingent consideration	11,276	4,131
Payroll and benefit-related liabilities	27,228	21,818
Accrued interest	0	0
Income taxes payable	0	0
Other current liabilities	3,065	7,517
Total current liabilities	284,648	248,345
Long-term borrowings	0	0
Deferred tax liabilities	462,274	496,228
Pension and other postretirement benefit liabilities	35,074	33,777
Noncurrent liability for uncertain tax positions	15,569	17,241
Notes payable and other amounts due to consolidated subsidiaries	932,718	957,451
Other liabilities	24,900	16,221
Total liabilities	1,755,183	1,769,263
Total common shareholdersb equity	5,250,426	5,430,859
Noncontrolling interest	0	0
Total equity	5,250,426	5,430,859
Total liabilities and equity	7,005,609	7,200,122
Non-Guarantor Subsidiaries
Current assets
Cash and cash equivalents	275,240	374,735	264,190	469,557
Accounts receivable, net	265,081	279,048
Accounts receivable from consolidated subsidiaries	272,811	214,469
Inventories, net	154,544	138,165
Prepaid expenses and other current assets	16,610	17,740
Prepaid taxes	16,763	9,017
Deferred tax assets	9,666	10,230
Assets held for sale	4,521	5,256
Total current assets	1,015,236	1,048,660
Property, plant and equipment, net	143,892	123,256
Goodwill	619,890	556,532
Intangibles assets, net	473,498	293,354
Investments in affiliates	21,253	21,382
Deferred tax assets	5,535	4,476
Notes receivable and other amounts due from consolidated subsidiaries	0	14,169
Other assets	29,210	38,074
Total assets	2,308,514	2,099,903
Current liabilities
Current borrowings	4,700	4,700
Accounts payable	29,959	23,971
Accounts payable to consolidated subsidiaries	163,291	88,395
Accrued expenses	33,755	38,179
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	37,521	35,296
Accrued interest	17	5
Income taxes payable	13,768	23,821
Other current liabilities	7,290	5,072
Total current liabilities	290,301	219,439
Long-term borrowings	0	0
Deferred tax liabilities	45,867	57,896
Pension and other postretirement benefit liabilities	21,337	18,315
Noncurrent liability for uncertain tax positions	23,884	26,522
Notes payable and other amounts due to consolidated subsidiaries	103,908	197,173
Other liabilities	12,658	12,401
Total liabilities	497,955	531,746
Total common shareholdersb equity	1,808,169	1,565,668
Noncontrolling interest	2,390	2,489
Total equity	1,810,559	1,568,157
Total liabilities and equity	$2,308,514	$2,099,903

Condensed_consolidating_guaran5

Condensed consolidating guarantor financial information - cash flows (Detail) (USD $)	0 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Aug. 26, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Cash Flow Statements Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations		$290,241	$231,299	$194,618
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		-67,571	-63,580	-65,394
Proceeds from sales of businesses and assets	45,200	5,251	0	66,660
Payments for businesses and intangibles acquired, net of cash acquired		-45,777	-309,008	-369,444
Investments in affiliates		-40	-50	-80
Intercompany dividends received		0
Net cash used in investing activities from continuing operations		-108,137	-372,638	-368,258
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings		250,000	680,000	0
Repayment of long-term borrowings		-480,102	-375,000	0
Debt issuance and amendment fees		-4,494	-6,400	0
Decrease in notes payable and current borrowings		0	0	-706
Proceeds from stock compensation plans and related tax impacts		4,245	6,181	8,238
Dividends		-56,258	-55,917	-55,589
Payments to noncontrolling shareholders		-1,094	-736	0
Payments for contingent consideration		0	-16,958	-17,596
Intercompany transactions		0	0	0
Intercompany dividends paid		0	0	0
Net cash (used in) provided by financing activities from continuing operations		-287,703	231,170	-65,653
Net cash used in operating activities		-3,676	-3,327	-7,799
Net cash used in investing activities		0	0	-2,351
Net cash used in discontinued operations		-3,676	-3,327	-10,150
Effect of exchange rate changes on cash and cash equivalents		-19,473	8,441	2,394
Net (decrease) increase in cash and cash equivalents		-128,748	94,945	-247,049
Cash and cash equivalents at the beginning of the year		431,984	337,039	584,088
Cash and cash equivalents at the end of the year		303,236	431,984	337,039
Eliminations
Condensed Cash Flow Statements Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations		-75,340	-147,902	-98,903
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		0	0	0
Proceeds from sales of businesses and assets		0		0
Payments for businesses and intangibles acquired, net of cash acquired		0	0	0
Investments in affiliates		0	0	0
Intercompany dividends received		-229,782
Net cash used in investing activities from continuing operations		-229,782	0	0
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings		0	0
Repayment of long-term borrowings		0	0
Debt issuance and amendment fees		0	0
Decrease in notes payable and current borrowings				0
Proceeds from stock compensation plans and related tax impacts		0	0	0
Dividends		0	0	0
Payments to noncontrolling shareholders		0	0
Payments for contingent consideration			0	0
Intercompany transactions		0	0	0
Intercompany dividends paid		305,122	147,902	98,903
Net cash (used in) provided by financing activities from continuing operations		305,122	147,902	98,903
Net cash used in operating activities		0	0	0
Net cash used in investing activities				0
Net cash used in discontinued operations		0	0	0
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Net (decrease) increase in cash and cash equivalents		0	0	0
Cash and cash equivalents at the beginning of the year		0	0	0
Cash and cash equivalents at the end of the year		0	0	0
Parent Company
Condensed Cash Flow Statements Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations		-80,651	-131,031	-178,017
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		-2,273	-1,553	-7,352
Proceeds from sales of businesses and assets		1,669		4,301
Payments for businesses and intangibles acquired, net of cash acquired		0	0	0
Investments in affiliates		-60	-50	-80
Intercompany dividends received		0
Net cash used in investing activities from continuing operations		-664	-1,603	-3,131
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings		250,000	680,000
Repayment of long-term borrowings		-480,102	-375,000
Debt issuance and amendment fees		-4,494	-6,400
Decrease in notes payable and current borrowings				0
Proceeds from stock compensation plans and related tax impacts		4,245	6,181	8,238
Dividends		-56,258	-55,917	-55,589
Payments to noncontrolling shareholders			0
Payments for contingent consideration			0	0
Intercompany transactions		356,847	-141,614	196,850
Intercompany dividends paid		0	0	0
Net cash (used in) provided by financing activities from continuing operations		70,238	107,250	149,499
Net cash used in operating activities		-3,676	-2,727	-12,022
Net cash used in investing activities				0
Net cash used in discontinued operations		-3,676	-2,727	-12,022
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Net (decrease) increase in cash and cash equivalents		-14,753	-28,111	-43,671
Cash and cash equivalents at the beginning of the year		42,749	70,860	114,531
Cash and cash equivalents at the end of the year		27,996	42,749	70,860
Guarantor Subsidiaries
Condensed Cash Flow Statements Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations		322,687	205,954	310,736
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		-30,586	-47,633	-39,118
Proceeds from sales of businesses and assets		3,421		45,204
Payments for businesses and intangibles acquired, net of cash acquired		-17,241	-250,912	-105,195
Investments in affiliates		20	0	0
Intercompany dividends received		0
Net cash used in investing activities from continuing operations		-44,386	-298,545	-99,109
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings		0	0
Repayment of long-term borrowings		0	0
Debt issuance and amendment fees		0	0
Decrease in notes payable and current borrowings				-421
Proceeds from stock compensation plans and related tax impacts		0	0	0
Dividends		0	0	0
Payments to noncontrolling shareholders		0	0
Payments for contingent consideration			-14,802	-16,289
Intercompany transactions		-292,801	137,304	-177,900
Intercompany dividends paid		0	-17,400	-16,900
Net cash (used in) provided by financing activities from continuing operations		-292,801	105,102	-211,510
Net cash used in operating activities		0	0	4,223
Net cash used in investing activities				-2,351
Net cash used in discontinued operations		0	0	1,872
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Net (decrease) increase in cash and cash equivalents		-14,500	12,511	1,989
Cash and cash equivalents at the beginning of the year		14,500	1,989	0
Cash and cash equivalents at the end of the year		0	14,500	1,989
Non-Guarantor Subsidiaries
Condensed Cash Flow Statements Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations		123,545	304,278	160,802
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		-34,712	-14,394	-18,924
Proceeds from sales of businesses and assets		161		17,155
Payments for businesses and intangibles acquired, net of cash acquired		-28,536	-58,096	-264,249
Investments in affiliates		0	0	0
Intercompany dividends received		229,782
Net cash used in investing activities from continuing operations		166,695	-72,490	-266,018
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from new borrowings		0	0
Repayment of long-term borrowings		0	0
Debt issuance and amendment fees		0	0
Decrease in notes payable and current borrowings				-285
Proceeds from stock compensation plans and related tax impacts		0	0	0
Dividends		0	0	0
Payments to noncontrolling shareholders		-1,094	-736
Payments for contingent consideration			-2,156	-1,307
Intercompany transactions		-64,046	4,310	-18,950
Intercompany dividends paid		-305,122	-130,502	-82,003
Net cash (used in) provided by financing activities from continuing operations		-370,262	-129,084	-102,545
Net cash used in operating activities		0	-600	0
Net cash used in investing activities				0
Net cash used in discontinued operations		0	-600	0
Effect of exchange rate changes on cash and cash equivalents		-19,473	8,441	2,394
Net (decrease) increase in cash and cash equivalents		-99,495	110,545	-205,367
Cash and cash equivalents at the beginning of the year		374,735	264,190	469,557
Cash and cash equivalents at the end of the year		$275,240	$374,735	$264,190

Divestiturerelated_activities_1

Divestiture-related activities - asset held for sale (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	building
Divestiture-Related Activities [Abstract]
Number of buildings	2
Property, plant and equipment	$7,422	$10,428
Total assets held for sale	$7,422	$10,428

Divestiturerelated_activities_2

Divestiture-related activities - schedule of operating results of operations treated as discontinued operations (Detail) (USD $)	0 Months Ended	3 Months Ended								12 Months Ended
	Aug. 26, 2012	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Divestiture-Related Activities [Abstract]
Retained liability income expenses on divested business										$3,400,000		($2,200,000)		($2,700,000)
Proceeds from divestiture of businesses	45,200,000									5,251,000		0		66,660,000
Loss on Disposition of Business	39,000
Net revenues										0		0		16,616,000
Disposal Group, Including Discontinued Operation, Other Expense										3,407,000		2,205,000		18,328,000
Goodwill impairment										0	[1]	0	[1]	9,700,000	[1]
Gain on disposition										0	[2]	0	[2]	2,205,000	[2]
Loss from discontinued operations before income taxes										-3,407,000		-2,205,000		-9,207,000
Taxes (benefit) on income (loss) from discontinued operations										-698,000		-1,770,000		-1,887,000
Loss from discontinued operations		($1,188,000)	($271,000)	($1,125,000)	($125,000)	($236,000)	$1,029,000	($766,000)	($462,000)	($2,709,000)		($435,000)		($7,320,000)
[1]	During 2012, the Company recognized a non-cash goodwill impairment charge of $9.7 million to adjust the carrying value of its former orthopedic business to its estimated fair value.
[2]	The $2.2 million pre-tax gain on disposition during 2012 primarily reflects the gain recognized on the working capital adjustment related to the sale of the Company's former cargo systems and cargo container businesses.

QUARTERLY_DATA_UNAUDITED_Detai

QUARTERLY DATA (UNAUDITED) (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 28, 2014	Jun. 29, 2014	Mar. 30, 2014	Dec. 31, 2013	Sep. 29, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Net revenues	$476,008	$457,173	$468,105	$438,546	$450,539	$413,796	$420,059	$411,877	$1,839,832	$1,696,271	$1,551,009
Gross profit	241,015	236,166	244,088	221,159	224,943	203,992	209,490	200,520	942,428	838,945	748,225
Income from continuing operations before interest and taxes	69,155	81,935	74,752	59,020	54,064	66,042	63,751	49,404	284,862	233,261	-97,375
Income from continuing operations	52,133	55,228	48,830	35,269	35,302	45,779	43,401	27,701	191,460	152,183	-181,782
Loss from discontinued operations	-1,188	-271	-1,125	-125	-236	1,029	-766	-462	-2,709	-435	-7,320
Net income	50,945	54,957	47,705	35,144	35,066	46,808	42,635	27,239	188,751	151,748	-189,102
Less: Income from continuing operations attributable to noncontrolling interest	307	126	453	186	238	234	194	201	1,072	867	955
Net Income (Loss) Attributable to Parent	$50,638	$54,831	$47,252	$34,958	$34,828	$46,574	$42,441	$27,038	$187,679	$150,881	($190,057)
Basic:
Income from continuing operations, basic (in dollars per share)	$1.25	$1.33	$1.17	$0.85	$0.85	$1.11	$1.05	$0.67	$4.60	$3.68	($4.47)
Loss from discontinued operations, basic (in dollars per share)	($0.03)	($0.01)	($0.03)	$0	$0	$0.02	($0.02)	($0.01)	($0.06)	($0.01)	($0.18)
Net income (in dollars per share)	$1.22	$1.32	$1.14	$0.85	$0.85	$1.13	$1.03	$0.66	$4.54	$3.67	($4.65)
Diluted:
Income from continuing operations, diluted (in dollars per share)	$1.10	$1.18	$1.04	$0.77	$0.78	$1.05	$0.99	$0.64	$4.10	$3.46	($4.47)
Loss from discontinued operations, diluted (in dollars per share)	($0.03)	$0	($0.02)	($0.01)	($0.01)	$0.03	($0.01)	($0.01)	($0.06)	($0.01)	($0.18)
Net income (in dollars per share)	$1.07	$1.18	$1.02	$0.76	$0.77	$1.08	$0.98	$0.63	$4.04	$3.45	($4.65)

SCHEDULE_II_VALUTAION_AND_QUAL1

SCHEDULE II - VALUTAION AND QUALIFYING ACCOUNTS ALLOWANCE FOR DOUBTFUL ACCOUNTS (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Movement in Valuation Allowances and Reserves [Roll Forward]
Allowance for Doubtful Accounts, End of Year	$8,800	$10,700
Allowance for Doubtful Accounts
Movement in Valuation Allowances and Reserves [Roll Forward]
Allowance for Doubtful Accounts, Beginning of Year	10,722	7,818	6,452
Valuation Allowances And Reserves Changes Businesses Dispositions Receivables Reserve	0	0	0
Valuation Allowances and Reserves, Charged to Cost and Expense	1,882	4,414	1,730
Valuation Allowances and Reserves, Deductions	-2,738	-1,446	-483
Valuation Allowances and Reserves, Translation and Other	-1,083	-64	119
Allowance for Doubtful Accounts, End of Year	$8,783	$10,722	$7,818

SCHEDULE_II_VALUTAION_AND_QUAL2

SCHEDULE II - VALUTAION AND QUALIFYING ACCOUNTS INVENTORY RESERVE (Detail) (Inventory Valuation Reserve, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Movement in Valuation Allowances and Reserves [Roll Forward]
Inventory Valuation Reserves, Beginning Balance	$32,373	$31,703	$32,919
Valuation Allowances And Reserves Changes Businesses Dispositions Inventory Reserve	0	0	-504
Valuation Allowances and Reserves, Charged to Cost and Expense	13,214	14,226	19,488
Valuation Allowances and Reserves, Deductions	-11,428	-17,777	-18,733
Valuation Allowances and Reserves, Translation and Other	-285	4,221	-1,467
Inventory Valuation Reserves, Ending Balance	33,874	32,373	31,703
Raw Material
Movement in Valuation Allowances and Reserves [Roll Forward]
Inventory Valuation Reserves, Beginning Balance	5,687	9,394	9,095
Valuation Allowances And Reserves Changes Businesses Dispositions Inventory Reserve	0	0	-504
Valuation Allowances and Reserves, Charged to Cost and Expense	1,840	1,931	5,206
Valuation Allowances and Reserves, Deductions	-2,391	-5,774	-4,346
Valuation Allowances and Reserves, Translation and Other	1,755	136	-57
Inventory Valuation Reserves, Ending Balance	6,891	5,687	9,394
Work In Process
Movement in Valuation Allowances and Reserves [Roll Forward]
Inventory Valuation Reserves, Beginning Balance	1,729	1,646	2,742
Valuation Allowances And Reserves Changes Businesses Dispositions Inventory Reserve	0	0	0
Valuation Allowances and Reserves, Charged to Cost and Expense	1,239	855	1,107
Valuation Allowances and Reserves, Deductions	-1,720	-340	-2,204
Valuation Allowances and Reserves, Translation and Other	-739	-432	1
Inventory Valuation Reserves, Ending Balance	509	1,729	1,646
Finished Goods
Movement in Valuation Allowances and Reserves [Roll Forward]
Inventory Valuation Reserves, Beginning Balance	24,957	20,663	21,082
Valuation Allowances And Reserves Changes Businesses Dispositions Inventory Reserve	0	0	0
Valuation Allowances and Reserves, Charged to Cost and Expense	10,135	11,440	13,175
Valuation Allowances and Reserves, Deductions	-7,317	-11,663	-12,183
Valuation Allowances and Reserves, Translation and Other	-1,301	4,517	-1,411
Inventory Valuation Reserves, Ending Balance	$26,474	$24,957	$20,663

SCHEDULE_II_VALUTAION_AND_QUAL3

SCHEDULE II - VALUTAION AND QUALIFYING ACCOUNTS DEFERRED TAX ASSET VALUATION ALLOWANCE (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Movement in Valuation Allowances and Reserves [Roll Forward]
Deferred Tax Assets Valuation Allowance, Ending Balance	$99,141	$86,510
Valuation Allowance of Deferred Tax Assets
Movement in Valuation Allowances and Reserves [Roll Forward]
Deferred Tax Assets Valuation Allowance, Beginning Balance	86,510	69,527	66,305
Valuation Allowances and Reserves, Charged to Cost and Expense	13,331	21,118	6,103
Valuation Allowances and Reserves, Deductions	-3,741	-1,553	-4,888
Valuation Allowances and Reserves, Translation and Other	3,041	-2,582	2,007
Deferred Tax Assets Valuation Allowance, Ending Balance	$99,141	$86,510	$69,527